hpscreg_name,publication_pmid,json_filename,json_filepath,basic_data_json,basic_data_cell_type,basic_data_frozen,basic_data_cell_line_alt_name,generator_json,generator_group,contact_json,contact_last_name,contact_group,contact_e_mail,contact_phone_number,contact_name_initials,contact_first_name,publications_json,publications_year,publications_pmid,publications_first_author,publications_title,publications_last_author,publications_journal,publications_doi,donor_json,donor_disease_description,donor_sex,donor_disease_name,donor_age,genomic_modifications_json,genomic_modifications_cytoband,genomic_modifications_mutation_type,genomic_modifications_genotype,genomic_modifications_description,genomic_modifications_delivery_method,genomic_modifications_loci_name,differentiation_results_json,undifferentiated_characterisation_json,undifferentiated_characterisation_pluri_test_score,undifferentiated_characterisation_pluri_novelty_score,undifferentiated_characterisation_epi_pluri_score,genomic_characterisation_json,genomic_characterisation_karyotype,genomic_characterisation_passage_number,genomic_characterisation_karyotype_method,genomic_characterisation_summary,induced_derivation_json,induced_derivation_derivation_year,induced_derivation_non_int_vector_name,induced_derivation_non_int_vector,induced_derivation_i_source_cell_origin_term,induced_derivation_i_source_cell_type_term,embryonic_derivation_json,ethics_json,ethics_approval_date,ethics_ethics_number,ethics_institutional_HREC,culture_medium_json,culture_medium_o2_concentration,culture_medium_passage_method,culture_medium_co2_concentration,differentiation_results_cell_type,differentiation_results_method_used,differentiation_results_marker_list,differentiation_results_show_potency,differentiation_results_differentiation_profile,embryonic_derivation_embryo_stage,embryonic_derivation_zp_removal_technique,embryonic_derivation_e_preimplant_genetic_diagnosis,embryonic_derivation_trophectoderm_morphology,embryonic_derivation_icm_morphology
MS2,35679759,MS2_m.json,35679759/MS2_m.json,"[{""cell_line_alt_name"": ""MS_001; MS_0002; MS_0003; MS_0006"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MS_001; MS_0002; MS_0003; MS_0006,"[{""group"": ""Menzies Institute for Medical Research, University of Tasmania""}]","Menzies Institute for Medical Research, University of Tasmania","[{""group"": ""Menzies Institute for Medical Research"", ""first_name"": ""Kaylene"", ""last_name"": ""Young"", ""name_initials"": ""K"", ""e_mail"": ""kaylene.young@utas.edu.au"", ""phone_number"": ""None""}]",Young,Menzies Institute for Medical Research,kaylene.young@utas.edu.au,,K,Kaylene,"[{""doi"": ""10.1016/j.scr.2022.102828"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation and characterisation of four multiple sclerosis iPSC lines from a single family"", ""first_author"": ""Alastair J. Fortune"", ""last_author"": ""Kaylene M. Young"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Alastair J. Fortune,Generation and characterisation of four multiple sclerosis iPSC lines from a single family,Kaylene M. Young,Stem Cell Research,10.1016/j.scr.2022.102828,"[{""age"": ""52"", ""sex"": ""None"", ""disease_name"": ""Multiple sclerosis"", ""disease_description"": ""Relapsing and secondary progressive multiple sclerosis""}]",Relapsing and secondary progressive multiple sclerosis,,Multiple sclerosis,52,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""2"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",2,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2021"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Sendai Virus Kit""}]",2021,Sendai Virus Kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""H0016915"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Tasmania Human Research Ethics Committee""}]",,H0016915,University of Tasmania Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
MS3,35679759,MS3_m.json,35679759/MS3_m.json,"[{""cell_line_alt_name"": ""MS_003; MS_006"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MS_003; MS_006,"[{""group"": ""Menzies Institute for Medical Research, University of Tasmania""}]","Menzies Institute for Medical Research, University of Tasmania","[{""group"": ""Menzies Institute for Medical Research"", ""first_name"": ""Kaylene"", ""last_name"": ""Young"", ""name_initials"": ""M"", ""e_mail"": ""kaylene.young@utas.edu.au"", ""phone_number"": ""None""}]",Young,Menzies Institute for Medical Research,kaylene.young@utas.edu.au,,M,Kaylene,"[{""doi"": ""10.1016/j.scr.2022.102828"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation and characterisation of four multiple sclerosis iPSC lines from a single family"", ""first_author"": ""A.J. Fortune"", ""last_author"": ""K.M. Young"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,A.J. Fortune,Generation and characterisation of four multiple sclerosis iPSC lines from a single family,K.M. Young,Stem Cell Research,10.1016/j.scr.2022.102828,"[{""age"": ""52"", ""sex"": ""None"", ""disease_name"": ""Multiple sclerosis"", ""disease_description"": ""Relapsing and secondary progressive multiple sclerosis""}]",Relapsing and secondary progressive multiple sclerosis,,Multiple sclerosis,52,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""2"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",2,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2021"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Sendai virus""}]",2021,Sendai virus,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""H0016915"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Tasmania Human Research Ethics Committee""}]",,H0016915,University of Tasmania Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,,,,,,,,,,
MS1,35679759,MS1_m.json,35679759/MS1_m.json,"[{""cell_line_alt_name"": ""MS_001; MS_0002; MS_0003; MS_0006"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MS_001; MS_0002; MS_0003; MS_0006,"[{""group"": ""Menzies Institute for Medical Research, University of Tasmania""}]","Menzies Institute for Medical Research, University of Tasmania","[{""group"": ""Menzies Institute for Medical Research"", ""first_name"": ""Kaylene"", ""last_name"": ""Young"", ""name_initials"": ""K"", ""e_mail"": ""kaylene.young@utas.edu.au"", ""phone_number"": ""None""}]",Young,Menzies Institute for Medical Research,kaylene.young@utas.edu.au,,K,Kaylene,"[{""doi"": ""10.1016/j.scr.2022.102828"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation and characterisation of four multiple sclerosis iPSC lines from a single family"", ""first_author"": ""A.J. Fortune"", ""last_author"": ""K.M. Young"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,A.J. Fortune,Generation and characterisation of four multiple sclerosis iPSC lines from a single family,K.M. Young,Stem Cell Research,10.1016/j.scr.2022.102828,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""Multiple sclerosis"", ""disease_description"": ""Relapsing remitting and secondary progressive multiple sclerosis""}]",Relapsing remitting and secondary progressive multiple sclerosis,,Multiple sclerosis,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""2"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs.""}]","46,XX",2,GB,Karyotyping occurred at a resolution of 300bphs.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2021"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2021,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""H0016915"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Tasmania Human Research Ethics Committee""}]",,H0016915,University of Tasmania Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""EF""}]",,EF,0.05,,,,,,,,,,
MS6,35679759,MS6_m.json,35679759/MS6_m.json,"[{""cell_line_alt_name"": ""MS_001; MS_0002; MS_0003; MS_0006"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MS_001; MS_0002; MS_0003; MS_0006,"[{""group"": ""Menzies Institute for Medical Research, University of Tasmania""}]","Menzies Institute for Medical Research, University of Tasmania","[{""group"": ""Menzies Institute for Medical Research"", ""first_name"": ""Kaylene"", ""last_name"": ""Young"", ""name_initials"": ""None"", ""e_mail"": ""kaylene.young@utas.edu.au"", ""phone_number"": ""None""}]",Young,Menzies Institute for Medical Research,kaylene.young@utas.edu.au,,,Kaylene,"[{""doi"": ""10.1016/j.scr.2022.102828"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation and characterisation of four multiple sclerosis iPSC lines from a single family"", ""first_author"": ""Alastair J. Fortune"", ""last_author"": ""Kaylene M. Young"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Alastair J. Fortune,Generation and characterisation of four multiple sclerosis iPSC lines from a single family,Kaylene M. Young,Stem Cell Research,10.1016/j.scr.2022.102828,"[{""age"": ""52"", ""sex"": ""None"", ""disease_name"": ""Multiple sclerosis"", ""disease_description"": ""Relapsing and secondary progressive multiple sclerosis""}]",Relapsing and secondary progressive multiple sclerosis,,Multiple sclerosis,52,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""2"", ""karyotype"": ""46,XX; 46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal karyotypes for all iPSC lines.""}]","46,XX; 46,XY",2,GB,Karyotyping confirmed normal karyotypes for all iPSC lines.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2021"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Sendai Virus Kit""}]",2021,Sendai Virus Kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""H0016915"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Tasmania Human Research Ethics Committee""}]",,H0016915,University of Tasmania Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,,,,,,,,,,
HC3,32887382,HC3_m.json,32887382/HC3_m.json,"[{""cell_line_alt_name"": ""RB9-8 (UOW001-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,RB9-8 (UOW001-A),"[{""group"": ""Illawarra Health and Medical Research Institute""}]",Illawarra Health and Medical Research Institute,"[{""group"": ""University of Wollongong"", ""first_name"": ""Lezanne"", ""last_name"": ""Ooi"", ""name_initials"": ""None"", ""e_mail"": ""lezanne@uow.edu.au"", ""phone_number"": ""+61-24-221-5865""}]",Ooi,University of Wollongong,lezanne@uow.edu.au,+61-24-221-5865,,Lezanne,"[{""doi"": ""10.3390/cells9092018"", ""journal"": ""Cells"", ""title"": ""A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer\u2019s Disease and Frontotemporal Dementia Disease Modeling"", ""first_author"": ""Sonia Sanz Mu\u00f1oz"", ""last_author"": ""Lezanne Ooi"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Sonia Sanz Muñoz,A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling,Lezanne Ooi,Cells,10.3390/cells9092018,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,[],,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""3%"", ""passage_method"": ""EF""}]",3%,EF,5%,,,,,,,,,,
SAD1,32887382,SAD1_m.json,32887382/SAD1_m.json,"[{""cell_line_alt_name"": ""RB7-11 (UOWI006-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,RB7-11 (UOWI006-A),"[{""group"": ""Illawarra Health and Medical Research Institute""}]",Illawarra Health and Medical Research Institute,"[{""group"": ""University of Wollongong"", ""first_name"": ""Lezanne"", ""last_name"": ""Ooi"", ""name_initials"": ""None"", ""e_mail"": ""lezanne@uow.edu.au"", ""phone_number"": ""+61-24-221-5865""}]",Ooi,University of Wollongong,lezanne@uow.edu.au,+61-24-221-5865,,Lezanne,"[{""doi"": ""10.3390/cells9092018"", ""journal"": ""Cells"", ""title"": ""A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer\u2019s Disease and Frontotemporal Dementia Disease Modeling"", ""first_author"": ""Sonia Sanz Mu\u00f1oz"", ""last_author"": ""Lezanne Ooi"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Sonia Sanz Muñoz,A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling,Lezanne Ooi,Cells,10.3390/cells9092018,"[{""age"": ""None"", ""sex"": ""F"", ""disease_name"": ""SAD"", ""disease_description"": ""Sporadic Alzheimer\u2019s Disease""}]",Sporadic Alzheimer’s Disease,F,SAD,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""20"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",20,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]","[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""3%"", ""passage_method"": ""EF""}]",3%,EF,5%,,,,False,,,,,,
FAD1,32887382,FAD1_m.json,32887382/FAD1_m.json,"[{""cell_line_alt_name"": ""6842.2 (UOW003-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,6842.2 (UOW003-A),"[{""group"": ""Illawarra Health and Medical Research Institute""}]",Illawarra Health and Medical Research Institute,"[{""group"": ""University of Wollongong"", ""first_name"": ""Lezanne"", ""last_name"": ""Ooi"", ""name_initials"": ""None"", ""e_mail"": ""lezanne@uow.edu.au"", ""phone_number"": ""+61-24-221-5865""}]",Ooi,University of Wollongong,lezanne@uow.edu.au,+61-24-221-5865,,Lezanne,"[{""doi"": ""10.3390/cells9092018"", ""journal"": ""Cells"", ""title"": ""A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer\u2019s Disease and Frontotemporal Dementia Disease Modeling"", ""first_author"": ""Sonia Sanz Mu\u00f1oz"", ""last_author"": ""Lezanne Ooi"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Sonia Sanz Muñoz,A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling,Lezanne Ooi,Cells,10.3390/cells9092018,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""Alzheimer's Disease"", ""disease_description"": ""Familial Alzheimer's Disease""}]",Familial Alzheimer's Disease,,Alzheimer's Disease,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""20"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",20,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2018"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2018,,,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""3%"", ""passage_method"": ""EF""}]",3%,EF,5%,,,,False,,,,,,
SAD2,32887382,SAD2_m.json,32887382/SAD2_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,,"[{""group"": ""Illawarra Health and Medical Research Institute""}]",Illawarra Health and Medical Research Institute,"[{""group"": ""University of Wollongong"", ""first_name"": ""Lezanne"", ""last_name"": ""Ooi"", ""name_initials"": ""None"", ""e_mail"": ""lezanne@uow.edu.au"", ""phone_number"": ""+61-24-221-5865""}]",Ooi,University of Wollongong,lezanne@uow.edu.au,+61-24-221-5865,,Lezanne,"[{""doi"": ""10.3390/cells9092018"", ""journal"": ""Cells"", ""title"": ""A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer\u2019s Disease and Frontotemporal Dementia Disease Modeling"", ""first_author"": ""Sonia Sanz Mu\u00f1oz"", ""last_author"": ""Lezanne Ooi"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Sonia Sanz Muñoz,A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling,Lezanne Ooi,Cells,10.3390/cells9092018,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""Alzheimer's Disease"", ""disease_description"": ""Sporadic Alzheimer's Disease""}]",Sporadic Alzheimer's Disease,,Alzheimer's Disease,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": 20, ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping performed with standard methods.""}]","46,XY",20,GB,Karyotyping performed with standard methods.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""3%"", ""passage_method"": ""EF""}]",3%,EF,5%,,,,,,,,,,
HC5,32887382,HC5_m.json,32887382/HC5_m.json,"[{""cell_line_alt_name"": ""MBE68-1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MBE68-1,"[{""group"": ""Illawarra Health and Medical Research Institute""}]",Illawarra Health and Medical Research Institute,"[{""group"": ""University of Wollongong"", ""first_name"": ""Lezanne"", ""last_name"": ""Ooi"", ""name_initials"": ""None"", ""e_mail"": ""lezanne@uow.edu.au"", ""phone_number"": ""+61-24-221-5865""}]",Ooi,University of Wollongong,lezanne@uow.edu.au,+61-24-221-5865,,Lezanne,"[{""doi"": ""10.3390/cells9092018"", ""journal"": ""Cells"", ""title"": ""A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer\u2019s Disease and Frontotemporal Dementia Disease Modeling"", ""first_author"": ""Sonia Sanz Mu\u00f1oz"", ""last_author"": ""Lezanne Ooi"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Sonia Sanz Muñoz,A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling,Lezanne Ooi,Cells,10.3390/cells9092018,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""20"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",20,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""3%"", ""passage_method"": ""EF""}]",3%,EF,5%,,,,,,,,,,
HC1,32887382,HC1_m.json,32887382/HC1_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,,"[{""group"": ""Illawarra Health and Medical Research Institute""}]",Illawarra Health and Medical Research Institute,"[{""group"": ""University of Wollongong"", ""first_name"": ""Lezanne"", ""last_name"": ""Ooi"", ""name_initials"": ""None"", ""e_mail"": ""lezanne@uow.edu.au"", ""phone_number"": ""+61-24-221-5865""}]",Ooi,University of Wollongong,lezanne@uow.edu.au,+61-24-221-5865,,Lezanne,"[{""doi"": ""10.3390/cells9092018"", ""journal"": ""Cells"", ""title"": ""A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer\u2019s Disease and Frontotemporal Dementia Disease Modeling"", ""first_author"": ""Sonia Sanz Mu\u00f1oz"", ""last_author"": ""Lezanne Ooi"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Sonia Sanz Muñoz,A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling,Lezanne Ooi,Cells,10.3390/cells9092018,"[{""age"": ""None"", ""sex"": ""M"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,M,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""True"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""1"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""None""}]",,1,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]","[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""3%"", ""passage_method"": ""None""}]",3%,,5%,,,,True,,,,,,
HC2,32887382,HC2_m.json,32887382/HC2_m.json,"[{""cell_line_alt_name"": ""6846.2 (UOW002-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,6846.2 (UOW002-A),"[{""group"": ""Illawarra Health and Medical Research Institute""}]",Illawarra Health and Medical Research Institute,"[{""group"": ""University of Wollongong"", ""first_name"": ""Lezanne"", ""last_name"": ""Ooi"", ""name_initials"": ""None"", ""e_mail"": ""lezanne@uow.edu.au"", ""phone_number"": ""+61-24-221-5865""}]",Ooi,University of Wollongong,lezanne@uow.edu.au,+61-24-221-5865,,Lezanne,"[{""doi"": ""10.3390/cells9092018"", ""journal"": ""Cells"", ""title"": ""A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer\u2019s Disease and Frontotemporal Dementia Disease Modeling"", ""first_author"": ""Sonia Sanz Mu\u00f1oz"", ""last_author"": ""Lezanne Ooi"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Sonia Sanz Muñoz,A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling,Lezanne Ooi,Cells,10.3390/cells9092018,"[{""age"": ""None"", ""sex"": ""F"", ""disease_name"": ""Alzheimer's Disease"", ""disease_description"": ""Sporadic Alzheimer's disease""}]",Sporadic Alzheimer's disease,F,Alzheimer's Disease,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""20"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",20,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]","[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""3%"", ""passage_method"": ""EF""}]",3%,EF,5%,,,,False,,,,,,
SAD3,32887382,SAD3_m.json,32887382/SAD3_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,,"[{""group"": ""Illawarra Health and Medical Research Institute""}]",Illawarra Health and Medical Research Institute,"[{""group"": ""University of Wollongong"", ""first_name"": ""Lezanne"", ""last_name"": ""Ooi"", ""name_initials"": ""None"", ""e_mail"": ""lezanne@uow.edu.au"", ""phone_number"": ""+61-24-221-5865""}]",Ooi,University of Wollongong,lezanne@uow.edu.au,+61-24-221-5865,,Lezanne,"[{""doi"": ""10.3390/cells9092018"", ""journal"": ""Cells"", ""title"": ""A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer\u2019s Disease and Frontotemporal Dementia Disease Modeling"", ""first_author"": ""Sonia Sanz Mu\u00f1oz"", ""last_author"": ""Lezanne Ooi"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Sonia Sanz Muñoz,A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling,Lezanne Ooi,Cells,10.3390/cells9092018,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""SAD"", ""disease_description"": ""Sporadic Alzheimer\u2019s Disease""}]",Sporadic Alzheimer’s Disease,,SAD,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""None"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",10,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]","[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""3%"", ""passage_method"": ""EF""}]",3%,EF,5%,,,,,,,,,,
HC4,32887382,HC4_m.json,32887382/HC4_m.json,"[{""cell_line_alt_name"": ""MBE60-1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MBE60-1,"[{""group"": ""Illawarra Health and Medical Research Institute""}]",Illawarra Health and Medical Research Institute,"[{""group"": ""University of Wollongong"", ""first_name"": ""Lezanne"", ""last_name"": ""Ooi"", ""name_initials"": ""None"", ""e_mail"": ""lezanne@uow.edu.au"", ""phone_number"": ""+61-24-221-5865""}]",Ooi,University of Wollongong,lezanne@uow.edu.au,+61-24-221-5865,,Lezanne,"[{""doi"": ""10.3390/cells9092018"", ""journal"": ""Cells"", ""title"": ""A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer\u2019s Disease and Frontotemporal Dementia Disease Modeling"", ""first_author"": ""Sonia Sanz Mu\u00f1oz"", ""last_author"": ""Lezanne Ooi"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Sonia Sanz Muñoz,A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling,Lezanne Ooi,Cells,10.3390/cells9092018,"[{""age"": ""None"", ""sex"": ""M"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,M,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,[],,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""3%"", ""passage_method"": ""EF""}]",3%,EF,5%,,,,,,,,,,
LEi018-A,34214897,LEi018-A_m.json,34214897/LEi018-A_m.json,"[{""cell_line_alt_name"": ""LEi018-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEi018-A,"[{""group"": ""Lions Eye Institute""}]",Lions Eye Institute,"[{""group"": ""Fred K. Chen"", ""first_name"": ""Fred"", ""last_name"": ""Chen"", ""name_initials"": ""K"", ""e_mail"": ""fred.chen@lei.org.au"", ""phone_number"": ""None""}]",Chen,Fred K. Chen,fred.chen@lei.org.au,,K,Fred,"[{""doi"": ""10.1016/j.scr.2021.102439"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of an induced pluripotent stem cell line from a patient with Stargardt disease caused by biallelic c.[5461\u201310T>C;5603A>T]; [6077>T>C] mutations in the ABCA4 gene"", ""first_author"": ""Di Huang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2021"", ""pmid"": ""34718495""}]",2021,34718495,Di Huang,Generation of an induced pluripotent stem cell line from a patient with Stargardt disease caused by biallelic c.[5461–10T>C;5603A>T]; [6077>T>C] mutations in the ABCA4 gene,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2021.102439,"[{""age"": ""9"", ""sex"": ""M"", ""disease_name"": ""Stargardt disease"", ""disease_description"": ""Inherited retinal dystrophy""}]",Inherited retinal dystrophy,M,Stargardt disease,9,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""ABCA4 c.[5461\u201310T>C;5603A>T]; [6077>T>C] mutations"", ""genotype"": ""ABCA4 (c.[5461\u201310T>C;5603A>T];[6077>T>C])"", ""loci_name"": ""ABCA4""}]",,,ABCA4 (c.[5461–10T>C;5603A>T];[6077>T>C]),ABCA4 c.[5461–10T>C;5603A>T]; [6077>T>C] mutations,,ABCA4,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping analysis demonstrated absence of reprogramming-induced chromosomal rearrangements.""}]","46,XY",10,GB,Karyotyping analysis demonstrated absence of reprogramming-induced chromosomal rearrangements.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,skin,dermal fibroblasts,[],"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""21/06/2021"", ""institutional_HREC"": ""University of Western Australia Human Research Ethics Committee""}]",21/06/2021,RA/4/1/7916,University of Western Australia Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
PB010,30605840,PB010_m.json,30605840/PB010_m.json,"[{""cell_line_alt_name"": ""PB010 (MCRI0010-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,PB010 (MCRI0010-A),"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Katerina"", ""last_name"": ""Vlahos"", ""name_initials"": ""None"", ""e_mail"": ""katerina.vlahos@mcri.edu"", ""phone_number"": ""None""}]",Vlahos,Murdoch Children's Research Institute,katerina.vlahos@mcri.edu,,,Katerina,"[{""doi"": ""10.1016/j.scr.2018.12.018"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults"", ""first_author"": ""Katerina Vlahos"", ""last_author"": ""Andrew G. Elefanty"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Katerina Vlahos,Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults,Andrew G. Elefanty,Stem Cell Research,10.1016/j.scr.2018.12.018,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Transgene free Sendai virus"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Transgene free Sendai virus,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""EPCAM; CXCR4; KIT"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation of iPS cells into three embryonic germ layers.""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""Normal (46,XY)"", ""karyotype_method"": ""SNP array"", ""summary"": ""Karyotyping confirmed normal karyotype.""}]","Normal (46,XY)",10,SNP array,Karyotyping confirmed normal karyotype.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2016"", ""non_int_vector"": ""Sendai virus"", ""non_int_vector_name"": ""None""}]",2016,,Sendai virus,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""35121A"", ""approval_date"": ""None"", ""institutional_HREC"": ""RCH Human Research Ethics Committee""}]",,35121A,RCH Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,EN,Flow cytometry,EPCAM; CXCR4; KIT,True,Directed differentiation of iPS cells into three embryonic germ layers.,,,,,
PB006,30605840,PB006_m.json,30605840/PB006_m.json,"[{""cell_line_alt_name"": ""PB006 (MCRI001-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,PB006 (MCRI001-A),"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Katerina"", ""last_name"": ""Vlahos"", ""name_initials"": ""None"", ""e_mail"": ""katerina.vlahos@mcri.edu"", ""phone_number"": ""None""}]",Vlahos,Murdoch Children's Research Institute,katerina.vlahos@mcri.edu,,,Katerina,"[{""doi"": ""10.1016/j.scr.2018.12.001"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults"", ""first_author"": ""Katerina Vlahos"", ""last_author"": ""Andrew G. Elefanty"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Katerina Vlahos,Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults,Andrew G. Elefanty,Stem Cell Research,10.1016/j.scr.2018.12.001,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Transgene free Sendai virus"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Transgene free Sendai virus,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""TRA-1-81; SSEA4; CD9"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""EPCAM; CD13"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}, {""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""MAP2"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""Normal, 46,XX"", ""karyotype_method"": ""SNP array"", ""summary"": ""Karyotyping confirmed normal karyotype with no abnormalities.""}]","Normal, 46,XX",10,SNP array,Karyotyping confirmed normal karyotype with no abnormalities.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2016"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Sendai Reprogramming Vector (RT-PCR)""}]",2016,Sendai Reprogramming Vector (RT-PCR),SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""35121A"", ""approval_date"": ""May 2016"", ""institutional_HREC"": ""RCH Human Research Ethics Committee""}]",May 2016,35121A,RCH Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,EN | ME | EC,Flow cytometry | Flow cytometry | Flow cytometry,TRA-1-81; SSEA4; CD9 | EPCAM; CD13 | MAP2,True | True | True,Directed differentiation | Directed differentiation | Directed differentiation,,,,,
PB001,30605840,PB001_m.json,30605840/PB001_m.json,"[{""cell_line_alt_name"": ""PB001 (MCRI001-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,PB001 (MCRI001-A),"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Katerina"", ""last_name"": ""Vlahos"", ""name_initials"": ""None"", ""e_mail"": ""katerina.vlahos@mcri.edu"", ""phone_number"": ""None""}]",Vlahos,Murdoch Children's Research Institute,katerina.vlahos@mcri.edu,,,Katerina,"[{""doi"": ""10.1016/j.scr.2018.12.018"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults"", ""first_author"": ""Katerina Vlahos"", ""last_author"": ""Andrew G. Elefanty"", ""year"": ""2019"", ""pmid"": ""30573464""}]",2019,30573464,Katerina Vlahos,Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults,Andrew G. Elefanty,Stem Cell Research,10.1016/j.scr.2018.12.018,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Transgene free Sendai viruses"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Transgene free Sendai viruses,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""TRA-1-81; SSEA4; CD9"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""EPCAM; CD13"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}, {""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""MAP2"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""Normal (46,XX)"", ""karyotype_method"": ""SNP array"", ""summary"": ""Normal karyotype was confirmed by SNP array analysis.""}]","Normal (46,XX)",10,SNP array,Normal karyotype was confirmed by SNP array analysis.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2016"", ""non_int_vector"": ""Sendai virus"", ""non_int_vector_name"": ""None""}]",2016,,Sendai virus,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""35121A"", ""approval_date"": ""May 2016"", ""institutional_HREC"": ""RCH Human Research Ethics Committee""}]",May 2016,35121A,RCH Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,EN | ME | EC,Flow cytometry | Flow cytometry | Flow cytometry,TRA-1-81; SSEA4; CD9 | EPCAM; CD13 | MAP2,True | True | True,Directed differentiation | Directed differentiation | Directed differentiation,,,,,
PB005,30605840,PB005_m.json,30605840/PB005_m.json,"[{""cell_line_alt_name"": ""PB005 (MCRI001-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,PB005 (MCRI001-A),"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Katerina"", ""last_name"": ""Vlahos"", ""name_initials"": ""None"", ""e_mail"": ""katerina.vlahos@mcri.edu"", ""phone_number"": ""None""}]",Vlahos,Murdoch Children's Research Institute,katerina.vlahos@mcri.edu,,,Katerina,"[{""doi"": ""10.1016/j.scr.2018.12.001"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults"", ""first_author"": ""Katerina Vlahos"", ""last_author"": ""Andrew G. Elefanty"", ""year"": ""2019"", ""pmid"": ""30550856""}]",2019,30550856,Katerina Vlahos,Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults,Andrew G. Elefanty,Stem Cell Research,10.1016/j.scr.2018.12.001,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Transgene free Sendai virus"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Transgene free Sendai virus,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""OCT4; TRA-1-81; SSEA4; CD9"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""EPCAM; CD13; CXCR4"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}, {""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""MAP2"", ""method_used"": ""Immunofluorescence"", ""differentiation_profile"": ""Directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""Normal"", ""karyotype_method"": ""SNP array"", ""summary"": ""Karyotyping confirmed normal karyotype.""}]",Normal,10,SNP array,Karyotyping confirmed normal karyotype.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2016"", ""non_int_vector"": ""Sendai virus"", ""non_int_vector_name"": ""None""}]",2016,,Sendai virus,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""35121A"", ""approval_date"": ""May 2016"", ""institutional_HREC"": ""RCH Human Research Ethics Committee""}]",May 2016,35121A,RCH Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,EN | ME | EC,Flow cytometry | Flow cytometry | Immunofluorescence,OCT4; TRA-1-81; SSEA4; CD9 | EPCAM; CD13; CXCR4 | MAP2,True | True | True,Directed differentiation | Directed differentiation | Directed differentiation,,,,,
PB004,30605840,PB004_m.json,30605840/PB004_m.json,"[{""cell_line_alt_name"": ""PB004 (MCRI001-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,PB004 (MCRI001-A),"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Katerina"", ""last_name"": ""Vlahos"", ""name_initials"": ""None"", ""e_mail"": ""katerina.vlahos@mcri.edu"", ""phone_number"": ""None""}]",Vlahos,Murdoch Children's Research Institute,katerina.vlahos@mcri.edu,,,Katerina,"[{""doi"": ""10.1016/j.scr.2018.12.018"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults"", ""first_author"": ""Katerina Vlahos"", ""last_author"": ""Andrew G. Elefanty"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Katerina Vlahos,Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults,Andrew G. Elefanty,Stem Cell Research,10.1016/j.scr.2018.12.018,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Transgene free Sendai virus"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Transgene free Sendai virus,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""OCT4; TRA-1-81; SSEA4"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""EPCAM; CD13; CKR4"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}, {""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""MAP2"", ""method_used"": ""Flow cytometry"", ""differentiation_profile"": ""Directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""Normal"", ""karyotype_method"": ""SNP array"", ""summary"": ""Normal karyotype confirmed by SNP array analysis.""}]",Normal,10,SNP array,Normal karyotype confirmed by SNP array analysis.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2016"", ""non_int_vector"": ""Sendai virus"", ""non_int_vector_name"": ""None""}]",2016,,Sendai virus,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""35121A"", ""approval_date"": ""May 2016"", ""institutional_HREC"": ""RCH Human Research Ethics Committee""}]",May 2016,35121A,RCH Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME | EC,Flow cytometry | Flow cytometry | Flow cytometry,OCT4; TRA-1-81; SSEA4 | EPCAM; CD13; CKR4 | MAP2,True | True | True,Directed differentiation | Directed differentiation | Directed differentiation,,,,,
FINI003-A,38479087,FINI003-A_m.json,38479087/FINI003-A_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,,"[{""group"": ""The Florey Institute for Neuroscience and Mental Health, University of Melbourne""}]","The Florey Institute for Neuroscience and Mental Health, University of Melbourne","[{""group"": ""The Florey / University of Melbourne"", ""first_name"": ""Snezana"", ""last_name"": ""Maljevic"", ""name_initials"": ""None"", ""e_mail"": ""snezana.maljevic@florey.edu.au"", ""phone_number"": ""None""}]",Maljevic,The Florey / University of Melbourne,snezana.maljevic@florey.edu.au,,,Snezana,"[{""doi"": ""10.1016/j.scr.2024.103367"", ""journal"": ""Stem Cell Research"", ""title"": ""An iPSC line (FINI003-A) from a male with late-onset developmental and epileptic encephalopathy caused by a heterozygous p.E1211K variant in the SCN2A gene encoding the voltage-gated sodium channel NaV1.2"", ""first_author"": ""Dmitry A. Ovchinnikov"", ""last_author"": ""Steve Petrou"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Dmitry A. Ovchinnikov,An iPSC line (FINI003-A) from a male with late-onset developmental and epileptic encephalopathy caused by a heterozygous p.E1211K variant in the SCN2A gene encoding the voltage-gated sodium channel NaV1.2,Steve Petrou,Stem Cell Research,10.1016/j.scr.2024.103367,"[{""age"": ""None"", ""sex"": ""M"", ""disease_name"": ""Developmental and epileptic encephalopathy"", ""disease_description"": ""None""}]",,M,Developmental and epileptic encephalopathy,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous missense variant (E1211K) in SCN2A"", ""genotype"": ""None"", ""loci_name"": ""SCN2A""}]",,,,Heterozygous missense variant (E1211K) in SCN2A,,SCN2A,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""1"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal karyotype with no detectable abnormalities.""}]","46,XY",1,GB,Karyotyping confirmed normal karyotype with no detectable abnormalities.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2023"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2023,,,skin,fibroblasts,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""The University of Melbourne HREC/16/Austin/472""}]",,,The University of Melbourne HREC/16/Austin/472,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
HPIi008-A,38582058,HPIi008-A_m.json,38582058/HPIi008-A_m.json,"[{""cell_line_alt_name"": ""HPIi008-A; HPIi008"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HPIi008-A; HPIi008,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""S"", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,S,Joshua,"[{""doi"": ""10.1016/j.scr.2024.103411"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Rhonda L. Taylor"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Joshua S. Clayton,Generation of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene,Rhonda L. Taylor,Stem Cell Research,10.1016/j.scr.2024.103411,"[{""age"": ""29"", ""sex"": ""F"", ""disease_name"": ""Central core disease"", ""disease_description"": ""A congenital myopathy typically diagnosed by the presence of central nuclei in type 1 myofibers.""}]",A congenital myopathy typically diagnosed by the presence of central nuclei in type 1 myofibers.,F,Central core disease,29,"[{""mutation_type"": ""Heterozygous variant"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""RYR1 c.1443C>T variant (HPIi008-A)"", ""genotype"": ""RYR1 c.1443C>T"", ""loci_name"": ""RYR1""}]",,Heterozygous variant,RYR1 c.1443C>T,RYR1 c.1443C>T variant (HPIi008-A),,RYR1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX2; TRA-1-60"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""Directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""lymphoblastoid cell line (LCL)"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2022"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0""}]",2022,CytoTune-iPS 2.0,SV,blood,lymphoblastoid cell line (LCL),,"[{""ethics_number"": ""RA/4/20/1008"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Western Australia Ethics Committee""}]",21/07/10,RA/4/20/1008,University of Western Australia Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual picking""}]",21%,Manual picking,5%,EN,qPCR,SOX2; TRA-1-60,True,Directed differentiation,,,,,
HPIi009-A,38582058,HPIi009-A_m.json,38582058/HPIi009-A_m.json,"[{""cell_line_alt_name"": ""HPIi009-A; HPI009-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HPIi009-A; HPI009-A,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""S"", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,S,Joshua,"[{""doi"": ""10.1016/j.scr.2024.103411"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Rhonda L. Taylor"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Joshua S. Clayton,Generation of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene,Rhonda L. Taylor,Stem Cell Research,10.1016/j.scr.2024.103411,"[{""age"": ""29"", ""sex"": ""F"", ""disease_name"": ""Central core disease"", ""disease_description"": ""A congenital myopathy typically diagnosed by the presence of central contractures in type I myofibers.""}]",A congenital myopathy typically diagnosed by the presence of central contractures in type I myofibers.,F,Central core disease,29,"[{""mutation_type"": ""Heterozygous"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""RYR1 c.4036C>A variant (HPI009-A)"", ""genotype"": ""RYR1 c.4036C>A"", ""loci_name"": ""RYR1""}]",,Heterozygous,RYR1 c.4036C>A,RYR1 c.4036C>A variant (HPI009-A),,RYR1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""OCT4; SOX2; NANOG"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""Directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""14"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed normal morphology with no spontaneous differentiation.""}]","46,XX",14,GB,Karyotyping showed normal morphology with no spontaneous differentiation.,"[{""i_source_cell_type_term"": ""lymphoblastoid cell line (LCL)"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0""}]",2023,CytoTune-iPS 2.0,SV,blood,lymphoblastoid cell line (LCL),,"[{""ethics_number"": ""RA/4/20/1008"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,RA/4/20/1008,University of Queensland Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual picking""}]",21%,Manual picking,5%,EN,qPCR,OCT4; SOX2; NANOG,True,Directed differentiation,,,,,
SCTi003-A,38582058,SCTi003-A_m.json,38582058/SCTi003-A_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""None"", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,,Joshua,"[{""doi"": ""10.1016/j.scr.2024.103411"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Rhonda L. Taylor"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Joshua S. Clayton,Generation of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene,Rhonda L. Taylor,Stem Cell Research,10.1016/j.scr.2024.103411,"[{""age"": ""29"", ""sex"": ""F"", ""disease_name"": ""Central core disease"", ""disease_description"": ""A congenital myopathy typically diagnosed by the presence of central contractures in type I myofibers.""}]",A congenital myopathy typically diagnosed by the presence of central contractures in type I myofibers.,F,Central core disease,29,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""RYR1 variants are confirmed heterozygous in each line."", ""genotype"": ""RYR1 c.4083C>A (RYR1-9)"", ""loci_name"": ""RYR1""}]",,,RYR1 c.4083C>A (RYR1-9),RYR1 variants are confirmed heterozygous in each line.,,RYR1,"[{""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""TBXT; SOX2; GATA4"", ""method_used"": ""qRT-PCR"", ""differentiation_profile"": ""Directed differentiation""}, {""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""OTX2; PAX6"", ""method_used"": ""qRT-PCR"", ""differentiation_profile"": ""Directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""2"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal karyotype.""}]","46,XX",2,GB,Karyotyping confirmed normal karyotype.,"[{""i_source_cell_type_term"": ""lymphoblastoid cell line (LCL)"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0""}]",2023,CytoTune-iPS 2.0,SV,blood,lymphoblastoid cell line (LCL),,"[{""ethics_number"": ""RA/4/20/1008"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,RA/4/20/1008,University of Queensland Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual passage""}]",21%,Manual passage,5%,ME | EC,qRT-PCR | qRT-PCR,TBXT; SOX2; GATA4 | OTX2; PAX6,True | True,Directed differentiation | Directed differentiation,,,,,
MCRIi026-B,36805468,MCRIi026-B_m.json,36805468/MCRIi026-B_m.json,"[{""cell_line_alt_name"": ""MCRIi026-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,MCRIi026-B,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Paul"", ""last_name"": ""Lockhart"", ""name_initials"": ""J"", ""e_mail"": ""paul.lockhart@mcri.edu.au"", ""phone_number"": ""None""}]",Lockhart,Murdoch Children's Research Institute,paul.lockhart@mcri.edu.au,,J,Paul,"[{""doi"": ""10.1016/j.scr.2023.103047"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1"", ""first_author"": ""Kayli C. Davies"", ""last_author"": ""Paul J. Lockhart"", ""year"": ""2023"", ""pmid"": ""36713047""}]",2023,36713047,Kayli C. Davies,"Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1",Paul J. Lockhart,Stem Cell Research,10.1016/j.scr.2023.103047,"[{""age"": ""26_30"", ""sex"": ""F"", ""disease_name"": ""Cerebellar ataxia, neuropathy and vestibular areflexia syndrome"", ""disease_description"": ""A progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions.""}]",A progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions.,F,"Cerebellar ataxia, neuropathy and vestibular areflexia syndrome",26_30,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous gene correction."", ""genotype"": ""None"", ""loci_name"": ""RFC1""}]",,,,Heterozygous gene correction.,,RFC1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": 1, ""karyotype"": ""C1-2 Het GC: 46,XX"", ""karyotype_method"": ""SNP array"", ""summary"": ""No aneuploidies were detected.""}]","C1-2 Het GC: 46,XX",1,SNP array,No aneuploidies were detected.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2021"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2021,,,skin,fibroblasts,[],"[{""ethics_number"": ""2020-25"", ""approval_date"": ""21/07/20"", ""institutional_HREC"": ""Murdoch Children's Hospital HREC""}]",21/07/20,2020-25,Murdoch Children's Hospital HREC,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
MCRIi025-A,36805468,MCRIi025-A_m.json,36805468/MCRIi025-A_m.json,"[{""cell_line_alt_name"": ""C1-2 Het GC; C3-2 Het GC; C4-6 Het GC"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,C1-2 Het GC; C3-2 Het GC; C4-6 Het GC,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Paul"", ""last_name"": ""Lockhart"", ""name_initials"": ""J"", ""e_mail"": ""paul.lockhart@mcri.edu.au"", ""phone_number"": ""None""}]",Lockhart,Murdoch Children's Research Institute,paul.lockhart@mcri.edu.au,,J,Paul,"[{""doi"": ""10.1016/j.scr.2023.103047"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1"", ""first_author"": ""Kayli C. Davies"", ""last_author"": ""Paul J. Lockhart"", ""year"": ""2023"", ""pmid"": ""3673061""}]",2023,3673061,Kayli C. Davies,"Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1",Paul J. Lockhart,Stem Cell Research,10.1016/j.scr.2023.103047,"[{""age"": ""21_25"", ""sex"": ""F"", ""disease_name"": ""Cerebellar ataxia, neuropathy and vestibular areflexia syndrome"", ""disease_description"": ""Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions""}, {""age"": ""21_25"", ""sex"": ""F"", ""disease_name"": ""Cerebellar ataxia, neuropathy and vestibular areflexia syndrome"", ""disease_description"": ""Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions""}, {""age"": ""56_60"", ""sex"": ""F"", ""disease_name"": ""Cerebellar ataxia, neuropathy and vestibular areflexia syndrome"", ""disease_description"": ""Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions""}]",Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions | Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions | Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions,F | F | F,"Cerebellar ataxia, neuropathy and vestibular areflexia syndrome | Cerebellar ataxia, neuropathy and vestibular areflexia syndrome | Cerebellar ataxia, neuropathy and vestibular areflexia syndrome",21_25 | 21_25 | 56_60,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous gene correction"", ""genotype"": ""None"", ""loci_name"": ""RFC1""}]",,,,Heterozygous gene correction,,RFC1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""3"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""S"", ""summary"": ""No aneuploidies were detected.""}]","46,XX",3,S,No aneuploidies were detected.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2021"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2021,,,skin,fibroblasts,[],"[{""ethics_number"": ""2020-25"", ""approval_date"": ""21/07/20"", ""institutional_HREC"": ""Murdoch Children's Research Institute Ethics Committee""}]",21/07/20,2020-25,Murdoch Children's Research Institute Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Electroporation""}]",21%,Electroporation,5%,,,,,,,,,,
CANVAS3-2 Het GC,36805468,CANVAS3-2 Het GC_m.json,36805468/CANVAS3-2 Het GC_m.json,"[{""cell_line_alt_name"": ""C1-2 Het GC; C3-2 Het GC; C4-6 Het GC"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,C1-2 Het GC; C3-2 Het GC; C4-6 Het GC,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Paul"", ""last_name"": ""Lockhart"", ""name_initials"": ""J"", ""e_mail"": ""paul.lockhart@mcri.edu.au"", ""phone_number"": ""None""}]",Lockhart,Murdoch Children's Research Institute,paul.lockhart@mcri.edu.au,,J,Paul,"[{""doi"": ""10.1016/j.scr.2023.103047"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1"", ""first_author"": ""Kayli C. Davies"", ""last_author"": ""Paul J. Lockhart"", ""year"": ""2023"", ""pmid"": ""3673061""}]",2023,3673061,Kayli C. Davies,"Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1",Paul J. Lockhart,Stem Cell Research,10.1016/j.scr.2023.103047,"[{""age"": ""C1-2: 67 years, Female, European; C3-2: 61 years, Female, European; C4-6: 58 years, Male, Greek"", ""sex"": ""None"", ""disease_name"": ""Cerebellar ataxia, neuropathy, vestibular areflexia syndrome"", ""disease_description"": ""nan""}]",nan,,"Cerebellar ataxia, neuropathy, vestibular areflexia syndrome","C1-2: 67 years, Female, European; C3-2: 61 years, Female, European; C4-6: 58 years, Male, Greek","[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous gene correction"", ""genotype"": ""None"", ""loci_name"": ""RFC1""}]",,,,Heterozygous gene correction,,RFC1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""C1-2 Het GC: 46XX; C3-2 Het GC: 46XX; C4-6 Het GC: 46XY"", ""karyotype_method"": ""SNP array (0.5 MB resolution)"", ""summary"": ""No aneuploidies were detected.""}]",C1-2 Het GC: 46XX; C3-2 Het GC: 46XX; C4-6 Het GC: 46XY,,SNP array (0.5 MB resolution),No aneuploidies were detected.,[],,,,,,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Electroporation""}]",21%,Electroporation,5%,,,,,,,,,,
MCRIi027-A,36805468,MCRIi027-A_m.json,36805468/MCRIi027-A_m.json,"[{""cell_line_alt_name"": ""C1-2 Het GC; C3-2 Het GC; C4-6 Het GC"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,C1-2 Het GC; C3-2 Het GC; C4-6 Het GC,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Paul"", ""last_name"": ""Lockhart"", ""name_initials"": ""J"", ""e_mail"": ""paul.lockhart@mcri.edu.au"", ""phone_number"": ""None""}]",Lockhart,Murdoch Children's Research Institute,paul.lockhart@mcri.edu.au,,J,Paul,"[{""doi"": ""10.1016/j.scr.2023.103047"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1"", ""first_author"": ""Kayli C. Davies"", ""last_author"": ""Paul J. Lockhart"", ""year"": ""2023"", ""pmid"": ""36817601""}]",2023,36817601,Kayli C. Davies,"Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1",Paul J. Lockhart,Stem Cell Research,10.1016/j.scr.2023.103047,"[{""age"": ""21_25"", ""sex"": ""F"", ""disease_name"": ""Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome"", ""disease_description"": ""Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions""}, {""age"": ""21_25"", ""sex"": ""F"", ""disease_name"": ""Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome"", ""disease_description"": ""Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions""}, {""age"": ""56_60"", ""sex"": ""F"", ""disease_name"": ""Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome"", ""disease_description"": ""Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions""}]",Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions | Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions | Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions,F | F | F,"Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome | Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome | Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome",21_25 | 21_25 | 56_60,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR/Cas9"", ""description"": ""Gene editing to correct AAGGG expansions"", ""genotype"": ""None"", ""loci_name"": ""RFC1""}]",,,,Gene editing to correct AAGGG expansions,CRISPR/Cas9,RFC1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""S"", ""summary"": ""No aneuploidies were detected.""}]","46,XX",,S,No aneuploidies were detected.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2021"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2021,,,skin,fibroblasts,[],"[{""ethics_number"": ""2021-02"", ""approval_date"": ""N/A"", ""institutional_HREC"": ""Murdoch Children's Research Institute Ethics Committee""}]",N/A,2021-02,Murdoch Children's Research Institute Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Electroporation""}]",21%,Electroporation,5%,,,,,,,,,,
CANVAS4-6 Het GC,36805468,CANVAS4-6 Het GC_m.json,36805468/CANVAS4-6 Het GC_m.json,"[{""cell_line_alt_name"": ""CANVAS4-6 Het GC"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,CANVAS4-6 Het GC,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Paul"", ""last_name"": ""Lockhart"", ""name_initials"": ""J"", ""e_mail"": ""paul.lockhart@mcri.edu.au"", ""phone_number"": ""None""}]",Lockhart,Murdoch Children's Research Institute,paul.lockhart@mcri.edu.au,,J,Paul,"[{""doi"": ""10.1016/j.scr.2023.103047"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1"", ""first_author"": ""Kayli C. Davies"", ""last_author"": ""Paul J. Lockhart"", ""year"": ""2023"", ""pmid"": ""36817606""}]",2023,36817606,Kayli C. Davies,"Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1",Paul J. Lockhart,Stem Cell Research,10.1016/j.scr.2023.103047,"[{""age"": ""61_65"", ""sex"": ""F"", ""disease_name"": ""Cerebellar ataxia, neuropathy and vestibular areflexia syndrome"", ""disease_description"": ""nan""}]",nan,F,"Cerebellar ataxia, neuropathy and vestibular areflexia syndrome",61_65,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous deletion of AAGGG expansion determined by PCR"", ""genotype"": ""None"", ""loci_name"": ""RFC1""}]",,,,Heterozygous deletion of AAGGG expansion determined by PCR,,RFC1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""C1-2 Het GC: 46XX; C3-2 Het GC: 46XX; C4-6 Het GC: 46XY"", ""karyotype_method"": ""SNP array"", ""summary"": ""No aneuploidies were detected.""}]",C1-2 Het GC: 46XX; C3-2 Het GC: 46XX; C4-6 Het GC: 46XY,,SNP array,No aneuploidies were detected.,[],,,,,,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""Electroporation""}]",,Electroporation,0.05,,,,,,,,,,
CANVAS1-2 Het GC,36805468,CANVAS1-2 Het GC_m.json,36805468/CANVAS1-2 Het GC_m.json,"[{""cell_line_alt_name"": ""CANVAS1-2 Het GC"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,CANVAS1-2 Het GC,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Paul"", ""last_name"": ""Lockhart"", ""name_initials"": ""J"", ""e_mail"": ""paul.lockhart@mcri.edu.au"", ""phone_number"": ""None""}]",Lockhart,Murdoch Children's Research Institute,paul.lockhart@mcri.edu.au,,J,Paul,"[{""doi"": ""10.1016/j.scr.2023.103047"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1"", ""first_author"": ""Kayli C. Davies"", ""last_author"": ""Paul J. Lockhart"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kayli C. Davies,"Generation and heterozygous repair of human iPSC lines from three individuals with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) carrying biallelic AAGGG expansions in RFC1",Paul J. Lockhart,Stem Cell Research,10.1016/j.scr.2023.103047,"[{""age"": ""21_25"", ""sex"": ""F"", ""disease_name"": ""Cerebellar ataxia, neuropathy and vestibular areflexia syndrome"", ""disease_description"": ""Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions""}]",Progressive neurodegenerative disorder predominantly caused by biallelic AAGGG expansions,F,"Cerebellar ataxia, neuropathy and vestibular areflexia syndrome",21_25,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous gene correction"", ""genotype"": ""None"", ""loci_name"": ""RFC1""}]",,,,Heterozygous gene correction,,RFC1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""C1-2 Het GC: 46XX"", ""karyotype_method"": ""SNP array"", ""summary"": ""No aneuploidies were detected.""}]",C1-2 Het GC: 46XX,,SNP array,No aneuploidies were detected.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2021"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2021,,,skin,fibroblasts,[],[],,,,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""Electroporation""}]",21%,Electroporation,0.05,,,,,,,,,,
LEIi012-A,32810830,LEIi012-A_m.json,32810830/LEIi012-A_m.json,"[{""cell_line_alt_name"": ""LEIi012-A; LEIi012-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi012-A; LEIi012-B,"[{""group"": ""University of Western Australia""}]",University of Western Australia,"[{""group"": ""Centre for Ophthalmology and Visual Science"", ""first_name"": ""Samuel"", ""last_name"": ""Mclenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mclenachan@lei.org.au"", ""phone_number"": ""None""}]",Mclenachan,Centre for Ophthalmology and Visual Science,s.mclenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2020.101947"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G > T and c.6079C > T mutations in ABCA4"", ""first_author"": ""Luke Jennings"", ""last_author"": ""Samuel Mclenachan"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Luke Jennings,Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G > T and c.6079C > T mutations in ABCA4,Samuel Mclenachan,Stem Cell Research,10.1016/j.scr.2020.101947,"[{""age"": ""31"", ""sex"": ""M"", ""disease_name"": ""Stargardt Macular Dystrophy"", ""disease_description"": ""Autosomal recessive Stargardt disease (STGD1) is a form of juvenile macular degeneration caused by mutations in the ABCA4 gene.""}]",Autosomal recessive Stargardt disease (STGD1) is a form of juvenile macular degeneration caused by mutations in the ABCA4 gene.,M,Stargardt Macular Dystrophy,31,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Compound heterozygous mutations in ABCA4 (c.768G > T and c.6079C > T)."", ""genotype"": ""ABCA4/c.768G > T; c.6079C > T"", ""loci_name"": ""ABCA4""}]",,,ABCA4/c.768G > T; c.6079C > T,Compound heterozygous mutations in ABCA4 (c.768G > T and c.6079C > T).,,ABCA4,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""16"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""S"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XY",16,S,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2017"", ""non_int_vector"": ""N/A"", ""non_int_vector_name"": ""N/A""}]",2017,N/A,N/A,skin,dermal fibroblasts,[],"[{""ethics_number"": ""None"", ""approval_date"": ""20/03/2017"", ""institutional_HREC"": ""Human Research Ethics Office, University of Western Australia""}]",20/03/2017,,"Human Research Ethics Office, University of Western Australia","[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
LEIi012-B,32810830,LEIi012-B_m.json,32810830/LEIi012-B_m.json,"[{""cell_line_alt_name"": ""LEIi012-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi012-B,"[{""group"": ""University of Western Australia""}]",University of Western Australia,"[{""group"": ""Centre for Ophthalmology and Visual Science"", ""first_name"": ""Samuel"", ""last_name"": ""Mclenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mclenachan@lei.org.au"", ""phone_number"": ""None""}]",Mclenachan,Centre for Ophthalmology and Visual Science,s.mclenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2020.101947"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G > T and c.6079C > T mutations in ABCA4"", ""first_author"": ""Luke Jennings"", ""last_author"": ""Samuel Mclenachan"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Luke Jennings,Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G > T and c.6079C > T mutations in ABCA4,Samuel Mclenachan,Stem Cell Research,10.1016/j.scr.2020.101947,"[{""age"": ""31"", ""sex"": ""M"", ""disease_name"": ""Stargardt Macular Dystrophy"", ""disease_description"": ""Autosomal recessive Stargardt disease (STGD1)""}]",Autosomal recessive Stargardt disease (STGD1),M,Stargardt Macular Dystrophy,31,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Compound heterozygous mutations in ABCA4"", ""genotype"": ""c.768G > T; c.6079C > T"", ""loci_name"": ""ABCA4""}]",,,c.768G > T; c.6079C > T,Compound heterozygous mutations in ABCA4,,ABCA4,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""16"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""S"", ""summary"": ""Karyotyping showed a normal diploid karyotype.""}]","46,XY",16,S,Karyotyping showed a normal diploid karyotype.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2020"", ""non_int_vector"": ""N/A"", ""non_int_vector_name"": ""N/A""}]",2020,N/A,N/A,skin,dermal fibroblasts,[],"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Western Australia Ethics Committee""}]",21/07/10,RA/4/1/7916,University of Western Australia Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
LEIi010-B,30904819,LEIi010-B_m.json,30904819/LEIi010-B_m.json,"[{""cell_line_alt_name"": ""LEIi010-A; LEIi010-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi010-A; LEIi010-B,"[{""group"": ""Centre for Ophthalmology and Visual Sciences, The University of Western Australia""}]","Centre for Ophthalmology and Visual Sciences, The University of Western Australia","[{""group"": ""Lions Eye Institute"", ""first_name"": ""Fred"", ""last_name"": ""Chen"", ""name_initials"": ""K."", ""e_mail"": ""fredchen@lei.org.au"", ""phone_number"": ""None""}, {""group"": ""Centre for Ophthalmology and Visual Sciences, The University of Western Australia"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""smclenachan@lei.org.au"", ""phone_number"": ""None""}]",Chen | McLenachan,"Lions Eye Institute | Centre for Ophthalmology and Visual Sciences, The University of Western Australia",fredchen@lei.org.au | smclenachan@lei.org.au,,K.,Fred | Samuel,"[{""doi"": ""10.1016/j.scr.2019.101420"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene"", ""first_author"": ""Samuel McLenachan"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Samuel McLenachan,Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2019.101420,"[{""age"": ""None"", ""sex"": ""F"", ""disease_name"": ""Usher syndrome"", ""disease_description"": ""Usher syndrome type 2""}]",Usher syndrome type 2,F,Usher syndrome,,"[{""mutation_type"": ""None"", ""cytoband"": ""1q41"", ""delivery_method"": ""None"", ""description"": ""Compound heterozygous mutations in USH2A gene"", ""genotype"": ""c.949C>A; c.1256G>T"", ""loci_name"": ""USH2A""}]",1q41,,c.949C>A; c.1256G>T,Compound heterozygous mutations in USH2A gene,,USH2A,"[{""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""PAX6; DCX; TBXT; AFP; SOX7"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""embryoid body formation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""12"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""S"", ""summary"": ""Karyotyping demonstrated normal karyotype.""}]","46,XX",12,S,Karyotyping demonstrated normal karyotype.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2016"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2016,,,skin,fibroblasts,,"[{""ethics_number"": ""2001-053"", ""approval_date"": ""None"", ""institutional_HREC"": ""Sir Charles Gairdner Hospital Human Research Ethics Committee""}, {""ethics_number"": ""RA/4/17/916"", ""approval_date"": ""None"", ""institutional_HREC"": ""Human Research Ethics Office, University of Western Australia""}]",,2001-053 | RA/4/17/916,"Sir Charles Gairdner Hospital Human Research Ethics Committee | Human Research Ethics Office, University of Western Australia","[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""mechanical scraping""}]",21%,mechanical scraping,5%,EC,RT-qPCR,PAX6; DCX; TBXT; AFP; SOX7,True,embryoid body formation,,,,,
LEIi010-A,30904819,LEIi010-A_m.json,30904819/LEIi010-A_m.json,"[{""cell_line_alt_name"": ""LEIi010-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi010-B,"[{""group"": ""Centre for Ophthalmology and Visual Sciences, The University of Western Australia""}]","Centre for Ophthalmology and Visual Sciences, The University of Western Australia","[{""group"": ""Lions Eye Institute"", ""first_name"": ""Fred"", ""last_name"": ""Chen"", ""name_initials"": ""None"", ""e_mail"": ""fredchen@lei.org.au"", ""phone_number"": ""None""}, {""group"": ""Centre for Ophthalmology and Visual Sciences"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""smclenachan@lei.org.au"", ""phone_number"": ""None""}]",Chen | McLenachan,Lions Eye Institute | Centre for Ophthalmology and Visual Sciences,fredchen@lei.org.au | smclenachan@lei.org.au,,,Fred | Samuel,"[{""doi"": ""10.1016/j.scr.2019.101420"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene"", ""first_author"": ""Samuel McLenachan"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Samuel McLenachan,Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2019.101420,"[{""age"": ""None"", ""sex"": ""F"", ""disease_name"": ""Usher syndrome type 2"", ""disease_description"": ""Usher syndrome is the most common cause of deafness-blindness.""}]",Usher syndrome is the most common cause of deafness-blindness.,F,Usher syndrome type 2,,"[{""mutation_type"": ""None"", ""cytoband"": ""1q41"", ""delivery_method"": ""None"", ""description"": ""Compound heterozygous mutations in USH2A gene."", ""genotype"": ""c.949C>A; c.1256G>T"", ""loci_name"": ""USH2A""}]",1q41,,c.949C>A; c.1256G>T,Compound heterozygous mutations in USH2A gene.,,USH2A,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""12"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""S"", ""summary"": ""Karyotyping performed with normal karyotype.""}]","46,XX",12,S,Karyotyping performed with normal karyotype.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2016"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2016,,,skin,fibroblasts,[],"[{""ethics_number"": ""2001-053"", ""approval_date"": ""None"", ""institutional_HREC"": ""Sir Charles Gairdner Hospital Human Research Ethics Committee""}, {""ethics_number"": ""RA/4/17/916"", ""approval_date"": ""None"", ""institutional_HREC"": ""Human Research Ethics Office, University of Western Australia""}]",,2001-053 | RA/4/17/916,"Sir Charles Gairdner Hospital Human Research Ethics Committee | Human Research Ethics Office, University of Western Australia","[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,,,,,,,,,,
SIVF03,18386991,SIVF03_m.json,18386991/SIVF03_m.json,"[{""cell_line_alt_name"": ""SIVF03"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF03,"[{""group"": ""Sydney IVF""}]",Sydney IVF,"[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,F,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""Female trisomy-16"", ""loci_name"": ""None""}]",,,Female trisomy-16,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""P6, P9, P55"", ""karyotype"": ""Female trisomy-16"", ""karyotype_method"": ""FISH"", ""summary"": ""Karyotyping confirmed the presence of trisomy-16.""}]",Female trisomy-16,"P6, P9, P55",FISH,Karyotyping confirmed the presence of trisomy-16.,[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
SIVF12,18386991,SIVF12_m.json,18386991/SIVF12_m.json,"[{""cell_line_alt_name"": ""SIVF12"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF12,"[{""group"": ""Sydney IVF""}]",Sydney IVF,"[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""8"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping performed, showing normal karyotype.""}]","46,XX",8,GB,"Karyotyping performed, showing normal karyotype.",[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
SIVF05,18386991,SIVF05_m.json,18386991/SIVF05_m.json,"[{""cell_line_alt_name"": ""SIVF05"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF05,"[{""group"": ""Sydney IVF, Research Department, New South Wales, Australia""}]","Sydney IVF, Research Department, New South Wales, Australia","[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""8"", ""karyotype"": ""Normal female [46,XX]"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal karyotype.""}]","Normal female [46,XX]",8,GB,Karyotyping confirmed normal karyotype.,[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
SIVF06,18386991,SIVF06_m.json,18386991/SIVF06_m.json,"[{""cell_line_alt_name"": ""SIVF06"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF06,"[{""group"": ""Sydney IVF""}]",Sydney IVF,"[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""8"", ""karyotype"": ""Normal female [46,XX]"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","Normal female [46,XX]",8,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
SIVF10,18386991,SIVF10_m.json,18386991/SIVF10_m.json,"[{""cell_line_alt_name"": ""SIVF10"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF10,"[{""group"": ""Sydney IVF""}]",Sydney IVF,"[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""8"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs.""}]","46,XX",8,GB,Karyotyping occurred at a resolution of 300bphs.,[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
SIVF09,18386991,SIVF09_m.json,18386991/SIVF09_m.json,"[{""cell_line_alt_name"": ""SIVF09"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF09,"[{""group"": ""Sydney IVF""}]",Sydney IVF,"[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""8"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal male karyotype.""}]","46,XY",8,GB,Karyotyping confirmed normal male karyotype.,[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
SIVF13,18386991,SIVF13_m.json,18386991/SIVF13_m.json,"[{""cell_line_alt_name"": ""SIVF13"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF13,"[{""group"": ""Sydney IVF, Research Department, New South Wales, Australia""}]","Sydney IVF, Research Department, New South Wales, Australia","[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""8"", ""karyotype"": ""Normal male [46,XY]"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotypically normal stem cell line derived from PGD-analyzed embryo.""}]","Normal male [46,XY]",8,GB,Karyotypically normal stem cell line derived from PGD-analyzed embryo.,[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
SIVF08,18386991,SIVF08_m.json,18386991/SIVF08_m.json,"[{""cell_line_alt_name"": ""SIVF08"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF08,"[{""group"": ""Sydney IVF""}]",Sydney IVF,"[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""7"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotypically normal stem cell line derived from PGD-analyzed embryo.""}]","46,XX",7,GB,Karyotypically normal stem cell line derived from PGD-analyzed embryo.,[],,,,,,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
SIVF11,18386991,SIVF11_m.json,18386991/SIVF11_m.json,"[{""cell_line_alt_name"": ""SIVF11"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF11,"[{""group"": ""Sydney IVF""}]",Sydney IVF,"[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""8"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed normal male karyotype.""}]","46,XY",8,GB,Karyotyping showed normal male karyotype.,[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
SIVF04,18386991,SIVF04_m.json,18386991/SIVF04_m.json,"[{""cell_line_alt_name"": ""SIVF04"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF04,"[{""group"": ""Sydney IVF, Research Department, New South Wales, Australia""}]","Sydney IVF, Research Department, New South Wales, Australia","[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""8"", ""karyotype"": ""Normal female [46,XX]"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal karyotype.""}]","Normal female [46,XX]",8,GB,Karyotyping confirmed normal karyotype.,[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
SIVF07,18386991,SIVF07_m.json,18386991/SIVF07_m.json,"[{""cell_line_alt_name"": ""SIVF07"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF07,"[{""group"": ""Sydney IVF""}]",Sydney IVF,"[{""group"": ""Sydney IVF"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""A"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Sydney IVF,,,A,Teija,"[{""doi"": ""10.1089/clo.2007.0062"", ""journal"": ""Cloning and Stem Cells"", ""title"": ""Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos"", ""first_author"": ""Teija Peura"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Teija Peura,Karyotypically Normal and Abnormal Human Embryonic Stem Cell Lines Derived from PGD-Analyzed Embryos,Tomas Stojanov,Cloning and Stem Cells,10.1089/clo.2007.0062,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""8"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",8,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,[],,,,,,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
NF1_047.7,33091851,NF1_047.7_m.json,33091851/NF1_047.7_m.json,"[{""cell_line_alt_name"": ""NF1_047.7"", ""cell_type"": ""iPSC"", ""frozen"": ""True""}]",iPSC,True,NF1_047.7,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""A/Prof Paul Lockhart"", ""first_name"": ""Paul"", ""last_name"": ""Lockhart"", ""name_initials"": ""None"", ""e_mail"": ""paul.lockhart@mcri.edu.au"", ""phone_number"": ""None""}]",Lockhart,A/Prof Paul Lockhart,paul.lockhart@mcri.edu.au,,,Paul,"[{""doi"": ""10.1016/j.scr.2020.102013"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of four iPSC lines from Neurofibromatosis Type 1 patients"", ""first_author"": ""Kiymet Bozaoglu"", ""last_author"": ""Paul J. Lockhart"", ""year"": ""2020"", ""pmid"": ""32918678""}]",2020,32918678,Kiymet Bozaoglu,Generation of four iPSC lines from Neurofibromatosis Type 1 patients,Paul J. Lockhart,Stem Cell Research,10.1016/j.scr.2020.102013,"[{""age"": ""9"", ""sex"": ""M"", ""disease_name"": ""Neurofibromatosis type 1"", ""disease_description"": ""nan""}]",nan,M,Neurofibromatosis type 1,9,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""Normal"", ""karyotype_method"": ""SNP Array"", ""summary"": ""All iPSC lines exhibited a normal karyotype.""}]",Normal,,SNP Array,All iPSC lines exhibited a normal karyotype.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Cytotune-iPS 2.0 Sendai reprogramming kit""}]",2020,Cytotune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""The Human Research Ethics Committee of the Royal Children's Hospital""}]",,,The Human Research Ethics Committee of the Royal Children's Hospital,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,False,,,,,,
NF1_162.1,33091851,NF1_162.1_m.json,33091851/NF1_162.1_m.json,"[{""cell_line_alt_name"": ""NF1_162.1"", ""cell_type"": ""iPSC"", ""frozen"": ""True""}]",iPSC,True,NF1_162.1,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""A/Prof Paul Lockhart"", ""first_name"": ""Paul"", ""last_name"": ""Lockhart"", ""name_initials"": ""None"", ""e_mail"": ""paul.lockhart@mcri.edu.au"", ""phone_number"": ""None""}]",Lockhart,A/Prof Paul Lockhart,paul.lockhart@mcri.edu.au,,,Paul,"[{""doi"": ""10.1016/j.scr.2020.102013"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of four iPSC lines from Neurofibromatosis Type 1 patients"", ""first_author"": ""Kiymet Bozaoglu"", ""last_author"": ""Paul J. Lockhart"", ""year"": ""2020"", ""pmid"": ""32919743""}]",2020,32919743,Kiymet Bozaoglu,Generation of four iPSC lines from Neurofibromatosis Type 1 patients,Paul J. Lockhart,Stem Cell Research,10.1016/j.scr.2020.102013,"[{""age"": ""13"", ""sex"": ""M"", ""disease_name"": ""Neurofibromatosis type 1"", ""disease_description"": ""N/A""}]",N/A,M,Neurofibromatosis type 1,13,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""SOX17; MAP2"", ""method_used"": ""Embryoid body formation (immunofluorescence)"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""N/A"", ""karyotype"": ""Normal"", ""karyotype_method"": ""SNP Array"", ""summary"": ""All iPSC lines exhibited a normal karyotype.""}]",Normal,N/A,SNP Array,All iPSC lines exhibited a normal karyotype.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Cytotune-iPS 2.0 Sendai Reprogramming Kit""}]",2020,Cytotune-iPS 2.0 Sendai Reprogramming Kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""N/A"", ""approval_date"": ""N/A"", ""institutional_HREC"": ""Human Research Ethics Committee of the Royal Children's Hospital""}]",N/A,N/A,Human Research Ethics Committee of the Royal Children's Hospital,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Trypsinization""}]",21%,Trypsinization,5%,EC,Embryoid body formation (immunofluorescence),SOX17; MAP2,True,in vitro directed differentiation,,,,,
NF1_043.7,33091851,NF1_043.7_m.json,33091851/NF1_043.7_m.json,"[{""cell_line_alt_name"": ""NF1_043.7"", ""cell_type"": ""iPSC"", ""frozen"": ""False""}]",iPSC,False,NF1_043.7,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""A/Prof Paul Lockhart"", ""first_name"": ""Paul"", ""last_name"": ""Lockhart"", ""name_initials"": ""None"", ""e_mail"": ""paul.lockhart@mcri.edu.au"", ""phone_number"": ""None""}]",Lockhart,A/Prof Paul Lockhart,paul.lockhart@mcri.edu.au,,,Paul,"[{""doi"": ""10.1016/j.scr.2020.102013"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of four iPSC lines from Neurofibromatosis Type 1 patients"", ""first_author"": ""Kiymet Bozaoglu"", ""last_author"": ""Paul J. Lockhart"", ""year"": ""2020"", ""pmid"": ""32919180""}]",2020,32919180,Kiymet Bozaoglu,Generation of four iPSC lines from Neurofibromatosis Type 1 patients,Paul J. Lockhart,Stem Cell Research,10.1016/j.scr.2020.102013,"[{""age"": ""7"", ""sex"": ""F"", ""disease_name"": ""Neurofibromatosis type 1"", ""disease_description"": ""nan""}]",nan,F,Neurofibromatosis type 1,7,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""Normal"", ""karyotype_method"": ""SNP Array"", ""summary"": ""Karyotyping performed showed a normal karyotype.""}]",Normal,,SNP Array,Karyotyping performed showed a normal karyotype.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""Human Research Ethics Committee of the Royal Children's Hospital""}]",,,Human Research Ethics Committee of the Royal Children's Hospital,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,False,,,,,,
NF1_093.2,33091851,NF1_093.2_m.json,33091851/NF1_093.2_m.json,"[{""cell_line_alt_name"": ""NF1_093.2"", ""cell_type"": ""iPSC"", ""frozen"": ""True""}]",iPSC,True,NF1_093.2,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""A/Prof Paul Lockhart"", ""first_name"": ""Paul"", ""last_name"": ""Lockhart"", ""name_initials"": ""None"", ""e_mail"": ""paul.lockhart@mcri.edu.au"", ""phone_number"": ""None""}]",Lockhart,A/Prof Paul Lockhart,paul.lockhart@mcri.edu.au,,,Paul,"[{""doi"": ""10.1016/j.scr.2020.102013"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of four iPSC lines from Neurofibromatosis Type 1 patients"", ""first_author"": ""Kiymet Bozaoglu"", ""last_author"": ""Paul J. Lockhart"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Kiymet Bozaoglu,Generation of four iPSC lines from Neurofibromatosis Type 1 patients,Paul J. Lockhart,Stem Cell Research,10.1016/j.scr.2020.102013,"[{""age"": ""13"", ""sex"": ""M"", ""disease_name"": ""Neurofibromatosis type 1"", ""disease_description"": ""nan""}]",nan,M,Neurofibromatosis type 1,13,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""Normal"", ""karyotype_method"": ""SNP Array"", ""summary"": ""Karyotyping performed using Illumina Infinium GSA v2.0.""}]",Normal,,SNP Array,Karyotyping performed using Illumina Infinium GSA v2.0.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Cytotune-iPS 2.0 Sendai reprogramming kit""}]",2020,Cytotune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""Human Research Ethics Committee of the Royal Children's Hospital""}]",,,Human Research Ethics Committee of the Royal Children's Hospital,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,False,,,,,,
LEi0101-A,33360097,LEi0101-A_m.json,33360097/LEi0101-A_m.json,"[{""cell_line_alt_name"": ""LEi0101-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEi0101-A,"[{""group"": ""Lions Eye Institute""}]",Lions Eye Institute,"[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""smclenachan@lei.org.au"", ""phone_number"": ""None""}]",McLenachan,Lions Eye Institute,smclenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2020.102129"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene"", ""first_author"": ""Khine Zaw"", ""last_author"": ""Fred K. Chen"", ""year"": ""2021"", ""pmid"": ""N/A""}]",2021,N/A,Khine Zaw,Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2020.102129,"[{""age"": ""15"", ""sex"": ""F"", ""disease_name"": ""Usher syndrome type 2"", ""disease_description"": ""Usher syndrome type 2""}]",Usher syndrome type 2,F,Usher syndrome type 2,15,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Compound heterozygous for c.949C > A and c.1256G > T variants"", ""genotype"": ""USH2A"", ""loci_name"": ""USH2A""}]",,,USH2A,Compound heterozygous for c.949C > A and c.1256G > T variants,,USH2A,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""N/A"", ""summary"": ""Karyotyping confirmed the absence of chromosomal rearrangements.""}]","46,XX",,N/A,Karyotyping confirmed the absence of chromosomal rearrangements.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2018"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2018,,,skin,dermal fibroblasts,[],"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""16/07/2018"", ""institutional_HREC"": ""University of Western Australia Human Research Ethics Committee""}]",16/07/2018,RA/4/1/7916,University of Western Australia Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""TrypLE""}]",21%,TrypLE,5%,,,,,,,,,,
LEi0101-B,33360097,LEi0101-B_m.json,33360097/LEi0101-B_m.json,"[{""cell_line_alt_name"": ""LEi0101-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEi0101-B,"[{""group"": ""Lions Eye Institute""}]",Lions Eye Institute,"[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""smclenachan@lei.org.au"", ""phone_number"": ""None""}]",McLenachan,Lions Eye Institute,smclenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2020.102129"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene"", ""first_author"": ""Khine Zaw"", ""last_author"": ""Samuel McLenachan"", ""year"": ""2021"", ""pmid"": ""None""}]",2021,,Khine Zaw,Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene,Samuel McLenachan,Stem Cell Research,10.1016/j.scr.2020.102129,"[{""age"": ""15 years old"", ""sex"": ""F"", ""disease_name"": ""Usher syndrome type 2"", ""disease_description"": ""USH2A (c.949C > A; c.1256G > T)""}]",USH2A (c.949C > A; c.1256G > T),F,Usher syndrome type 2,15 years old,"[{""mutation_type"": ""Inherited mutations"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""USH2A (c.949C > A; c.1256G > T)"", ""loci_name"": ""USH2A""}]",,Inherited mutations,USH2A (c.949C > A; c.1256G > T),,,USH2A,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""None"", ""summary"": ""Karyotyping confirmed the absence of chromosomal rearrangements.""}]","46,XX",,,Karyotyping confirmed the absence of chromosomal rearrangements.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2018"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2018,,,skin,dermal fibroblasts,[],"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""16/07/2018"", ""institutional_HREC"": ""University of Western Australia Human Research Ethics Committee""}]",16/07/2018,RA/4/1/7916,University of Western Australia Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""TrypLE""}]",21%,TrypLE,5%,,,,,,,,,,
LEi0101-C,33360097,LEi0101-C_m.json,33360097/LEi0101-C_m.json,"[{""cell_line_alt_name"": ""LEi0101-A; LEi0101-B; LEi0101-C"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEi0101-A; LEi0101-B; LEi0101-C,"[{""group"": ""Lions Eye Institute""}]",Lions Eye Institute,"[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""smclenachan@lei.org.au"", ""phone_number"": ""None""}]",McLenachan,Lions Eye Institute,smclenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2020.102129"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene"", ""first_author"": ""Khine Zaw"", ""last_author"": ""Fred K. Chen"", ""year"": ""2021"", ""pmid"": ""N/A""}]",2021,N/A,Khine Zaw,Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2020.102129,"[{""age"": ""15"", ""sex"": ""F"", ""disease_name"": ""Usher syndrome type 2"", ""disease_description"": ""Usher syndrome type 2""}]",Usher syndrome type 2,F,Usher syndrome type 2,15,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Inherited mutations"", ""genotype"": ""USH2A (c.949C > A; c.1256G > T)"", ""loci_name"": ""USH2A""}]",,,USH2A (c.949C > A; c.1256G > T),Inherited mutations,,USH2A,"[{""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""OCT4; NANOG; SOX2; TRA-1-81"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""5"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed the absence of chromosomal rearrangements.""}]","46,XX",5,GB,Karyotyping confirmed the absence of chromosomal rearrangements.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2018"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2018,,,skin,dermal fibroblasts,,"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""16/07/2018"", ""institutional_HREC"": ""University of Western Australia Human Research Ethics Committee""}]",16/07/2018,RA/4/1/7916,University of Western Australia Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""TrypLE""}]",21%,TrypLE,5%,ME,RT-qPCR,OCT4; NANOG; SOX2; TRA-1-81,True,in vitro directed differentiation,,,,,
E1C1,18271699,E1C1_m.json,18271699/E1C1_m.json,"[{""cell_line_alt_name"": ""E1C1; E1C2; E1C3; E1C4"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,E1C1; E1C2; E1C3; E1C4,"[{""group"": ""University of New South Wales""}]",University of New South Wales,"[{""group"": ""Stem Cell Laboratory, University of New South Wales"", ""first_name"": ""Kuldip"", ""last_name"": ""Sidhu"", ""name_initials"": ""P."", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Sidhu,"Stem Cell Laboratory, University of New South Wales",,,P.,Kuldip,"[{""doi"": ""10.1089/scd.2007.0055"", ""journal"": ""Stem Cells and Development"", ""title"": ""Derivation of a New Human Embryonic Stem Cell Line, Endeavour-1, and Its Clonal Propagation"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernie E. Tuch"", ""year"": ""2008"", ""pmid"": ""18248167""}]",2008,18248167,Kuldip S. Sidhu,"Derivation of a New Human Embryonic Stem Cell Line, Endeavour-1, and Its Clonal Propagation",Bernie E. Tuch,Stem Cells and Development,10.1089/scd.2007.0055,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX17; GATA4"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""24"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed normal karyotype (46XX) for all clonal lines.""}]","46,XX",24,GB,Karyotyping showed normal karyotype (46XX) for all clonal lines.,[],,,,,,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,EN,RT-qPCR,SOX17; GATA4,True,in vitro directed differentiation,,,,,
E1C4,18271699,E1C4_m.json,18271699/E1C4_m.json,"[{""cell_line_alt_name"": ""E1C4"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,E1C4,"[{""group"": ""University of New South Wales""}]",University of New South Wales,"[{""group"": ""hES Cell Laboratory"", ""first_name"": ""Kuldip"", ""last_name"": ""Sidhu"", ""name_initials"": ""S"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Sidhu,hES Cell Laboratory,,,S,Kuldip,"[{""doi"": ""10.1089/scd.2007.0055"", ""journal"": ""Stem Cells and Development"", ""title"": ""Derivation of a New Human Embryonic Stem Cell Line, Endeavour-1, and Its Clonal Propagation"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernie E. Tuch"", ""year"": ""2008"", ""pmid"": ""18248171""}]",2008,18248171,Kuldip S. Sidhu,"Derivation of a New Human Embryonic Stem Cell Line, Endeavour-1, and Its Clonal Propagation",Bernie E. Tuch,Stem Cells and Development,10.1089/scd.2007.0055,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX17; GATA4"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""24"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotype analysis showed stable karyotype with no abnormalities.""}]","46,XX",24,GB,Karyotype analysis showed stable karyotype with no abnormalities.,[],,,,,,[],"[{""ethics_number"": ""01270"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",,01270,University of Queensland Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN,RT-qPCR,SOX17; GATA4,True,in vitro directed differentiation,,,,,
E1,18271699,E1_m.json,18271699/E1_m.json,"[{""cell_line_alt_name"": ""Endeavour-1 (E1)"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,Endeavour-1 (E1),"[{""group"": ""University of New South Wales""}]",University of New South Wales,"[{""group"": ""hES Cell Laboratory"", ""first_name"": ""Kuldip"", ""last_name"": ""Sidhu"", ""name_initials"": ""S"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Sidhu,hES Cell Laboratory,,,S,Kuldip,"[{""doi"": ""10.1089/scd.2007.0055"", ""journal"": ""Stem Cells and Development"", ""title"": ""Derivation of a New Human Embryonic Stem Cell Line, Endeavour-1, and Its Clonal Propagation"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernie E. Tuch"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Kuldip S. Sidhu,"Derivation of a New Human Embryonic Stem Cell Line, Endeavour-1, and Its Clonal Propagation",Bernie E. Tuch,Stem Cells and Development,10.1089/scd.2007.0055,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX17; GATA4"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""24"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed a normal karyotype (46XX) for E1.""}]","46,XX",24,GB,Karyotyping showed a normal karyotype (46XX) for E1.,[],,,,,,[],"[{""ethics_number"": ""01270"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",,01270,University of Queensland Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN,RT-qPCR,SOX17; GATA4,True,in vitro directed differentiation,,,,,
E1C3,18271699,E1C3_m.json,18271699/E1C3_m.json,"[{""cell_line_alt_name"": ""E1C3"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,E1C3,"[{""group"": ""University of New South Wales""}]",University of New South Wales,"[{""group"": ""Stem Cell Laboratory, University of New South Wales"", ""first_name"": ""Kuldip"", ""last_name"": ""Sidhu"", ""name_initials"": ""S"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Sidhu,"Stem Cell Laboratory, University of New South Wales",,,S,Kuldip,"[{""doi"": ""10.1089/scd.2007.0055"", ""journal"": ""Stem Cells and Development"", ""title"": ""Derivation of a New Human Embryonic Stem Cell Line, Endeavour-1, and Its Clonal Propagation"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernie E. Tuch"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Kuldip S. Sidhu,"Derivation of a New Human Embryonic Stem Cell Line, Endeavour-1, and Its Clonal Propagation",Bernie E. Tuch,Stem Cells and Development,10.1089/scd.2007.0055,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""1"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed a normal karyotype (46XX) for E1C3.""}]","46,XX",1,GB,Karyotyping showed a normal karyotype (46XX) for E1C3.,[],,,,,,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
E1C2,18271699,E1C2_m.json,18271699/E1C2_m.json,"[{""cell_line_alt_name"": ""E1C2"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,E1C2,"[{""group"": ""University of New South Wales""}]",University of New South Wales,"[{""group"": ""Stem Cell Laboratory"", ""first_name"": ""Kuldip"", ""last_name"": ""Sidhu"", ""name_initials"": ""S"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Sidhu,Stem Cell Laboratory,,,S,Kuldip,"[{""doi"": ""10.1089/scd.2007.0055"", ""journal"": ""Stem Cells and Development"", ""title"": ""Derivation of a New Human Embryonic Stem Cell Line, Endeavour-1, and Its Clonal Propagation"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernie E. Tuch"", ""year"": ""2008"", ""pmid"": ""None""}]",2008,,Kuldip S. Sidhu,"Derivation of a New Human Embryonic Stem Cell Line, Endeavour-1, and Its Clonal Propagation",Bernie E. Tuch,Stem Cells and Development,10.1089/scd.2007.0055,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""1"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotype analysis showed a normal diploid chromosome number.""}]","46,XX",1,GB,Karyotype analysis showed a normal diploid chromosome number.,[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
LEIi011-C,31494449,LEIi011-C_m.json,31494449/LEIi011-C_m.json,"[{""cell_line_alt_name"": ""LEIi011-C"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi011-C,"[{""group"": ""Centre for Ophthalmology and Visual Science, The University of Western Australia""}]","Centre for Ophthalmology and Visual Science, The University of Western Australia","[{""group"": ""Samuel McLenachan"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mclenachan@le.org.au"", ""phone_number"": ""None""}, {""group"": ""Fred K. Chen"", ""first_name"": ""Fred"", ""last_name"": ""Chen"", ""name_initials"": ""None"", ""e_mail"": ""fred.chen@le.org.au"", ""phone_number"": ""None""}]",McLenachan | Chen,Samuel McLenachan | Fred K. Chen,s.mclenachan@le.org.au | fred.chen@le.org.au,,,Samuel | Fred,"[{""doi"": ""10.1016/j.scr.2019.101549"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations"", ""first_author"": ""Zhiqin Huang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Zhiqin Huang,Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2019.101549,"[{""age"": ""45"", ""sex"": ""F"", ""disease_name"": ""Retinal dystrophy"", ""disease_description"": ""Inherited retinal dystrophy associated with RCBTB1 mutations""}]",Inherited retinal dystrophy associated with RCBTB1 mutations,F,Retinal dystrophy,45,"[{""mutation_type"": ""frameshift"", ""cytoband"": ""13q14"", ""delivery_method"": ""None"", ""description"": ""c.170delG and c.707delA mutations in RCBTB1"", ""genotype"": ""None"", ""loci_name"": ""RCBTB1""}]",13q14,frameshift,,c.170delG and c.707delA mutations in RCBTB1,,RCBTB1,"[{""cell_type"": ""None"", ""show_potency"": ""None"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""11"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal diploid karyotype""}]","46,XX",11,GB,Karyotyping confirmed normal diploid karyotype,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2019"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2019,,,skin,fibroblasts,,"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia Ethics Committee""}]",,,University of Western Australia Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
LEIi011-B,31494449,LEIi011-B_m.json,31494449/LEIi011-B_m.json,"[{""cell_line_alt_name"": ""LEIi011-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,LEIi011-B,"[{""group"": ""Centre for Ophthalmology and Visual Science, The University of Western Australia""}]","Centre for Ophthalmology and Visual Science, The University of Western Australia","[{""group"": ""Samuel McLenachan"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mclenachan@le.org.au"", ""phone_number"": ""None""}, {""group"": ""Fred K. Chen"", ""first_name"": ""Fred"", ""last_name"": ""Chen"", ""name_initials"": ""None"", ""e_mail"": ""fred.chen@le.org.au"", ""phone_number"": ""None""}]",McLenachan | Chen,Samuel McLenachan | Fred K. Chen,s.mclenachan@le.org.au | fred.chen@le.org.au,,,Samuel | Fred,"[{""doi"": ""10.1016/j.scr.2019.101549"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations"", ""first_author"": ""Zhiqin Huang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Zhiqin Huang,Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2019.101549,"[{""age"": ""45"", ""sex"": ""F"", ""disease_name"": ""Chorioretinal atrophy"", ""disease_description"": ""Inherited retinal dystrophy""}]",Inherited retinal dystrophy,F,Chorioretinal atrophy,45,"[{""mutation_type"": ""frameshift"", ""cytoband"": ""13q14"", ""delivery_method"": ""None"", ""description"": ""c.170delG and c.707delA in RCBTB1"", ""genotype"": ""None"", ""loci_name"": ""RCBTB1""}]",13q14,frameshift,,c.170delG and c.707delA in RCBTB1,,RCBTB1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""OCT4; NANOG; SOX2; MYC; KLF4"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""5"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal diploid karyotype.""}]","46,XX",5,GB,Karyotyping confirmed normal diploid karyotype.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2019"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2019,,,skin,fibroblasts,,"[{""ethics_number"": ""None"", ""approval_date"": ""04/06/2016"", ""institutional_HREC"": ""Human Research Ethics Office, University of Western Australia""}]",04/06/2016,,"Human Research Ethics Office, University of Western Australia","[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN,RT-qPCR,OCT4; NANOG; SOX2; MYC; KLF4,True,in vitro directed differentiation,,,,,
LEIi011-A,31494449,LEIi011-A_m.json,31494449/LEIi011-A_m.json,"[{""cell_line_alt_name"": ""LEIi011-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,LEIi011-A,"[{""group"": ""Centre for Ophthalmology and Visual Science, The University of Western Australia""}]","Centre for Ophthalmology and Visual Science, The University of Western Australia","[{""group"": ""Samuel McLenachan"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mclenachan@le.org.au"", ""phone_number"": ""None""}, {""group"": ""Fred K. Chen"", ""first_name"": ""Fred"", ""last_name"": ""Chen"", ""name_initials"": ""None"", ""e_mail"": ""fred.chen@le.org.au"", ""phone_number"": ""None""}]",McLenachan | Chen,Samuel McLenachan | Fred K. Chen,s.mclenachan@le.org.au | fred.chen@le.org.au,,,Samuel | Fred,"[{""doi"": ""10.1016/j.scr.2019.101549"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations"", ""first_author"": ""Zhiqin Huang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Zhiqin Huang,Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2019.101549,"[{""age"": ""45"", ""sex"": ""F"", ""disease_name"": ""Retinal dystrophy"", ""disease_description"": ""Cataract retinopathy associated with RCBTB1 mutations""}]",Cataract retinopathy associated with RCBTB1 mutations,F,Retinal dystrophy,45,"[{""mutation_type"": ""frameshift"", ""cytoband"": ""13q14"", ""delivery_method"": ""None"", ""description"": ""c.170delG and c.707delA mutations in RCBTB1"", ""genotype"": ""None"", ""loci_name"": ""RCBTB1""}]",13q14,frameshift,,c.170delG and c.707delA mutations in RCBTB1,,RCBTB1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""OCT4; NANOG; SOX2; MYC; KLF4"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""5"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal diploid karyotype.""}]","46,XX",5,GB,Karyotyping confirmed normal diploid karyotype.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2019"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2019,,,skin,fibroblasts,,"[{""ethics_number"": ""None"", ""approval_date"": ""04/06/2016"", ""institutional_HREC"": ""Human Research Ethics Office, University of Western Australia""}]",04/06/2016,,"Human Research Ethics Office, University of Western Australia","[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN,RT-qPCR,OCT4; NANOG; SOX2; MYC; KLF4,True,in vitro directed differentiation,,,,,
LEI1005-B,31059986,LEI1005-B_m.json,31059986/LEI1005-B_m.json,"[{""cell_line_alt_name"": ""LEI1005-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,LEI1005-B,"[{""group"": ""The University of Western Australia""}]",The University of Western Australia,"[{""group"": ""Samuel McLenachan"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mcLenachan@uwa.edu.au"", ""phone_number"": ""None""}]",McLenachan,Samuel McLenachan,s.mcLenachan@uwa.edu.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2019.101452"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation"", ""first_author"": ""Xiao Zhang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Xiao Zhang,Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2019.101452,"[{""age"": ""76"", ""sex"": ""F"", ""disease_name"": ""Retinitis pigmentosa"", ""disease_description"": ""Autosomal dominant retinitis pigmentosa caused by a nonsense mutation in the RP1 gene""}]",Autosomal dominant retinitis pigmentosa caused by a nonsense mutation in the RP1 gene,F,Retinitis pigmentosa,76,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous for the c.2098G>T mutation in the RP1 gene"", ""genotype"": ""None"", ""loci_name"": ""RP1""}]",,,,Heterozygous for the c.2098G>T mutation in the RP1 gene,,RP1,"[{""cell_type"": ""None"", ""show_potency"": ""None"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""None"", ""summary"": ""Normal karyotype in LEI1005-B""}]","46,XX",,,Normal karyotype in LEI1005-B,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin biopsy"", ""derivation_year"": ""2017"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2017,,,skin biopsy,dermal fibroblasts,[],"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia Ethics Committee""}]",,RA/4/1/7916,University of Western Australia Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
HuiP5C,31059986,HuiP5C_m.json,31059986/HuiP5C_m.json,"[{""cell_line_alt_name"": ""LEI005-B; RP1i56"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,LEI005-B; RP1i56,"[{""group"": ""The University of Western Australia""}]",The University of Western Australia,"[{""group"": ""Samuel McLenachan"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mcLenachan@uwa.edu.au"", ""phone_number"": ""None""}]",McLenachan,Samuel McLenachan,s.mcLenachan@uwa.edu.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2019.101452"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation"", ""first_author"": ""Xiao Zhang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Xiao Zhang,Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2019.101452,"[{""age"": ""76"", ""sex"": ""F"", ""disease_name"": ""Retinitis pigmentosa"", ""disease_description"": ""Autosomal dominant retinitis pigmentosa""}]",Autosomal dominant retinitis pigmentosa,F,Retinitis pigmentosa,76,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""RP1 c.2098 G > T heterozygous nonsense mutation"", ""loci_name"": ""RP1""}]",,,RP1 c.2098 G > T heterozygous nonsense mutation,,,RP1,"[{""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""OCT4; NANOG; SOX2; KLF4"", ""method_used"": ""Immunocytochemistry"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""5"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""S"", ""summary"": ""Karyotyping analysis confirmed a normal female karyotype.""}]","46,XX",5,S,Karyotyping analysis confirmed a normal female karyotype.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2017"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2017,,,skin,dermal fibroblasts,[],"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia Ethics Committee""}]",,RA/4/1/7916,University of Western Australia Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EC,Immunocytochemistry,OCT4; NANOG; SOX2; KLF4,True,in vitro directed differentiation,,,,,
RP1ip56,31059986,RP1ip56_m.json,31059986/RP1ip56_m.json,"[{""cell_line_alt_name"": ""RP1ip56"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,RP1ip56,"[{""group"": ""The University of Western Australia""}]",The University of Western Australia,"[{""group"": ""Samuel McLenachan"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mc.lenachan@uwa.edu.au"", ""phone_number"": ""None""}]",McLenachan,Samuel McLenachan,s.mc.lenachan@uwa.edu.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2019.101452"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation"", ""first_author"": ""Xiao Zhang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Xiao Zhang,Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2019.101452,"[{""age"": ""76"", ""sex"": ""F"", ""disease_name"": ""Retinitis pigmentosa"", ""disease_description"": ""Heterogeneous group of inherited retinal diseases""}]",Heterogeneous group of inherited retinal diseases,F,Retinitis pigmentosa,76,"[{""mutation_type"": ""Nonsense mutation"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""c.2098G>T mutation in the RP1 gene"", ""genotype"": ""None"", ""loci_name"": ""RP1""}]",,Nonsense mutation,,c.2098G>T mutation in the RP1 gene,,RP1,"[{""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""OCT4; NANOG; SOX2; KLF4"", ""method_used"": ""Immunocytochemistry"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""5"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""S"", ""summary"": ""Karyotyping confirmed a normal female karyotype.""}]","46,XX",5,S,Karyotyping confirmed a normal female karyotype.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2017"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2017,,,skin,dermal fibroblasts,,"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia Ethics Committee""}]",,RA/4/1/7916,University of Western Australia Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,EC,Immunocytochemistry,OCT4; NANOG; SOX2; KLF4,True,in vitro directed differentiation,,,,,
LEIi015-B,33429167,LEIi015-B_m.json,33429167/LEIi015-B_m.json,"[{""cell_line_alt_name"": ""LEIi015-A; LEIi015-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi015-A; LEIi015-B,"[{""group"": ""Lions Eye Institute""}]",Lions Eye Institute,"[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLeanachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mcleanachan@lei.org.au"", ""phone_number"": ""None""}]",McLeanachan,Lions Eye Institute,s.mcleanachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2020.102154"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200"", ""first_author"": ""Dan Zhang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2021"", ""pmid"": ""None""}]",2021,,Dan Zhang,Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2020.102154,"[{""age"": ""9"", ""sex"": ""F"", ""disease_name"": ""Retinitis pigmentosa"", ""disease_description"": ""Inherited retinal disease""}]",Inherited retinal disease,F,Retinitis pigmentosa,9,"[{""mutation_type"": ""Hereditary"", ""cytoband"": ""None"", ""delivery_method"": ""Episomal vectors"", ""description"": ""Compound heterozygous mutations in SNRNP200"", ""genotype"": ""c.1792C>T; c.3341T>C"", ""loci_name"": ""SNRNP200""}]",,Hereditary,c.1792C>T; c.3341T>C,Compound heterozygous mutations in SNRNP200,Episomal vectors,SNRNP200,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""None"", ""summary"": ""No reprogramming-related alterations detected.""}]","46,XX",,,No reprogramming-related alterations detected.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2017"", ""non_int_vector"": ""Inducible/constitutive"", ""non_int_vector_name"": ""Episomal vectors""}]",2017,Episomal vectors,Inducible/constitutive,skin,dermal fibroblasts,,"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""06/09/2017"", ""institutional_HREC"": ""Human Research Ethics Office, University of Western Australia""}]",06/09/2017,RA/4/1/7916,"Human Research Ethics Office, University of Western Australia","[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""Geltrex-coated plates""}]",21%,Geltrex-coated plates,0.05,,,,,,,,,,
LEIi015-A,33429167,LEIi015-A_m.json,33429167/LEIi015-A_m.json,"[{""cell_line_alt_name"": ""LEIi015-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi015-B,"[{""group"": ""Lions Eye Institute""}]",Lions Eye Institute,"[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLeanachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mcleanachan@lei.org.au"", ""phone_number"": ""None""}]",McLeanachan,Lions Eye Institute,s.mcleanachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2020.102154"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200"", ""first_author"": ""Dan Zhang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2021"", ""pmid"": ""None""}]",2021,,Dan Zhang,Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2020.102154,"[{""age"": ""9"", ""sex"": ""F"", ""disease_name"": ""Retinitis pigmentosa"", ""disease_description"": ""Inherited retinal disease""}]",Inherited retinal disease,F,Retinitis pigmentosa,9,"[{""mutation_type"": ""Hereditary"", ""cytoband"": ""None"", ""delivery_method"": ""Episomal vectors"", ""description"": ""Compound heterozygous mutations in SNRNP200"", ""genotype"": ""c.1792C>T; c.3341T>C"", ""loci_name"": ""SNRNP200""}]",,Hereditary,c.1792C>T; c.3341T>C,Compound heterozygous mutations in SNRNP200,Episomal vectors,SNRNP200,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""5"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed normal female karyotype with no reprogramming-related alterations detected.""}]","46,XX",5,GB,Karyotyping showed normal female karyotype with no reprogramming-related alterations detected.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2017"", ""non_int_vector"": ""Inducible/constitutive"", ""non_int_vector_name"": ""Episomal vectors""}]",2017,Episomal vectors,Inducible/constitutive,skin,dermal fibroblasts,[],"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""06/09/2017"", ""institutional_HREC"": ""Human Research Ethics Office, University of Western Australia""}]",06/09/2017,RA/4/1/7916,"Human Research Ethics Office, University of Western Australia","[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""Geltrex-coated plates""}]",21%,Geltrex-coated plates,0.05,,,,,,,,,,
MCRi019-A-6,36682125,MCRi019-A-6_m.json,36682125/MCRi019-A-6_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Shireen"", ""last_name"": ""Lamnade"", ""name_initials"": ""R"", ""e_mail"": ""shireen.lamnade@mcri.edu.au"", ""phone_number"": ""None""}]",Lamnade,Murdoch Children's Research Institute,shireen.lamnade@mcri.edu.au,,R,Shireen,"[{""doi"": ""10.1016/j.scr.2023.103020"", ""journal"": ""Stem Cell Research"", ""title"": ""Using CRISPR/Cas9 to generate a heterozygous COL2A1 p.R719C iPSC line (MCRi019-A-6) model of human precocious osteoarthritis"", ""first_author"": ""Kathryn M. Yammin"", ""last_author"": ""Matthew D. Shoulders"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kathryn M. Yammin,Using CRISPR/Cas9 to generate a heterozygous COL2A1 p.R719C iPSC line (MCRi019-A-6) model of human precocious osteoarthritis,Matthew D. Shoulders,Stem Cell Research,10.1016/j.scr.2023.103020,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""Induced mutation"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR/Cas9"", ""description"": ""Heterozygous COL2A1 c.2155C>T (p.R719C)"", ""genotype"": ""None"", ""loci_name"": ""COL2A1""}]",,Induced mutation,,Heterozygous COL2A1 c.2155C>T (p.R719C),CRISPR/Cas9,COL2A1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX17; FOXA2"", ""method_used"": ""Directed differentiation"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""37"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed the absence of chromosomal abnormalities in the edited iPSC line.""}]","46,XX",37,GB,Karyotyping confirmed the absence of chromosomal abnormalities in the edited iPSC line.,"[{""i_source_cell_type_term"": ""dermal fibroblast"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,skin,dermal fibroblast,[],"[{""ethics_number"": ""None"", ""approval_date"": ""February 2020"", ""institutional_HREC"": ""Human Research Ethics Committee of the Royal Children's Hospital""}]",February 2020,,Human Research Ethics Committee of the Royal Children's Hospital,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""TrypLE""}]",21%,TrypLE,5%,EN,Directed differentiation,SOX17; FOXA2,True,in vitro directed differentiation,,,,,
MCRi019-A,36682125,MCRi019-A_m.json,36682125/MCRi019-A_m.json,"[{""cell_line_alt_name"": ""MCRi019-A-6; MCRi019-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,MCRi019-A-6; MCRi019-A,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Matthew"", ""last_name"": ""Shoulders"", ""name_initials"": ""D"", ""e_mail"": ""mshould@mit.edu"", ""phone_number"": ""None""}]",Shoulders,Murdoch Children's Research Institute,mshould@mit.edu,,D,Matthew,"[{""doi"": ""10.1016/j.scr.2023.103020"", ""journal"": ""Stem Cell Research"", ""title"": ""Using CRISPR/Cas9 to generate a heterozygous COL2A1 p.R719C line (MCRi019-A-6) model of human precocious osteoarthritis"", ""first_author"": ""Kathryn M. Yammine"", ""last_author"": ""Matthew D. Shoulders"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kathryn M. Yammine,Using CRISPR/Cas9 to generate a heterozygous COL2A1 p.R719C line (MCRi019-A-6) model of human precocious osteoarthritis,Matthew D. Shoulders,Stem Cell Research,10.1016/j.scr.2023.103020,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""Induced mutation"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR/Cas9"", ""description"": ""Heterozygous COL2A1 c.2155C>T (p.R719C)"", ""genotype"": ""None"", ""loci_name"": ""COL2A1""}]",,Induced mutation,,Heterozygous COL2A1 c.2155C>T (p.R719C),CRISPR/Cas9,COL2A1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX17; FOXA2"", ""method_used"": ""Directed differentiation"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""Brachyury"", ""method_used"": ""Directed differentiation"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""NESTIN; PAX6"", ""method_used"": ""Directed differentiation"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""37"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed the absence of chromosomal abnormalities in the edited iPSC line.""}]","46,XX",37,GB,Karyotyping confirmed the absence of chromosomal abnormalities in the edited iPSC line.,"[{""i_source_cell_type_term"": ""dermal fibroblast"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,skin,dermal fibroblast,[],"[{""ethics_number"": ""None"", ""approval_date"": ""February 2020"", ""institutional_HREC"": ""Royal Children's Hospital Human Research Ethics Committee""}]",February 2020,,Royal Children's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME | EC,Directed differentiation | Directed differentiation | Directed differentiation,SOX17; FOXA2 | Brachyury | NESTIN; PAX6,True | True | True,in vitro directed differentiation | in vitro directed differentiation | in vitro directed differentiation,,,,,
MONU003-B,37494850,MONU003-B_m.json,37494850/MONU003-B_m.json,"[{""cell_line_alt_name"": ""MONU001-A; MONU001-B; MONU001-C; MONU002-A; MONU002-B; MONU003-A; MONU003-B; MONU003-C"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,MONU001-A; MONU001-B; MONU001-C; MONU002-A; MONU002-B; MONU003-A; MONU003-B; MONU003-C,"[{""group"": ""Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia""}]","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia","[{""group"": ""Professor Mark A. Bellgrove, Dr Ziarh Hawi"", ""first_name"": ""Mark"", ""last_name"": ""Bellgrove"", ""name_initials"": ""A"", ""e_mail"": ""mark.bellgrove@monash.edu"", ""phone_number"": ""None""}]",Bellgrove,"Professor Mark A. Bellgrove, Dr Ziarh Hawi",mark.bellgrove@monash.edu,,A,Mark,"[{""doi"": ""10.1016/j.scr.2023.103170"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder"", ""first_author"": ""Kealan Pugsley"", ""last_author"": ""Mark A Bellgrove"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kealan Pugsley,Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder,Mark A Bellgrove,Stem Cell Research,10.1016/j.scr.2023.103170,"[{""age"": ""35_39"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""10_14"", ""sex"": ""F"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""18_24"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}]",,M | F | M,Autism spectrum disorder | Autism spectrum disorder | Autism spectrum disorder,35_39 | 10_14 | 18_24,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""Normal"", ""karyotype_method"": ""None"", ""summary"": ""Normal karyotype was confirmed.""}]",Normal,9,,Normal karyotype was confirmed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""None""}]",2023,,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""25688"", ""approval_date"": ""None"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",,25688,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,,,,,,,,,,
MONU001-B,37494850,MONU001-B_m.json,37494850/MONU001-B_m.json,"[{""cell_line_alt_name"": ""MONU001-A; MONU001-B; MONU001-C"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,MONU001-A; MONU001-B; MONU001-C,"[{""group"": ""Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia""}]","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia","[{""group"": ""Professor Mark A. Bellgrove, Dr Ziarh Hawi"", ""first_name"": ""Mark"", ""last_name"": ""Bellgrove"", ""name_initials"": ""A."", ""e_mail"": ""mark.bellgrove@monash.edu"", ""phone_number"": ""None""}]",Bellgrove,"Professor Mark A. Bellgrove, Dr Ziarh Hawi",mark.bellgrove@monash.edu,,A.,Mark,"[{""doi"": ""10.1016/j.scr.2023.103170"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder"", ""first_author"": ""Kealan Pugsley"", ""last_author"": ""Mark A Bellgrove"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kealan Pugsley,Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder,Mark A Bellgrove,Stem Cell Research,10.1016/j.scr.2023.103170,"[{""age"": ""35_39"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""10_14"", ""sex"": ""F"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""18_24"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}]",,M | F | M,Autism spectrum disorder | Autism spectrum disorder | Autism spectrum disorder,35_39 | 10_14 | 18_24,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Normal karyotype""}]","46,XY",9,GB,Normal karyotype,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""N/A""}]",2023,N/A,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""25688"", ""approval_date"": ""N/A"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",N/A,25688,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
MONU003-C,37494850,MONU003-C_m.json,37494850/MONU003-C_m.json,"[{""cell_line_alt_name"": ""MONU001-C; MONU002-C; MONU003-C"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,MONU001-C; MONU002-C; MONU003-C,"[{""group"": ""Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia""}]","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia","[{""group"": ""Monash University"", ""first_name"": ""Mark"", ""last_name"": ""Bellgrove"", ""name_initials"": ""A"", ""e_mail"": ""mark.bellgrove@monash.edu"", ""phone_number"": ""None""}]",Bellgrove,Monash University,mark.bellgrove@monash.edu,,A,Mark,"[{""doi"": ""10.1016/j.scr.2023.103170"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder"", ""first_author"": ""Kealan Pugsley"", ""last_author"": ""Mark A Bellgrove"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kealan Pugsley,Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder,Mark A Bellgrove,Stem Cell Research,10.1016/j.scr.2023.103170,"[{""age"": ""35_39"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""10_14"", ""sex"": ""F"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""18_24"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}]",,M | F | M,Autism spectrum disorder | Autism spectrum disorder | Autism spectrum disorder,35_39 | 10_14 | 18_24,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XY",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""N/A""}]",2023,N/A,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""25688"", ""approval_date"": ""N/A"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",N/A,25688,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
MONU002-A,37494850,MONU002-A_m.json,37494850/MONU002-A_m.json,"[{""cell_line_alt_name"": ""MONU001-A; MONU001-B; MONU001-C; MONU002-A; MONU002-B; MONU002-C; MONU003-A; MONU003-B; MONU003-C"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,MONU001-A; MONU001-B; MONU001-C; MONU002-A; MONU002-B; MONU002-C; MONU003-A; MONU003-B; MONU003-C,"[{""group"": ""Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC, Australia""}]","Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, VIC, Australia","[{""group"": ""Monash University"", ""first_name"": ""Mark"", ""last_name"": ""Bellgrove"", ""name_initials"": ""A"", ""e_mail"": ""mark.bellgrove@monash.edu"", ""phone_number"": ""None""}, {""group"": ""Monash University"", ""first_name"": ""Ziarh"", ""last_name"": ""Hawi"", ""name_initials"": ""T"", ""e_mail"": ""ziarh.hawi@monash.edu"", ""phone_number"": ""None""}]",Bellgrove | Hawi,Monash University | Monash University,mark.bellgrove@monash.edu | ziarh.hawi@monash.edu,,A | T,Mark | Ziarh,"[{""doi"": ""10.1016/j.scr.2023.103170"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder"", ""first_author"": ""Kealan Pugsley"", ""last_author"": ""Mark A Bellgrove"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kealan Pugsley,Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder,Mark A Bellgrove,Stem Cell Research,10.1016/j.scr.2023.103170,"[{""age"": ""35_39"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""10_0"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""18_3"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}]",,M | M | M,Autism spectrum disorder | Autism spectrum disorder | Autism spectrum disorder,35_39 | 10_0 | 18_3,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,[],,,,,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""N/A""}]",2023,N/A,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""25688"", ""approval_date"": ""N/A"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",N/A,25688,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,0.05,,,,,,,,,,
MONU003-A,37494850,MONU003-A_m.json,37494850/MONU003-A_m.json,"[{""cell_line_alt_name"": ""MONU001-A; MONU001-B; MONU001-C; MONU002-A; MONU002-B; MONU003-A; MONU003-B; MONU003-C"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MONU001-A; MONU001-B; MONU001-C; MONU002-A; MONU002-B; MONU003-A; MONU003-B; MONU003-C,"[{""group"": ""Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia""}]","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia","[{""group"": ""Monash University"", ""first_name"": ""Mark"", ""last_name"": ""Bellgrove"", ""name_initials"": ""A"", ""e_mail"": ""mark.bellgrove@monash.edu"", ""phone_number"": ""None""}]",Bellgrove,Monash University,mark.bellgrove@monash.edu,,A,Mark,"[{""doi"": ""10.1016/j.scr.2023.103170"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder"", ""first_author"": ""Kealan Pugsley"", ""last_author"": ""Mark A Bellgrove"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kealan Pugsley,Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder,Mark A Bellgrove,Stem Cell Research,10.1016/j.scr.2023.103170,"[{""age"": ""35_39"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""10_14"", ""sex"": ""F"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""18_24"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}]",,M | F | M,Autism spectrum disorder | Autism spectrum disorder | Autism spectrum disorder,35_39 | 10_14 | 18_24,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""Normal"", ""karyotype_method"": ""S"", ""summary"": ""Normal karyotype was validated by flow cytometry.""}]",Normal,9,S,Normal karyotype was validated by flow cytometry.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""None""}]",2023,,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""25688"", ""approval_date"": ""None"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",,25688,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
MONU002-B,37494850,MONU002-B_m.json,37494850/MONU002-B_m.json,"[{""cell_line_alt_name"": ""MONU001; MONU002; MONU003"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MONU001; MONU002; MONU003,"[{""group"": ""Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia""}]","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia","[{""group"": ""Professor Mark A. Bellgrove, Dr Ziarih Hawi"", ""first_name"": ""Mark"", ""last_name"": ""Bellgrove"", ""name_initials"": ""A."", ""e_mail"": ""mark.bellgrove@monash.edu"", ""phone_number"": ""None""}]",Bellgrove,"Professor Mark A. Bellgrove, Dr Ziarih Hawi",mark.bellgrove@monash.edu,,A.,Mark,"[{""doi"": ""10.1016/j.scr.2023.103170"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder"", ""first_author"": ""Kealan Pugsley"", ""last_author"": ""Mark A Bellgrove"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kealan Pugsley,Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder,Mark A Bellgrove,Stem Cell Research,10.1016/j.scr.2023.103170,"[{""age"": ""35_39"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""10_14"", ""sex"": ""F"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""18_24"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}]",,M | F | M,Autism spectrum disorder | Autism spectrum disorder | Autism spectrum disorder,35_39 | 10_14 | 18_24,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""Normal"", ""karyotype_method"": ""None"", ""summary"": ""Normal morphology, positive immunostaining for pluripotency markers OCT4 and SSEA4.""}]",Normal,9,,"Normal morphology, positive immunostaining for pluripotency markers OCT4 and SSEA4.","[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""None""}]",2023,,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""25688"", ""approval_date"": ""28/06/2023"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",28/06/2023,25688,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,,,,,,,,,,
MONU001-C,37494850,MONU001-C_m.json,37494850/MONU001-C_m.json,"[{""cell_line_alt_name"": ""86220001; 86220001-1; 86220001-2; 86220001-3"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,86220001; 86220001-1; 86220001-2; 86220001-3,"[{""group"": ""Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia""}]","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia","[{""group"": ""Professor Mark A. Bellgrove, Dr Ziarh Hawi"", ""first_name"": ""Mark"", ""last_name"": ""Bellgrove"", ""name_initials"": ""A."", ""e_mail"": ""mark.bellgrove@monash.edu"", ""phone_number"": ""None""}]",Bellgrove,"Professor Mark A. Bellgrove, Dr Ziarh Hawi",mark.bellgrove@monash.edu,,A.,Mark,"[{""doi"": ""10.1016/j.scr.2023.103170"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder"", ""first_author"": ""Kealan Pugsley"", ""last_author"": ""Mark A Bellgrove"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kealan Pugsley,Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder,Mark A Bellgrove,Stem Cell Research,10.1016/j.scr.2023.103170,"[{""age"": ""35_39"", ""sex"": ""M"", ""disease_name"": ""Autism Spectrum Disorder"", ""disease_description"": ""None""}, {""age"": ""10_14"", ""sex"": ""F"", ""disease_name"": ""Autism Spectrum Disorder"", ""disease_description"": ""None""}, {""age"": ""18_24"", ""sex"": ""M"", ""disease_name"": ""Autism Spectrum Disorder"", ""disease_description"": ""None""}]",,M | F | M,Autism Spectrum Disorder | Autism Spectrum Disorder | Autism Spectrum Disorder,35_39 | 10_14 | 18_24,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""Normal"", ""karyotype_method"": ""None"", ""summary"": ""Normal karyotype with no abnormalities detected.""}]",Normal,9,,Normal karyotype with no abnormalities detected.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""N/A""}]",2023,N/A,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""25688"", ""approval_date"": ""28/06/2023"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",28/06/2023,25688,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
MONU001-A,37494850,MONU001-A_m.json,37494850/MONU001-A_m.json,"[{""cell_line_alt_name"": ""MONU001-A; MONU001-B; MONU001-C"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MONU001-A; MONU001-B; MONU001-C,"[{""group"": ""Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia""}]","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia","[{""group"": ""Professor Mark A. Bellgrove, Dr Ziarih Hawi"", ""first_name"": ""Mark"", ""last_name"": ""Bellgrove"", ""name_initials"": ""A."", ""e_mail"": ""mark.bellgrove@monash.edu"", ""phone_number"": ""None""}]",Bellgrove,"Professor Mark A. Bellgrove, Dr Ziarih Hawi",mark.bellgrove@monash.edu,,A.,Mark,"[{""doi"": ""10.1016/j.scr.2023.103170"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder"", ""first_author"": ""Kealan Pugsley"", ""last_author"": ""Mark A Bellgrove"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Kealan Pugsley,Generation of induced pluripotent stem cell lines from three individuals with autism spectrum disorder,Mark A Bellgrove,Stem Cell Research,10.1016/j.scr.2023.103170,"[{""age"": ""35_39"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""10_14"", ""sex"": ""F"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}, {""age"": ""18_24"", ""sex"": ""M"", ""disease_name"": ""Autism spectrum disorder"", ""disease_description"": ""None""}]",,M | F | M,Autism spectrum disorder | Autism spectrum disorder | Autism spectrum disorder,35_39 | 10_14 | 18_24,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""Normal"", ""karyotype_method"": ""S"", ""summary"": ""Normal karyotype was validated by flow cytometry.""}]",Normal,9,S,Normal karyotype was validated by flow cytometry.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""N/A""}]",2023,N/A,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""25688"", ""approval_date"": ""N/A"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",N/A,25688,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,,,,,,,,,,
GENIE 81,35074713,GENIE 81_m.json,35074713/GENIE 81_m.json,"[{""cell_line_alt_name"": ""GENIE 81"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 81,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""35_39"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,F,Epilepsy,35_39,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX2; FOXA2"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""PAX6; NR2F2"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""5"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",5,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Non-integrative Sendai virus delivery""}]",2020,Non-integrative Sendai virus delivery,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}]",,2019/QRBW/54086,Royal Brisbane and Women's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME,qPCR | qPCR,SOX2; FOXA2 | PAX6; NR2F2,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
GENIE 116,35074713,GENIE 116_m.json,35074713/GENIE 116_m.json,"[{""cell_line_alt_name"": ""GENIE 116"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 116,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Australian Institute for Bioengineering and Nanotechnology,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""None"", ""sex"": ""M"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,M,Epilepsy,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XY",,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Non-integrative Sendai virus delivery""}]",2020,Non-integrative Sendai virus delivery,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}]",,2019/QRBW/54086,Royal Brisbane and Women's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
AIBNi008-A,35074713,AIBNi008-A_m.json,35074713/AIBNi008-A_m.json,"[{""cell_line_alt_name"": ""GENIE 7; GENIE 11; GENIE 29; GENIE 49; GENIE 75; GENIE 81; GENIE 116"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 7; GENIE 11; GENIE 29; GENIE 49; GENIE 75; GENIE 81; GENIE 116,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""25"", ""sex"": ""M"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""29"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""56"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,M | F | F | F,Epilepsy | Epilepsy | Epilepsy | Epilepsy,25 | 29 | 35 | 56,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""5"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotype analysis revealed a normal male and female karyotype (46,XX; 46,XY) without G-banding abnormalities.""}]","46,XY",5,GB,"Karyotype analysis revealed a normal male and female karyotype (46,XX; 46,XY) without G-banding abnormalities.","[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Non-integrative Sendai virus delivery""}]",2020,Non-integrative Sendai virus delivery,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}]",,2019/QRBW/54086,Royal Brisbane and Women's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
GENIE 29,35074713,GENIE 29_m.json,35074713/GENIE 29_m.json,"[{""cell_line_alt_name"": ""GENIE 29"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 29,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Professor Ernst J Wolvetang"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Professor Ernst J Wolvetang,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""29"", ""sex"": ""M"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,M,Epilepsy,29,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""18"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XY",18,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}]",,2019/QRBW/54086,Royal Brisbane and Women's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
GENIE 49,35074713,GENIE 49_m.json,35074713/GENIE 49_m.json,"[{""cell_line_alt_name"": ""GENIE 49"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 49,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""25"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""29"", ""sex"": ""M"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""56"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,F | M | F | F,Epilepsy | Epilepsy | Epilepsy | Epilepsy,25 | 29 | 35 | 56,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""18"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XY",18,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}]",,2019/QRBW/54086,Royal Brisbane and Women's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
AIBNi007-A,35074713,AIBNi007-A_m.json,35074713/AIBNi007-A_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""25"", ""sex"": ""M"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""29"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""56"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,M | F | F | F,Epilepsy | Epilepsy | Epilepsy | Epilepsy,25 | 29 | 35 | 56,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XY",,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Non-integrative Sendai virus delivery""}]",2020,Non-integrative Sendai virus delivery,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}]",,2019/QRBW/54086,Royal Brisbane and Women's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
AIBNi010-A,35074713,AIBNi010-A_m.json,35074713/AIBNi010-A_m.json,"[{""cell_line_alt_name"": ""GENIE 11; GENIE 29; GENIE 49; GENIE 75; GENIE 81; GENIE 116"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 11; GENIE 29; GENIE 49; GENIE 75; GENIE 81; GENIE 116,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""35_39"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""25"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""56"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,F | F | F | F,Epilepsy | Epilepsy | Epilepsy | Epilepsy,35_39 | 25 | 56 | 35,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Non-integrative Sendai virus delivery""}]",2020,Non-integrative Sendai virus delivery,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}, {""ethics_number"": ""201900223"", ""approval_date"": ""None"", ""institutional_HREC"": ""The University of Queensland Human Ethics Research Office""}]",,2019/QRBW/54086 | 201900223,Royal Brisbane and Women's Hospital Human Research Ethics Committee | The University of Queensland Human Ethics Research Office,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
AIBNi009-A,35074713,AIBNi009-A_m.json,35074713/AIBNi009-A_m.json,"[{""cell_line_alt_name"": ""AIBNi009-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,AIBNi009-A,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""35_39"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,F,Epilepsy,35_39,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XY",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Non-integrative Sendai virus delivery""}]",2020,Non-integrative Sendai virus delivery,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}]",,2019/QRBW/54086,Royal Brisbane and Women's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
GENIE 75,35074713,GENIE 75_m.json,35074713/GENIE 75_m.json,"[{""cell_line_alt_name"": ""GENIE 75"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 75,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Australian Institute for Bioengineering and Nanotechnology,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""None"", ""sex"": ""M"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,M,Epilepsy,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX2; TRA-1-60"", ""method_used"": ""Immunofluorescence staining"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""None"", ""summary"": ""Karyotype analysis revealed a normal male and male karyotype (46XY) without G-banding abnormalities.""}]","46,XY",,,Karyotype analysis revealed a normal male and male karyotype (46XY) without G-banding abnormalities.,"[{""i_source_cell_type_term"": ""Peripheral blood mononuclear cells"", ""i_source_cell_origin_term"": ""Blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Non-integrative Sendai virus delivery""}]",2020,Non-integrative Sendai virus delivery,SV,Blood,Peripheral blood mononuclear cells,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}]",,2019/QRBW/54086,Royal Brisbane and Women's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual passaging""}]",21%,Manual passaging,5%,EN,Immunofluorescence staining,SOX2; TRA-1-60,True,in vitro directed differentiation,,,,,
GENIE 11,35074713,GENIE 11_m.json,35074713/GENIE 11_m.json,"[{""cell_line_alt_name"": ""GENIE 11"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 11,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Australian Institute for Bioengineering and Nanotechnology,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,,Epilepsy,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""OCT4; SOX2; NANOG; TRA-1-60"", ""method_used"": ""Immunofluorescence staining"", ""differentiation_profile"": ""in vitro differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""None"", ""summary"": ""Karyotype analysis revealed a normal male and male karyotype.""}]","46,XY",,,Karyotype analysis revealed a normal male and male karyotype.,"[{""i_source_cell_type_term"": ""Peripheral blood mononuclear cells"", ""i_source_cell_origin_term"": ""Blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,Blood,Peripheral blood mononuclear cells,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}]",,2019/QRBW/54086,Royal Brisbane and Women's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual passaging""}]",21%,Manual passaging,5%,EN,Immunofluorescence staining,OCT4; SOX2; NANOG; TRA-1-60,True,in vitro differentiation,,,,,
AIBNi011-A,35074713,AIBNi011-A_m.json,35074713/AIBNi011-A_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102673"", ""journal"": ""Stem Cell Research"", ""title"": ""Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Zoe L. Hunter,Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2022.102673,"[{""age"": ""35_39"", ""sex"": ""M"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""25"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""56"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}, {""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""None""}]",,M | F | F | F,Epilepsy | Epilepsy | Epilepsy | Epilepsy,35_39 | 25 | 56 | 35,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""None"", ""summary"": ""Karyotype analysis revealed a normal male and female karyotype.""}]","46,XY",,,Karyotype analysis revealed a normal male and female karyotype.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""Non-integrative Sendai virus delivery""}]",2020,Non-integrative Sendai virus delivery,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Brisbane and Women's Hospital Human Research Ethics Committee""}]",,2019/QRBW/54086,Royal Brisbane and Women's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual passaging""}]",21%,Manual passaging,5%,,,,,,,,,,
LEIi009-A,30611018,LEIi009-A_m.json,30611018/LEIi009-A_m.json,"[{""cell_line_alt_name"": ""LEIi009-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi009-A,"[{""group"": ""Lions Eye Institute, Nedlands, Western Australia, Australia""}]","Lions Eye Institute, Nedlands, Western Australia, Australia","[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mcLenachan@lei.org.au"", ""phone_number"": ""None""}]",McLenachan,Lions Eye Institute,s.mcLenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2018.11.018"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier"", ""first_author"": ""Samuel McLenachan"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Samuel McLenachan,Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2018.11.018,"[{""age"": ""28"", ""sex"": ""M"", ""disease_name"": ""Retinitis Pigmentosa 11"", ""disease_description"": ""nan""}]",nan,M,Retinitis Pigmentosa 11,28,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""c.1205C > A"", ""loci_name"": ""PRPF31""}]",,,c.1205C > A,,,PRPF31,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XY",,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2017"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2017,,,skin,dermal fibroblasts,,"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""17/11/17"", ""institutional_HREC"": ""Human Research Ethics Office, University of Western Australia""}]",17/11/17,RA/4/1/7916,"Human Research Ethics Office, University of Western Australia","[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
LEIi008-A,30611018,LEIi008-A_m.json,30611018/LEIi008-A_m.json,"[{""cell_line_alt_name"": ""LEIi008-A; LEIi009-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi008-A; LEIi009-A,"[{""group"": ""Lions Eye Institute, Nedlands, Western Australia, Australia""}]","Lions Eye Institute, Nedlands, Western Australia, Australia","[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mc.lenachan@lei.org.au"", ""phone_number"": ""None""}]",McLenachan,Lions Eye Institute,s.mc.lenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2018.11.018"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier"", ""first_author"": ""Samuel McLenachan"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Samuel McLenachan,Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2018.11.018,"[{""age"": ""28"", ""sex"": ""M"", ""disease_name"": ""Retinitis Pigmentosa 11"", ""disease_description"": ""nan""}]",nan,M,Retinitis Pigmentosa 11,28,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""c.1205C > A"", ""loci_name"": ""PRPF31""}]",,,c.1205C > A,,,PRPF31,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed a normal karyotype.""}]","46,XY",,GB,Karyotyping showed a normal karyotype.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2017"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2017,,,skin,dermal fibroblasts,,"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""17/11/17"", ""institutional_HREC"": ""University of Western Australia""}]",17/11/17,RA/4/1/7916,University of Western Australia,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
LEIi007-A,30634128,LEIi007-A_m.json,30634128/LEIi007-A_m.json,"[{""cell_line_alt_name"": ""LEIi007-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi007-A,"[{""group"": ""The University of Western Australia""}]",The University of Western Australia,"[{""group"": ""Dr Samuel McLean"", ""first_name"": ""Samuel"", ""last_name"": ""McLean"", ""name_initials"": ""None"", ""e_mail"": ""s.mclean@uwa.edu.au"", ""phone_number"": ""None""}]",McLean,Dr Samuel McLean,s.mclean@uwa.edu.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2018.11.013"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy"", ""first_author"": ""Johann N. Claassen"", ""last_author"": ""Fred K. Chen"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Johann N. Claassen,Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy,Fred K. Chen,Stem Cell Research,10.1016/j.scr.2018.11.013,"[{""age"": ""15"", ""sex"": ""F"", ""disease_name"": ""Stargardt Macular Dystrophy"", ""disease_description"": ""Recessive mutations in the ABCA4 gene cause Stargardt disease, an early-onset autosomal recessive degenerative disease.""}]","Recessive mutations in the ABCA4 gene cause Stargardt disease, an early-onset autosomal recessive degenerative disease.",F,Stargardt Macular Dystrophy,15,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Episomal Vectors"", ""description"": ""Reprogramming of patient dermal fibroblasts was performed using episomal plasmids."", ""genotype"": ""Compound heterozygous ABCA4 c.4139C > T and c.5461-10T > C"", ""loci_name"": ""ABCA4""}]",,,Compound heterozygous ABCA4 c.4139C > T and c.5461-10T > C,Reprogramming of patient dermal fibroblasts was performed using episomal plasmids.,Episomal Vectors,ABCA4,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""15"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed that LEIi007-A had a normal karyotype.""}]","46,XX",15,GB,Karyotyping confirmed that LEIi007-A had a normal karyotype.,"[{""i_source_cell_type_term"": ""dermal fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2018"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2018,,,skin,dermal fibroblasts,[],"[{""ethics_number"": ""RA/4/1/7916"", ""approval_date"": ""None"", ""institutional_HREC"": ""Human Research Ethics Office, University of Western Australia""}]",,RA/4/1/7916,"Human Research Ethics Office, University of Western Australia","[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,,,,,,,,,,
HIPI004-A,35728440,HIPI004-A_m.json,35728440/HIPI004-A_m.json,"[{""cell_line_alt_name"": ""HIPI004-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HIPI004-B,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""None"", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,,Joshua,"[{""doi"": ""10.1016/j.scr.2022.102830"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two isogenic induced pluripotent stem cell lines from a 1-month-old nemaline myopathy patient harbouring a homozygous recessive c.121C > T (p.Arg39Ter) variant in the ACTA1 gene"", ""first_author"": ""Isabella S. Suleski"", ""last_author"": ""Joshua S. Clayton"", ""year"": ""2022"", ""pmid"": ""35619329""}]",2022,35619329,Isabella S. Suleski,Generation of two isogenic induced pluripotent stem cell lines from a 1-month-old nemaline myopathy patient harbouring a homozygous recessive c.121C > T (p.Arg39Ter) variant in the ACTA1 gene,Joshua S. Clayton,Stem Cell Research,10.1016/j.scr.2022.102830,"[{""age"": ""1 month"", ""sex"": ""M"", ""disease_name"": ""Nemaline myopathy"", ""disease_description"": ""Congenital skeletal muscle disorder""}]",Congenital skeletal muscle disorder,M,Nemaline myopathy,1 month,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Homozygous ACTA1 variant; NM_001100.0; c.121C > T"", ""genotype"": ""None"", ""loci_name"": ""ACTA1""}]",,,,Homozygous ACTA1 variant; NM_001100.0; c.121C > T,,ACTA1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Normal male karyotype""}]","46,XY",10,GB,Normal male karyotype,"[{""i_source_cell_type_term"": ""lymphoblastoid cell line (LCL)"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2021"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2021,CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,lymphoblastoid cell line (LCL),[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia's Human Research Ethics Committee""}]",,,University of Western Australia's Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
HIPI004-B,35728440,HIPI004-B_m.json,35728440/HIPI004-B_m.json,"[{""cell_line_alt_name"": ""HIPI004-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HIPI004-B,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""J.S."", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,J.S.,Joshua,"[{""doi"": ""10.1016/j.scr.2022.102830"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two isogenic induced pluripotent stem cell lines from a 1-month-old melamine myopathy patient harbouring a homozygous recessive c.121C > T (p.Arg39Ter) variant in the ACTA1 gene"", ""first_author"": ""Isabella S. Suleski"", ""last_author"": ""Joshua S. Clayton"", ""year"": ""2022"", ""pmid"": ""35650999""}]",2022,35650999,Isabella S. Suleski,Generation of two isogenic induced pluripotent stem cell lines from a 1-month-old melamine myopathy patient harbouring a homozygous recessive c.121C > T (p.Arg39Ter) variant in the ACTA1 gene,Joshua S. Clayton,Stem Cell Research,10.1016/j.scr.2022.102830,"[{""age"": ""1 month"", ""sex"": ""M"", ""disease_name"": ""Nemaline myopathy"", ""disease_description"": ""Congenital skeletal muscle disorder""}]",Congenital skeletal muscle disorder,M,Nemaline myopathy,1 month,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Homozygous ACTA1 variant; NM_001100, c.121C > T"", ""genotype"": ""None"", ""loci_name"": ""ACTA1""}]",,,,"Homozygous ACTA1 variant; NM_001100, c.121C > T",,ACTA1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Normal male karyotype""}]","46,XY",10,GB,Normal male karyotype,"[{""i_source_cell_type_term"": ""lymphoblastoid cell line (LCL)"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2021"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2021,CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,lymphoblastoid cell line (LCL),[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia's Human Research Ethics Committee""}]",,,University of Western Australia's Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
HPI001-B,33740643,HPI001-B_m.json,33740643/HPI001-B_m.json,"[{""cell_line_alt_name"": ""HPI001-A; HPI001-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,HPI001-A; HPI001-B,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""S."", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,S.,Joshua,"[{""doi"": ""10.1016/j.scr.2021.102273"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two isogenic induced pluripotent stem cell lines from a 4-month-old severe nemaline myopathy patient with a heterozygous dominant c.553C > A (p.Arg183Ser) variant in the ACTA1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Rhonda L. Taylor"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Joshua S. Clayton,Generation of two isogenic induced pluripotent stem cell lines from a 4-month-old severe nemaline myopathy patient with a heterozygous dominant c.553C > A (p.Arg183Ser) variant in the ACTA1 gene,Rhonda L. Taylor,Stem Cell Research,10.1016/j.scr.2021.102273,"[{""age"": ""4 months"", ""sex"": ""F"", ""disease_name"": ""Nemaline myopathy"", ""disease_description"": ""severe form""}]",severe form,F,Nemaline myopathy,4 months,"[{""mutation_type"": ""Spontaneous variant"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous ACTA1 mutation; NM_001100: c.553C > A"", ""genotype"": ""None"", ""loci_name"": ""ACTA1""}]",,Spontaneous variant,,Heterozygous ACTA1 mutation; NM_001100: c.553C > A,,ACTA1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Normal karyotype with no chromosomal abnormalities.""}]","46,XX",10,GB,Normal karyotype with no chromosomal abnormalities.,"[{""i_source_cell_type_term"": ""lymphoblastoid cell line"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,lymphoblastoid cell line,[],"[{""ethics_number"": ""None"", ""approval_date"": ""September 2020"", ""institutional_HREC"": ""Human Research Ethics Committee (approval number: RWA/20/1008)""}]",September 2020,,Human Research Ethics Committee (approval number: RWA/20/1008),"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
HPI001-A,33740643,HPI001-A_m.json,33740643/HPI001-A_m.json,"[{""cell_line_alt_name"": ""HPI001-A; HPI001-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,HPI001-A; HPI001-B,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""S."", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,S.,Joshua,"[{""doi"": ""10.1016/j.scr.2021.102273"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two isogenic induced pluripotent stem cell lines from a 4-month-old severe nemaline myopathy patient with a heterozygous dominant c.553C > A (p.Arg183Ser) variant in the ACTA1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Rhonda L. Taylor"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Joshua S. Clayton,Generation of two isogenic induced pluripotent stem cell lines from a 4-month-old severe nemaline myopathy patient with a heterozygous dominant c.553C > A (p.Arg183Ser) variant in the ACTA1 gene,Rhonda L. Taylor,Stem Cell Research,10.1016/j.scr.2021.102273,"[{""age"": ""4 months"", ""sex"": ""F"", ""disease_name"": ""Nemaline myopathy"", ""disease_description"": ""severe form""}]",severe form,F,Nemaline myopathy,4 months,"[{""mutation_type"": ""Spontaneous variant"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous ACTA1 mutation; NM_001100.1:c.553C > A"", ""genotype"": ""None"", ""loci_name"": ""ACTA1""}]",,Spontaneous variant,,Heterozygous ACTA1 mutation; NM_001100.1:c.553C > A,,ACTA1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping indicated normal copy number (2n = 46, XX). No chromosomal abnormalities were found in either line.""}]","46,XX",10,GB,"Karyotyping indicated normal copy number (2n = 46, XX). No chromosomal abnormalities were found in either line.","[{""i_source_cell_type_term"": ""lymphoblastoid cell line (LCL)"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""Sendai virus"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,CytoTune-iPS 2.0 Sendai reprogramming kit,Sendai virus,blood,lymphoblastoid cell line (LCL),[],"[{""ethics_number"": ""None"", ""approval_date"": ""September 2020"", ""institutional_HREC"": ""University of Western Australia Human Research Ethics Committee""}]",September 2020,,University of Western Australia Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
PB007,37150143,PB007_m.json,37150143/PB007_m.json,"[{""cell_line_alt_name"": ""PB007 (MCRI1007-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,PB007 (MCRI1007-A),"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Katerina"", ""last_name"": ""Vlahos"", ""name_initials"": ""None"", ""e_mail"": ""Katerina.Vlahos@mcri.edu.au"", ""phone_number"": ""None""}]",Vlahos,Murdoch Children's Research Institute,Katerina.Vlahos@mcri.edu.au,,,Katerina,"[{""doi"": ""10.1016/j.scr.2023.103109"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors"", ""first_author"": ""Katerina Vlahos"", ""last_author"": ""Andrew G. Elefanty"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Katerina Vlahos,Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors,Andrew G. Elefanty,Stem Cell Research,10.1016/j.scr.2023.103109,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}, {""age"": ""56"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}, {""age"": ""40"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,F | F | F,,35 | 56 | 40,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""12"", ""karyotype"": ""Normal"", ""karyotype_method"": ""SNP array"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs.""}]",Normal,12,SNP array,Karyotyping occurred at a resolution of 300bphs.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""None""}]",2023,,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
PB003,37150143,PB003_m.json,37150143/PB003_m.json,"[{""cell_line_alt_name"": ""PB003 (MCRI1003-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,PB003 (MCRI1003-A),"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Katerina"", ""last_name"": ""Vlahos"", ""name_initials"": ""None"", ""e_mail"": ""Katerina.Vlahos@mcri.edu.au"", ""phone_number"": ""None""}]",Vlahos,Murdoch Children's Research Institute,Katerina.Vlahos@mcri.edu.au,,,Katerina,"[{""doi"": ""10.1016/j.scr.2023.103109"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors"", ""first_author"": ""Katerina Vlahos"", ""last_author"": ""Andrew G. Elefanty"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Katerina Vlahos,Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors,Andrew G. Elefanty,Stem Cell Research,10.1016/j.scr.2023.103109,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}, {""age"": ""56"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}, {""age"": ""40"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,F | F | F,,35 | 56 | 40,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""12"", ""karyotype"": ""arr(1-22)x2,(XY)x1"", ""karyotype_method"": ""SNP"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","arr(1-22)x2,(XY)x1",12,SNP,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""None""}]",2023,,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""3512A"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Children's Hospital Ethics Committee""}]",,3512A,Royal Children's Hospital Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
PB002,37150143,PB002_m.json,37150143/PB002_m.json,"[{""cell_line_alt_name"": ""PB002 (MCRI002-A)"", ""cell_type"": ""iPSC"", ""frozen"": ""False""}]",iPSC,False,PB002 (MCRI002-A),"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Katerina"", ""last_name"": ""Vlahos"", ""name_initials"": ""None"", ""e_mail"": ""Katerina.Vlahos@mcri.edu.au"", ""phone_number"": ""None""}]",Vlahos,Murdoch Children's Research Institute,Katerina.Vlahos@mcri.edu.au,,,Katerina,"[{""doi"": ""10.1016/j.scr.2023.103109"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors"", ""first_author"": ""Katerina Vlahos"", ""last_author"": ""Andrew G. Elefanty"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Katerina Vlahos,Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors,Andrew G. Elefanty,Stem Cell Research,10.1016/j.scr.2023.103109,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,F,,35,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""12"", ""karyotype"": ""arr(1-22)x2,(XY)x1"", ""karyotype_method"": ""SNP"", ""summary"": ""Normal karyotype and no differences detected between the original PBMC sample and its corresponding iPSC line.""}]","arr(1-22)x2,(XY)x1",12,SNP,Normal karyotype and no differences detected between the original PBMC sample and its corresponding iPSC line.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""None""}]",2023,,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""351213"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Children's Hospital Ethics Committee""}]",,351213,Royal Children's Hospital Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
PB009,37150143,PB009_m.json,37150143/PB009_m.json,"[{""cell_line_alt_name"": ""PB009 (MCRI1009-A)"", ""cell_type"": ""iPSC"", ""frozen"": ""False""}]",iPSC,False,PB009 (MCRI1009-A),"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Katerina"", ""last_name"": ""Vlahos"", ""name_initials"": ""None"", ""e_mail"": ""Katerina.Vlahos@mcri.edu.au"", ""phone_number"": ""None""}]",Vlahos,Murdoch Children's Research Institute,Katerina.Vlahos@mcri.edu.au,,,Katerina,"[{""doi"": ""10.1016/j.scr.2023.103109"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors"", ""first_author"": ""Katerina Vlahos"", ""last_author"": ""Andrew G. Elefanty"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Katerina Vlahos,Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors,Andrew G. Elefanty,Stem Cell Research,10.1016/j.scr.2023.103109,"[{""age"": ""51"", ""sex"": ""M"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,M,,51,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""12"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""S"", ""summary"": ""Karyotype analysis confirmed normal male karyotype.""}]","46,XY",12,S,Karyotype analysis confirmed normal male karyotype.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""None""}]",2023,,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""MCRI1009-A"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Children's Hospital Ethics Committee""}]",,MCRI1009-A,Royal Children's Hospital Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
PB008,37150143,PB008_m.json,37150143/PB008_m.json,"[{""cell_line_alt_name"": ""PB008 (MCRI1008-A)"", ""cell_type"": ""iPSC"", ""frozen"": ""False""}]",iPSC,False,PB008 (MCRI1008-A),"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Katerina"", ""last_name"": ""Vlahos"", ""name_initials"": ""None"", ""e_mail"": ""Katerina.Vlahos@mcri.edu.au"", ""phone_number"": ""None""}]",Vlahos,Murdoch Children's Research Institute,Katerina.Vlahos@mcri.edu.au,,,Katerina,"[{""doi"": ""10.1016/j.scr.2023.103109"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors"", ""first_author"": ""Katerina Vlahos"", ""last_author"": ""Andrew G. Elefanty"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Katerina Vlahos,Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors,Andrew G. Elefanty,Stem Cell Research,10.1016/j.scr.2023.103109,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}, {""age"": ""56"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}, {""age"": ""40"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,F | F | F,,35 | 56 | 40,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""12"", ""karyotype"": ""arr(1-22)x2,(XY)x1"", ""karyotype_method"": ""SNP"", ""summary"": ""Karyotyping occurred at a resolution of 0.5 Mb.""}]","arr(1-22)x2,(XY)x1",12,SNP,Karyotyping occurred at a resolution of 0.5 Mb.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2016"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2016,,,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""MCRI1009-A"", ""approval_date"": ""None"", ""institutional_HREC"": ""Murdoch Children's Research Institute""}]",,MCRI1009-A,Murdoch Children's Research Institute,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
P8010.5.ACTA1Tom,38277710,P8010.5.ACTA1Tom_m.json,38277710/P8010.5.ACTA1Tom_m.json,"[{""cell_line_alt_name"": ""ACTA1Tom; P8010.5.ACTA1Tom"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,ACTA1Tom; P8010.5.ACTA1Tom,"[{""group"": ""Murdoch Children's Research Institute""}]",Murdoch Children's Research Institute,"[{""group"": ""Murdoch Children's Research Institute"", ""first_name"": ""Peter"", ""last_name"": ""Houweling"", ""name_initials"": ""J"", ""e_mail"": ""peter.houweling@mcri.edu.au"", ""phone_number"": ""None""}]",Houweling,Murdoch Children's Research Institute,peter.houweling@mcri.edu.au,,J,Peter,"[{""doi"": ""10.1016/j.scr.2024.103313"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing"", ""first_author"": ""P.J. Houweling"", ""last_author"": ""K.N. North"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,P.J. Houweling,Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing,K.N. North,Stem Cell Research,10.1016/j.scr.2024.103313,"[{""age"": ""20"", ""sex"": ""M"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,M,,20,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR/Cas9"", ""description"": ""Insertion of tdTomato reporter into ACTA1 locus"", ""genotype"": ""None"", ""loci_name"": ""ACTA1""}]",,,,Insertion of tdTomato reporter into ACTA1 locus,CRISPR/Cas9,ACTA1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,[],,,,,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""35121A"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Children's Hospital""}]",,35121A,Royal Children's Hospital,[],,,,,,,,,,,,,
MCRI010-A,38277710,MCRI010-A_m.json,38277710/MCRI010-A_m.json,"[{""cell_line_alt_name"": ""ACTA1tdTom; PB010.5.ACTA1tdTom"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,ACTA1tdTom; PB010.5.ACTA1tdTom,"[{""group"": ""Murdoch Children\u2019s Research Institute (MCRI)""}]",Murdoch Children’s Research Institute (MCRI),"[{""group"": ""Murdoch Children\u2019s Research Institute (MCRI)"", ""first_name"": ""Peter"", ""last_name"": ""Houweling"", ""name_initials"": ""J"", ""e_mail"": ""Peter.houweling@mcri.edu.au"", ""phone_number"": ""None""}]",Houweling,Murdoch Children’s Research Institute (MCRI),Peter.houweling@mcri.edu.au,,J,Peter,"[{""doi"": ""10.1016/j.scr.2024.103313"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing"", ""first_author"": ""P.J. Houweling"", ""last_author"": ""K.N. North"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,P.J. Houweling,Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing,K.N. North,Stem Cell Research,10.1016/j.scr.2024.103313,"[{""age"": ""20"", ""sex"": ""M"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,M,,20,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Insertion of tdTomato reporter into the ACTA1 locus."", ""genotype"": ""None"", ""loci_name"": ""ACTA1""}]",,,,Insertion of tdTomato reporter into the ACTA1 locus.,,ACTA1,[],[],,,,[],,,,,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""35121A"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Children\u2019s Hospital""}]",,35121A,Royal Children’s Hospital,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
ACTA1TdTom,38277710,ACTA1TdTom_m.json,38277710/ACTA1TdTom_m.json,"[{""cell_line_alt_name"": ""ACTA1TdTom; MCRI010-A"", ""cell_type"": ""iPSC"", ""frozen"": ""False""}]",iPSC,False,ACTA1TdTom; MCRI010-A,"[{""group"": ""Murdoch Children's Research Institute (MCRI)""}]",Murdoch Children's Research Institute (MCRI),"[{""group"": ""Murdoch Children's Research Institute (MCRI)"", ""first_name"": ""Peter"", ""last_name"": ""Houweling"", ""name_initials"": ""J"", ""e_mail"": ""peter.houweling@mcri.edu.au"", ""phone_number"": ""None""}]",Houweling,Murdoch Children's Research Institute (MCRI),peter.houweling@mcri.edu.au,,J,Peter,"[{""doi"": ""10.1016/j.scr.2024.103313"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing"", ""first_author"": ""P.J. Houweling"", ""last_author"": ""K.N. North"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,P.J. Houweling,Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing,K.N. North,Stem Cell Research,10.1016/j.scr.2024.103313,"[{""age"": ""20"", ""sex"": ""M"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,M,,20,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Insertion of tdTomato reporter into ACTA1 locus."", ""genotype"": ""None"", ""loci_name"": ""ACTA1""}]",,,,Insertion of tdTomato reporter into ACTA1 locus.,,ACTA1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""Normal"", ""karyotype_method"": ""None"", ""summary"": ""No aneuploidies detected.""}]",Normal,,,No aneuploidies detected.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""35121A"", ""approval_date"": ""None"", ""institutional_HREC"": ""Royal Children's Hospital""}]",,35121A,Royal Children's Hospital,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
E-2,20178001,E-2_m.json,20178001/E-2_m.json,"[{""cell_line_alt_name"": ""Endeavour-2; E-2"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,Endeavour-2; E-2,"[{""group"": ""Diabetes Transplant Unit, Prince of Wales Hospital & University of New South Wales""}]","Diabetes Transplant Unit, Prince of Wales Hospital & University of New South Wales","[{""group"": ""Stem Cell Lab, School of Biotechnology and Biomolecular Sciences and School of Psychiatry, Faculty of Medicine, University of New South Wales"", ""first_name"": ""Kuldip"", ""last_name"": ""Sidhu"", ""name_initials"": ""S."", ""e_mail"": ""k.s.sidhu@unsw.edu.au"", ""phone_number"": ""None""}]",Sidhu,"Stem Cell Lab, School of Biotechnology and Biomolecular Sciences and School of Psychiatry, Faculty of Medicine, University of New South Wales",k.s.sidhu@unsw.edu.au,,S.,Kuldip,"[{""doi"": ""10.1007/s16216-010-9280-8"", ""journal"": ""In Vitro Cell Dev Biol - Animal"", ""title"": ""Derivation of a new human embryonic stem cell line, Endeavour-2, and its characterization"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernard E. Tuch"", ""year"": ""2010"", ""pmid"": ""None""}]",2010,,Kuldip S. Sidhu,"Derivation of a new human embryonic stem cell line, Endeavour-2, and its characterization",Bernard E. Tuch,In Vitro Cell Dev Biol - Animal,10.1007/s16216-010-9280-8,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""NESTIN; SOX17"", ""method_used"": ""Q-PCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""VIMENTIN"", ""method_used"": ""Q-PCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""E-2 shows a normal karyotype and has been successfully cryopreserved and thawed several times.""}]","46,XX",9,GB,E-2 shows a normal karyotype and has been successfully cryopreserved and thawed several times.,[],,,,,,[],"[{""ethics_number"": ""02247/02267"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of New South Wales Human Research Ethics Committee""}]",,02247/02267,University of New South Wales Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,EN | ME,Q-PCR | Q-PCR,NESTIN; SOX17 | VIMENTIN,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
Endeavour-2,20178001,Endeavour-2_m.json,20178001/Endeavour-2_m.json,"[{""cell_line_alt_name"": ""E-2; Endeavour-2"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,E-2; Endeavour-2,"[{""group"": ""Diabetes Transplant Unit, Prince of Wales Hospital & University of New South Wales""}]","Diabetes Transplant Unit, Prince of Wales Hospital & University of New South Wales","[{""group"": ""Stem Cell Lab, School of Biotechnology and Biomolecular Sciences and School of Psychiatry, Faculty of Medicine, University of New South Wales"", ""first_name"": ""Kuldip"", ""last_name"": ""Sidhu"", ""name_initials"": ""S."", ""e_mail"": ""k.s.sidhu@unsw.edu.au"", ""phone_number"": ""None""}]",Sidhu,"Stem Cell Lab, School of Biotechnology and Biomolecular Sciences and School of Psychiatry, Faculty of Medicine, University of New South Wales",k.s.sidhu@unsw.edu.au,,S.,Kuldip,"[{""doi"": ""10.1007/s16216-010-9280-8"", ""journal"": ""In Vitro Cell Dev Biol - Animal"", ""title"": ""Derivation of a new human embryonic stem cell line, Endeavour-2, and its characterization"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernard E. Tuch"", ""year"": ""2010"", ""pmid"": ""None""}]",2010,,Kuldip S. Sidhu,"Derivation of a new human embryonic stem cell line, Endeavour-2, and its characterization",Bernard E. Tuch,In Vitro Cell Dev Biol - Animal,10.1007/s16216-010-9280-8,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""NESTIN; SOX17"", ""method_used"": ""Q-PCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""VIMENTIN; SOX17"", ""method_used"": ""Q-PCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""E-2 has been cultured over a period of more than 6 months without any apparent deterioration in pluripotency characteristics.""}]","46,XX",9,GB,E-2 has been cultured over a period of more than 6 months without any apparent deterioration in pluripotency characteristics.,[],,,,,,[],"[{""ethics_number"": ""02247/02267"", ""approval_date"": ""None"", ""institutional_HREC"": ""Institutional Human Research Ethics Committee""}]",,02247/02267,Institutional Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,EN | ME,Q-PCR | Q-PCR,NESTIN; SOX17 | VIMENTIN; SOX17,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
MICCNi002-B,30622032,MICCNi002-B_m.json,30622032/MICCNi002-B_m.json,"[{""cell_line_alt_name"": ""MICCNi002-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MICCNi002-B,"[{""group"": ""Monash Institute of Cognitive and Clinical Neurosciences, Monash University""}]","Monash Institute of Cognitive and Clinical Neurosciences, Monash University","[{""group"": ""Monash Institute of Cognitive and Clinical Neurosciences"", ""first_name"": ""Janette"", ""last_name"": ""Tong"", ""name_initials"": ""None"", ""e_mail"": ""janette.tong@monash.edu"", ""phone_number"": ""None""}]",Tong,Monash Institute of Cognitive and Clinical Neurosciences,janette.tong@monash.edu,,,Janette,"[{""doi"": ""10.1016/j.scr.2018.11.014"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family"", ""first_author"": ""Janette Tong"", ""last_author"": ""Mark A. Bellgrove"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Janette Tong,Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family,Mark A. Bellgrove,Stem Cell Research,10.1016/j.scr.2018.11.014,"[{""age"": ""16"", ""sex"": ""M"", ""disease_name"": ""Attention Deficit Hyperactivity Disorder"", ""disease_description"": ""nan""}]",nan,M,Attention Deficit Hyperactivity Disorder,16,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""46,XY"", ""loci_name"": ""None""}]",,,"46,XY",,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""15"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Performed DNA profiling of 15 iPSC lines with 100% concordance with parental PBMCs.""}]","46,XY",15,GB,Performed DNA profiling of 15 iPSC lines with 100% concordance with parental PBMCs.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2018"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai Reprogramming Kit""}]",2018,CytoTune-iPS 2.0 Sendai Reprogramming Kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""CF15/2566 - 201501048"", ""approval_date"": ""None"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",,CF15/2566 - 201501048,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
MICCNi002-A,30622032,MICCNi002-A_m.json,30622032/MICCNi002-A_m.json,"[{""cell_line_alt_name"": ""MICCNi002-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MICCNi002-A,"[{""group"": ""Monash Institute of Cognitive and Clinical Neurosciences, Melbourne, Australia""}]","Monash Institute of Cognitive and Clinical Neurosciences, Melbourne, Australia","[{""group"": ""Monash Institute of Cognitive and Clinical Neurosciences"", ""first_name"": ""Janette"", ""last_name"": ""Tong"", ""name_initials"": ""None"", ""e_mail"": ""janette.tong@monash.edu"", ""phone_number"": ""None""}]",Tong,Monash Institute of Cognitive and Clinical Neurosciences,janette.tong@monash.edu,,,Janette,"[{""doi"": ""10.1016/j.scr.2018.11.014"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family"", ""first_author"": ""Janette Tong"", ""last_author"": ""Mark A. Bellgrove"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Janette Tong,Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family,Mark A. Bellgrove,Stem Cell Research,10.1016/j.scr.2018.11.014,"[{""age"": ""16"", ""sex"": ""M"", ""disease_name"": ""Attention Deficit Hyperactivity Disorder"", ""disease_description"": ""nan""}]",nan,M,Attention Deficit Hyperactivity Disorder,16,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""15"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XY",15,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2018"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai Reprogramming Kit""}]",2018,CytoTune-iPS 2.0 Sendai Reprogramming Kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""CF15/2566 \u2013 201501048"", ""approval_date"": ""None"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",,CF15/2566 – 201501048,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
MICCNi001-B,30622032,MICCNi001-B_m.json,30622032/MICCNi001-B_m.json,"[{""cell_line_alt_name"": ""MICCNi001-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MICCNi001-B,"[{""group"": ""Monash Institute of Cognitive and Clinical Neurosciences, Monash University""}]","Monash Institute of Cognitive and Clinical Neurosciences, Monash University","[{""group"": ""Monash Institute of Cognitive and Clinical Neurosciences"", ""first_name"": ""Janette"", ""last_name"": ""Tong"", ""name_initials"": ""J"", ""e_mail"": ""janette.tong@monash.edu"", ""phone_number"": ""None""}]",Tong,Monash Institute of Cognitive and Clinical Neurosciences,janette.tong@monash.edu,,J,Janette,"[{""doi"": ""10.1016/j.scr.2018.11.014"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family"", ""first_author"": ""Janette Tong"", ""last_author"": ""Mark A. Bellgrove"", ""year"": ""2019"", ""pmid"": ""30502834""}]",2019,30502834,Janette Tong,Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family,Mark A. Bellgrove,Stem Cell Research,10.1016/j.scr.2018.11.014,"[{""age"": ""16"", ""sex"": ""M"", ""disease_name"": ""Attention Deficit Hyperactivity Disorder"", ""disease_description"": ""nan""}]",nan,M,Attention Deficit Hyperactivity Disorder,16,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""46,XY"", ""loci_name"": ""None""}]",,,"46,XY",,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""15"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Performed DNA profiling of 15 iPSC lines with 100% concordance with parental PBMCs.""}]","46,XY",15,GB,Performed DNA profiling of 15 iPSC lines with 100% concordance with parental PBMCs.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2018"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai Reprogramming Kit""}]",2018,CytoTune-iPS 2.0 Sendai Reprogramming Kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""CF15/2566 - 201501048"", ""approval_date"": ""None"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",,CF15/2566 - 201501048,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
MICCNi001-A,30622032,MICCNi001-A_m.json,30622032/MICCNi001-A_m.json,"[{""cell_line_alt_name"": ""MICCNi001-A"", ""cell_type"": ""iPSC"", ""frozen"": ""True""}]",iPSC,True,MICCNi001-A,"[{""group"": ""Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Australia""}]","Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Australia","[{""group"": ""Monash Institute of Cognitive and Clinical Neurosciences"", ""first_name"": ""Janette"", ""last_name"": ""Tong"", ""name_initials"": ""None"", ""e_mail"": ""janette.tong@monash.edu"", ""phone_number"": ""None""}]",Tong,Monash Institute of Cognitive and Clinical Neurosciences,janette.tong@monash.edu,,,Janette,"[{""doi"": ""10.1016/j.scr.2018.11.014"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family"", ""first_author"": ""Janette Tong"", ""last_author"": ""Mark A. Bellgrove"", ""year"": ""2019"", ""pmid"": ""None""}]",2019,,Janette Tong,Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an attention deficit hyperactivity disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family,Mark A. Bellgrove,Stem Cell Research,10.1016/j.scr.2018.11.014,"[{""age"": ""16"", ""sex"": ""M"", ""disease_name"": ""Attention Deficit Hyperactivity Disorder"", ""disease_description"": ""nan""}]",nan,M,Attention Deficit Hyperactivity Disorder,16,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""15"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Performed DNA profiling of 15 iPSC lines with 100% concordance with parental PBMCs.""}]","46,XY",15,GB,Performed DNA profiling of 15 iPSC lines with 100% concordance with parental PBMCs.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2018"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai Reprogramming Kit""}]",2018,CytoTune-iPS 2.0 Sendai Reprogramming Kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""CF15/2566 \u2013 201501048"", ""approval_date"": ""None"", ""institutional_HREC"": ""Monash University Human Research Ethics Committee""}]",,CF15/2566 – 201501048,Monash University Human Research Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,,,,,,,,,,
VCCR1003-A,37939621,VCCR1003-A_m.json,37939621/VCCR1003-A_m.json,"[{""cell_line_alt_name"": ""VCCR1002-A; VCCR1003-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,VCCR1002-A; VCCR1003-A,"[{""group"": ""Victor Chang Cardiac Research Institute""}]",Victor Chang Cardiac Research Institute,"[{""group"": ""Victor Chang Cardiac Research Institute"", ""first_name"": ""Robert"", ""last_name"": ""Graham"", ""name_initials"": ""M"", ""e_mail"": ""Graham@victorchang.edu.au"", ""phone_number"": ""None""}]",Graham,Victor Chang Cardiac Research Institute,Graham@victorchang.edu.au,,M,Robert,"[{""doi"": ""10.1016/j.scr.2023.103238"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from a sister pair who suffered post-partum or recurrent Spontaneous Coronary Artery Dissections"", ""first_author"": ""Monique Bax"", ""last_author"": ""Robert M Graham"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Monique Bax,Generation of induced pluripotent stem cell lines from a sister pair who suffered post-partum or recurrent Spontaneous Coronary Artery Dissections,Robert M Graham,Stem Cell Research,10.1016/j.scr.2023.103238,"[{""age"": ""37"", ""sex"": ""F"", ""disease_name"": ""Spontaneous Coronary Artery Dissection"", ""disease_description"": ""None""}, {""age"": ""41"", ""sex"": ""F"", ""disease_name"": ""Spontaneous Coronary Artery Dissection"", ""disease_description"": ""None""}]",,F | F,Spontaneous Coronary Artery Dissection | Spontaneous Coronary Artery Dissection,37 | 41,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Sendai Virus"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Sendai Virus,,"[{""cell_type"": ""EC"", ""show_potency"": ""True"", ""marker_list"": ""SOX17; Brachyury"", ""method_used"": ""In Vitro Differentiation AND Scorecard"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""PAX6"", ""method_used"": ""In Vitro Differentiation AND Scorecard"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""15"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 400 bphs.""}]","46,XX",15,GB,Karyotyping occurred at a resolution of 400 bphs.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2023,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""16/245"", ""approval_date"": ""09.03.2020"", ""institutional_HREC"": ""St Vincent's Hospital Human Research Ethics Committee""}]",09.03.2020,16/245,St Vincent's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EC | ME,In Vitro Differentiation AND Scorecard | In Vitro Differentiation AND Scorecard,SOX17; Brachyury | PAX6,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
VCCR1002-A,37939621,VCCR1002-A_m.json,37939621/VCCR1002-A_m.json,"[{""cell_line_alt_name"": ""VCCR1002-A; 069; VCCR1003-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,VCCR1002-A; 069; VCCR1003-A,"[{""group"": ""Victor Chang Cardiac Research Institute""}]",Victor Chang Cardiac Research Institute,"[{""group"": ""Victor Chang Cardiac Research Institute"", ""first_name"": ""Robert"", ""last_name"": ""Graham"", ""name_initials"": ""M"", ""e_mail"": ""Graham@victorchang.edu.au"", ""phone_number"": ""None""}]",Graham,Victor Chang Cardiac Research Institute,Graham@victorchang.edu.au,,M,Robert,"[{""doi"": ""10.1016/j.scr.2023.103238"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from a sister pair who suffered post-partum or recurrent Spontaneous Coronary Artery Dissections"", ""first_author"": ""Monique Bax"", ""last_author"": ""Robert M Graham"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Monique Bax,Generation of induced pluripotent stem cell lines from a sister pair who suffered post-partum or recurrent Spontaneous Coronary Artery Dissections,Robert M Graham,Stem Cell Research,10.1016/j.scr.2023.103238,"[{""age"": ""37"", ""sex"": ""F"", ""disease_name"": ""Spontaneous Coronary Artery Dissection"", ""disease_description"": ""None""}, {""age"": ""41"", ""sex"": ""F"", ""disease_name"": ""Spontaneous Coronary Artery Dissection"", ""disease_description"": ""None""}]",,F | F,Spontaneous Coronary Artery Dissection | Spontaneous Coronary Artery Dissection,37 | 41,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""PAX6"", ""method_used"": ""hPSC Scorecard Assay"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""Brachyury; SOX17"", ""method_used"": ""hPSC Scorecard Assay"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""15"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 400 bphs.""}]","46,XX",15,GB,Karyotyping occurred at a resolution of 400 bphs.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2023"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2023,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""16/245"", ""approval_date"": ""09.03.2020"", ""institutional_HREC"": ""St Vincent's Hospital Human Research Ethics Committee""}]",09.03.2020,16/245,St Vincent's Hospital Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME,hPSC Scorecard Assay | hPSC Scorecard Assay,PAX6 | Brachyury; SOX17,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
SPG2,36166872,SPG2_m.json,36166872/SPG2_m.json,"[{""cell_line_alt_name"": ""SPG2"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,SPG2,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Australian Institute for Bioengineering and Nanotechnology,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102917"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations"", ""first_author"": ""Hannah C. Leeson"", ""last_author"": ""Ernst J. Wolvetang"", ""year"": ""2022"", ""pmid"": ""36117854""}]",2022,36117854,Hannah C. Leeson,Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations,Ernst J. Wolvetang,Stem Cell Research,10.1016/j.scr.2022.102917,"[{""age"": ""37"", ""sex"": ""M"", ""disease_name"": ""Hereditary spastic paraplegia 56"", ""disease_description"": ""CYP2U1 compound heterozygous""}, {""age"": ""34"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",CYP2U1 compound heterozygous,M | F,Hereditary spastic paraplegia 56,37 | 34,"[{""mutation_type"": ""CYP2U1 compound heterozygous"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrating Sendai virus delivery"", ""description"": ""Exon 4 substitution: c.1376C > T; p.(Arg459Leu)"", ""genotype"": ""None"", ""loci_name"": ""CYP2U1""}]",,CYP2U1 compound heterozygous,,Exon 4 substitution: c.1376C > T; p.(Arg459Leu),Non-integrating Sendai virus delivery,CYP2U1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""2"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""STR"", ""summary"": ""Karyotyping confirmed normal karyotype.""}]","46,XY",2,STR,Karyotyping confirmed normal karyotype.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2022"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai Reprogramming Kit""}]",2022,CytoTune-iPS 2.0 Sendai Reprogramming Kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""UQ HREC 2019/000,159"", ""approval_date"": ""December 2021"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",December 2021,"UQ HREC 2019/000,159",University of Queensland Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual passage""}]",21%,Manual passage,5%,EN | ME,qPCR | qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
SPG1,36166872,SPG1_m.json,36166872/SPG1_m.json,"[{""cell_line_alt_name"": ""SPG1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,SPG1,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Australian Institute for Bioengineering and Nanotechnology,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102917"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations"", ""first_author"": ""Hannah C. Leeson"", ""last_author"": ""Ernst J. Wolvetang"", ""year"": ""2022"", ""pmid"": ""36017361""}]",2022,36017361,Hannah C. Leeson,Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations,Ernst J. Wolvetang,Stem Cell Research,10.1016/j.scr.2022.102917,"[{""age"": ""None"", ""sex"": ""F"", ""disease_name"": ""Hereditary spastic paraplegia 56"", ""disease_description"": ""SPG56 causes progressive spasticity in upper and lower limbs""}]",SPG56 causes progressive spasticity in upper and lower limbs,F,Hereditary spastic paraplegia 56,,"[{""mutation_type"": ""CYP2U1 compound heterozygous"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrating Sendai virus delivery"", ""description"": ""Exon 4 substitution: c.1376C > T; p.(Arg459Leu)"", ""genotype"": ""None"", ""loci_name"": ""CYP2U1""}]",,CYP2U1 compound heterozygous,,Exon 4 substitution: c.1376C > T; p.(Arg459Leu),Non-integrating Sendai virus delivery,CYP2U1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""2"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""STR analysis"", ""summary"": ""Karyotyping confirmed normal karyotype.""}]","46,XX",2,STR analysis,Karyotyping confirmed normal karyotype.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2022"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai Reprogramming Kit""}]",2022,CytoTune-iPS 2.0 Sendai Reprogramming Kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""UQ HREC 2019/000,159"", ""approval_date"": ""December 2021"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",December 2021,"UQ HREC 2019/000,159",University of Queensland Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual passage""}]",21%,Manual passage,5%,EN | ME,qPCR | qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
SPGh1,36166872,SPGh1_m.json,36166872/SPGh1_m.json,"[{""cell_line_alt_name"": ""SPGh1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,SPGh1,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Australian Institute for Bioengineering and Nanotechnology,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102917"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations"", ""first_author"": ""Hannah C. Leeson"", ""last_author"": ""H.C. Leeson et al."", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Hannah C. Leeson,Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations,H.C. Leeson et al.,Stem Cell Research,10.1016/j.scr.2022.102917,"[{""age"": ""1"", ""sex"": ""F"", ""disease_name"": ""Hereditary spastic paraplegia 56 (SPG56)"", ""disease_description"": ""Hereditary spastic paraplegia caused by mutations in CYP2U1""}]",Hereditary spastic paraplegia caused by mutations in CYP2U1,F,Hereditary spastic paraplegia 56 (SPG56),1,"[{""mutation_type"": ""CYP2U1 compound heterozygous"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrating Sendai virus delivery"", ""description"": ""Exon 4 substitution: c.1376C>T; p.(Arg459Leu)"", ""genotype"": ""None"", ""loci_name"": ""CYP2U1""}]",,CYP2U1 compound heterozygous,,Exon 4 substitution: c.1376C>T; p.(Arg459Leu),Non-integrating Sendai virus delivery,CYP2U1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": 2, ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""iPSCs were maintained daily in ReproTeSR until colony formation.""}]",,2,,iPSCs were maintained daily in ReproTeSR until colony formation.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2022"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai Reprogramming Kit""}]",2022,CytoTune-iPS 2.0 Sendai Reprogramming Kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""UQ HREC 2019/000,159"", ""approval_date"": ""December 2021"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",December 2021,"UQ HREC 2019/000,159",University of Queensland Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
SPGh2,36166872,SPGh2_m.json,36166872/SPGh2_m.json,"[{""cell_line_alt_name"": ""SPGh2"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,SPGh2,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Australian Institute for Bioengineering and Nanotechnology,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2022.102917"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations"", ""first_author"": ""Hannah C. Leeson"", ""last_author"": ""H.C. Leeson et al."", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Hannah C. Leeson,Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations,H.C. Leeson et al.,Stem Cell Research,10.1016/j.scr.2022.102917,"[{""age"": ""37"", ""sex"": ""M"", ""disease_name"": ""Hereditary spastic paraplegia 56 (SPG56)"", ""disease_description"": ""CYP2U1 compound heterozygous""}, {""age"": ""34"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",CYP2U1 compound heterozygous,M | F,Hereditary spastic paraplegia 56 (SPG56),37 | 34,"[{""mutation_type"": ""CYP2U1 compound heterozygous"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrating Sendai virus delivery"", ""description"": ""Exon 4 substitution: c.1376C > T; p.(Pro459Leu)"", ""genotype"": ""None"", ""loci_name"": ""CYP2U1""}]",,CYP2U1 compound heterozygous,,Exon 4 substitution: c.1376C > T; p.(Pro459Leu),Non-integrating Sendai virus delivery,CYP2U1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""2"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""STR"", ""summary"": ""Karyotyping confirmed normal karyotype.""}]","46,XX",2,STR,Karyotyping confirmed normal karyotype.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2022"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai Reprogramming Kit""}]",2022,CytoTune-iPS 2.0 Sendai Reprogramming Kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""None"", ""approval_date"": ""December 2021"", ""institutional_HREC"": ""UQ HREC, 2019,000,159 - Generation, differentiation and genetic manipulation of human induced pluripotent stem cells""}]",December 2021,,"UQ HREC, 2019,000,159 - Generation, differentiation and genetic manipulation of human induced pluripotent stem cells","[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,EN | ME,qPCR | qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
HPIi006-A,38583293,HPIi006-A_m.json,38583293/HPIi006-A_m.json,"[{""cell_line_alt_name"": ""HPIi006-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HPIi006-A,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""None"", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,,Joshua,"[{""doi"": ""10.1016/j.scr.2024.103410"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Rhonda L. Taylor"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Joshua S. Clayton,Generation of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene,Rhonda L. Taylor,Stem Cell Research,10.1016/j.scr.2024.103410,"[{""age"": ""3"", ""sex"": ""None"", ""disease_name"": ""Central core disease; Malignant hyperthermia susceptibility"", ""disease_description"": ""Inherited condition characterized by muscle rigidity and hyperthermia""}]",Inherited condition characterized by muscle rigidity and hyperthermia,,Central core disease; Malignant hyperthermia susceptibility,3,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""RYR1""}]",,,,,,RYR1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotype analysis showed normal 46,XY karyotype.""}]","46,XY",,GB,"Karyotype analysis showed normal 46,XY karyotype.","[{""i_source_cell_type_term"": ""muscle biopsy"", ""i_source_cell_origin_term"": ""muscle"", ""derivation_year"": ""2022"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0""}]",2022,CytoTune-iPS 2.0,SV,muscle,muscle biopsy,[],"[{""ethics_number"": ""2018-914"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,2018-914,University of Queensland Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual passaging""}]",21%,Manual passaging,5%,,,,,,,,,,
HPIi007-A,38583293,HPIi007-A_m.json,38583293/HPIi007-A_m.json,"[{""cell_line_alt_name"": ""HPIi007-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HPIi007-A,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""S."", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,S.,Joshua,"[{""doi"": ""10.1016/j.scr.2024.103410"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Rhonda L. Taylor"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Joshua S. Clayton,Generation of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene,Rhonda L. Taylor,Stem Cell Research,10.1016/j.scr.2024.103410,"[{""age"": ""40 years"", ""sex"": ""None"", ""disease_name"": ""Central core disease; Malignant hyperthermia susceptibility"", ""disease_description"": ""None""}]",,,Central core disease; Malignant hyperthermia susceptibility,40 years,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Inherited variant (dominant, inherited from affected father)"", ""genotype"": ""None"", ""loci_name"": ""RYR1""}]",,,,"Inherited variant (dominant, inherited from affected father)",,RYR1,"[{""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""TBXT; SOX2; NANOG; CRIPTO"", ""method_used"": ""Directed differentiation"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": 22, ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotype analysis confirmed normal karyotype.""}]","46,XY",22,GB,Karyotype analysis confirmed normal karyotype.,"[{""i_source_cell_type_term"": ""lymphoblastoid cell line (LCL)"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2022"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0""}]",2022,CytoTune-iPS 2.0,SV,blood,lymphoblastoid cell line (LCL),,"[{""ethics_number"": ""No. 2018-3156"", ""approval_date"": ""21/07/2018"", ""institutional_HREC"": ""University of Western Australia's Human Research Ethics Committee""}]",21/07/2018,No. 2018-3156,University of Western Australia's Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,ME,Directed differentiation,TBXT; SOX2; NANOG; CRIPTO,True,in vitro directed differentiation,,,,,
SCTI003-A,38583293,SCTI003-A_m.json,38583293/SCTI003-A_m.json,"[{""cell_line_alt_name"": ""HPI1006-A; HPI007-A; SCTI003-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HPI1006-A; HPI007-A; SCTI003-A,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""S"", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,S,Joshua,"[{""doi"": ""10.1016/j.scr.2024.103410"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Rhonda L. Taylor"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Joshua S. Clayton,Generation of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene,Rhonda L. Taylor,Stem Cell Research,10.1016/j.scr.2024.103410,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""Central core disease; Malignant hyperthermia"", ""disease_description"": ""Inherited central core disease (CCD) and malignant hyperthermia (MH)""}]",Inherited central core disease (CCD) and malignant hyperthermia (MH),,Central core disease; Malignant hyperthermia,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""RYR1""}]",,,,,,RYR1,"[{""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""TBXT; SOX2; NANOG; CRIPTO"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""Directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Both lines had a normal 46,XY karyotype by G-banding.""}]","46,XX",,GB,"Both lines had a normal 46,XY karyotype by G-banding.","[{""i_source_cell_type_term"": ""lymphoblastoid cell line (LCL)"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0""}]",2020,CytoTune-iPS 2.0,SV,blood,lymphoblastoid cell line (LCL),,"[{""ethics_number"": ""No. 2018-3156"", ""approval_date"": ""2018"", ""institutional_HREC"": ""University of Western Australia\u2019s Human Research Ethics Committee""}]",2018,No. 2018-3156,University of Western Australia’s Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,ME,RT-qPCR,TBXT; SOX2; NANOG; CRIPTO,True,Directed differentiation,,,,,
iPericytes,38433209,iPericytes_m.json,38433209/iPericytes_m.json,"[{""cell_line_alt_name"": ""iPericytes"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,iPericytes,"[{""group"": ""University of Tasmania""}]",University of Tasmania,"[{""group"": ""Brad A. Sutherland"", ""first_name"": ""Brad"", ""last_name"": ""Sutherland"", ""name_initials"": ""A"", ""e_mail"": ""brad.sutherland@utas.edu.au"", ""phone_number"": ""None""}]",Sutherland,Brad A. Sutherland,brad.sutherland@utas.edu.au,,A,Brad,"[{""doi"": ""10.1186/s13287-024-03671-x"", ""journal"": ""Stem Cell Research & Therapy"", ""title"": ""Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility"", ""first_author"": ""Natalie E. King"", ""last_author"": ""Brad A. Sutherland"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Natalie E. King,Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility,Brad A. Sutherland,Stem Cell Research & Therapy,10.1186/s13287-024-03671-x,"[{""age"": ""67"", ""sex"": ""M"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,M,,67,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""35"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs.""}]","46,XY",35,GB,Karyotyping occurred at a resolution of 300bphs.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""HREC 186351"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Tasmania Ethics Committee""}]",21/07/10,HREC 186351,University of Tasmania Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,,,,,,,,,,
MNZTASi019-A,38433209,MNZTASi019-A_m.json,38433209/MNZTASi019-A_m.json,"[{""cell_line_alt_name"": ""MNZTASi019-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MNZTASi019-A,"[{""group"": ""University of Tasmania""}]",University of Tasmania,"[{""group"": ""Brad A. Sutherland"", ""first_name"": ""Brad"", ""last_name"": ""Sutherland"", ""name_initials"": ""A"", ""e_mail"": ""brad.sutherland@utas.edu.au"", ""phone_number"": ""None""}]",Sutherland,Brad A. Sutherland,brad.sutherland@utas.edu.au,,A,Brad,"[{""doi"": ""10.1186/s13287-024-03671-x"", ""journal"": ""Stem Cell Research & Therapy"", ""title"": ""Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility"", ""first_author"": ""Natalie E. King"", ""last_author"": ""Brad A. Sutherland"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Natalie E. King,Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility,Brad A. Sutherland,Stem Cell Research & Therapy,10.1186/s13287-024-03671-x,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,[],,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
HBVPs,38433209,HBVPs_m.json,38433209/HBVPs_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,,"[{""group"": ""University of Tasmania""}]",University of Tasmania,"[{""group"": ""Brad A. Sutherland"", ""first_name"": ""Brad"", ""last_name"": ""Sutherland"", ""name_initials"": ""A"", ""e_mail"": ""brad.sutherland@utas.edu.au"", ""phone_number"": ""None""}]",Sutherland,Brad A. Sutherland,brad.sutherland@utas.edu.au,,A,Brad,"[{""doi"": ""10.1186/s13287-024-03671-x"", ""journal"": ""Stem Cell Research & Therapy"", ""title"": ""Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility"", ""first_author"": ""Natalie E. King"", ""last_author"": ""Brad A. Sutherland"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Natalie E. King,Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility,Brad A. Sutherland,Stem Cell Research & Therapy,10.1186/s13287-024-03671-x,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,[],,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
MNZTASi022-A,38433209,MNZTASi022-A_m.json,38433209/MNZTASi022-A_m.json,"[{""cell_line_alt_name"": ""MNZTASi022-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MNZTASi022-A,"[{""group"": ""University of Tasmania""}]",University of Tasmania,"[{""group"": ""Brad A. Sutherland"", ""first_name"": ""Brad"", ""last_name"": ""Sutherland"", ""name_initials"": ""A"", ""e_mail"": ""brad.sutherland@utas.edu.au"", ""phone_number"": ""None""}]",Sutherland,Brad A. Sutherland,brad.sutherland@utas.edu.au,,A,Brad,"[{""doi"": ""10.1186/s13287-024-03671-x"", ""journal"": ""Stem Cell Research & Therapy"", ""title"": ""Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility"", ""first_author"": ""Natalie E. King"", ""last_author"": ""Brad A. Sutherland"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Natalie E. King,Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility,Brad A. Sutherland,Stem Cell Research & Therapy,10.1186/s13287-024-03671-x,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,[],,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
MNZTASi021-A,38433209,MNZTASi021-A_m.json,38433209/MNZTASi021-A_m.json,"[{""cell_line_alt_name"": ""MNZTASi021-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,MNZTASi021-A,"[{""group"": ""University of Tasmania""}]",University of Tasmania,"[{""group"": ""Brad A. Sutherland"", ""first_name"": ""Brad"", ""last_name"": ""Sutherland"", ""name_initials"": ""A"", ""e_mail"": ""brad.sutherland@utas.edu.au"", ""phone_number"": ""None""}]",Sutherland,Brad A. Sutherland,brad.sutherland@utas.edu.au,,A,Brad,"[{""doi"": ""10.1186/s13287-024-03671-x"", ""journal"": ""Stem Cell Research & Therapy"", ""title"": ""Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility"", ""first_author"": ""Natalie E. King"", ""last_author"": ""Brad A. Sutherland"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Natalie E. King,Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility,Brad A. Sutherland,Stem Cell Research & Therapy,10.1186/s13287-024-03671-x,"[{""age"": ""76"", ""sex"": ""M"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,M,,76,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,[],,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Tasmania Ethics Committee""}]",,,University of Tasmania Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
hES 3.2,16522163,hES 3.2_m.json,16522163/hES 3.2_m.json,"[{""cell_line_alt_name"": ""hES 3.1; hES 3.2; hES 3.3"", ""cell_type"": ""ESC"", ""frozen"": ""False""}]",ESC,False,hES 3.1; hES 3.2; hES 3.3,"[{""group"": ""Embryonic Stem Cell International Pte, Ltd.""}]","Embryonic Stem Cell International Pte, Ltd.","[{""group"": ""Stem Cell Group, Diabetes Transplant Unit"", ""first_name"": ""Kuldip"", ""last_name"": ""Sidhu"", ""name_initials"": ""None"", ""e_mail"": ""k.sidhu@unsw.edu.au"", ""phone_number"": ""None""}]",Sidhu,"Stem Cell Group, Diabetes Transplant Unit",k.sidhu@unsw.edu.au,,,Kuldip,"[{""doi"": ""10.1089/scd.2005.15.61"", ""journal"": ""Stem Cells and Development"", ""title"": ""Derivation of Three Clones from Human Embryonic Stem Cell Lines by FACS Sorting and Their Characterization"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernard E. Tuch"", ""year"": ""2006"", ""pmid"": ""16460482""}]",2006,16460482,Kuldip S. Sidhu,Derivation of Three Clones from Human Embryonic Stem Cell Lines by FACS Sorting and Their Characterization,Bernard E. Tuch,Stem Cells and Development,10.1089/scd.2005.15.61,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",10,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,[],,,,,,[],"[{""ethics_number"": ""HREC 01270"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of New South Wales""}, {""ethics_number"": ""HREC 02247"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of New South Wales""}]",,HREC 01270 | HREC 02247,University of New South Wales | University of New South Wales,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Trypsin digestion""}]",21%,Trypsin digestion,5%,,,,False,,,,,,
hES 3,16522163,hES 3_m.json,16522163/hES 3_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""ESC"", ""frozen"": ""False""}]",ESC,False,,"[{""group"": ""Embryonic Stem Cell International Pte, Ltd. (Singapore)""}]","Embryonic Stem Cell International Pte, Ltd. (Singapore)","[{""group"": ""Stem Cell Group, Diabetes Transplant Unit"", ""first_name"": ""Kuldip S."", ""last_name"": ""Sidhu"", ""name_initials"": ""None"", ""e_mail"": ""k.sidhu@unsw.edu.au"", ""phone_number"": ""None""}]",Sidhu,"Stem Cell Group, Diabetes Transplant Unit",k.sidhu@unsw.edu.au,,,Kuldip S.,"[{""doi"": ""10.1089/scd.2005.15.61"", ""journal"": ""STEM CELLS AND DEVELOPMENT"", ""title"": ""Derivation of Three Clones from Human Embryonic Stem Cell Lines by FACS Sorting and Their Characterization"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernard E. Tuch"", ""year"": ""2006"", ""pmid"": ""None""}]",2006,,Kuldip S. Sidhu,Derivation of Three Clones from Human Embryonic Stem Cell Lines by FACS Sorting and Their Characterization,Bernard E. Tuch,STEM CELLS AND DEVELOPMENT,10.1089/scd.2005.15.61,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""46XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed a normal 46 XX karyotype.""}]",46XX,10,GB,Karyotyping showed a normal 46 XX karyotype.,[],,,,,,[],"[{""ethics_number"": ""HREC 01270"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}, {""ethics_number"": ""HREC 02247"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,HREC 01270 | HREC 02247,,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""Trypsin digestion""}]",,Trypsin digestion,0.05,,,,,,,,,,
hES 3.3,16522163,hES 3.3_m.json,16522163/hES 3.3_m.json,"[{""cell_line_alt_name"": ""hES 3.3"", ""cell_type"": ""ESC"", ""frozen"": ""False""}]",ESC,False,hES 3.3,"[{""group"": ""Embryonic Stem Cell International Pte, Ltd.""}]","Embryonic Stem Cell International Pte, Ltd.","[{""group"": ""Stem Cell Group, Diabetes Transplant Unit"", ""first_name"": ""Kuldip"", ""last_name"": ""Sidhu"", ""name_initials"": ""None"", ""e_mail"": ""k.sidhu@unsw.edu.au"", ""phone_number"": ""None""}]",Sidhu,"Stem Cell Group, Diabetes Transplant Unit",k.sidhu@unsw.edu.au,,,Kuldip,"[{""doi"": ""10.1089/scd.2005.15.61"", ""journal"": ""Stem Cells and Development"", ""title"": ""Derivation of Three Clones from Human Embryonic Stem Cell Lines by FACS Sorting and Their Characterization"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernard E. Tuch"", ""year"": ""2006"", ""pmid"": ""16460476""}]",2006,16460476,Kuldip S. Sidhu,Derivation of Three Clones from Human Embryonic Stem Cell Lines by FACS Sorting and Their Characterization,Bernard E. Tuch,Stem Cells and Development,10.1089/scd.2005.15.61,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed a normal 46 XX karyotype.""}]","46,XX",10,GB,Karyotyping showed a normal 46 XX karyotype.,[],,,,,,[],"[{""ethics_number"": ""HREC 01270"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}, {""ethics_number"": ""HREC 02247"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,HREC 01270 | HREC 02247,,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""Trypsin digestion""}]",,Trypsin digestion,0.05,,,,,,,,,,
hES 3.1,16522163,hES 3.1_m.json,16522163/hES 3.1_m.json,"[{""cell_line_alt_name"": ""hES 3.1"", ""cell_type"": ""ESC"", ""frozen"": ""False""}]",ESC,False,hES 3.1,"[{""group"": ""Embryonic Stem Cell International Pte. Ltd.""}]",Embryonic Stem Cell International Pte. Ltd.,"[{""group"": ""Stem Cell Group, Diabetes Transplant Unit"", ""first_name"": ""Kuldip"", ""last_name"": ""Sidhu"", ""name_initials"": ""None"", ""e_mail"": ""k.sidhu@unsw.edu.au"", ""phone_number"": ""None""}]",Sidhu,"Stem Cell Group, Diabetes Transplant Unit",k.sidhu@unsw.edu.au,,,Kuldip,"[{""doi"": ""10.1089/scd.2005.15.61"", ""journal"": ""Stem Cells and Development"", ""title"": ""Derivation of Three Clones from Human Embryonic Stem Cell Lines by FACS Sorting and Their Characterization"", ""first_author"": ""Kuldip S. Sidhu"", ""last_author"": ""Bernard E. Tuch"", ""year"": ""2006"", ""pmid"": ""16460436""}]",2006,16460436,Kuldip S. Sidhu,Derivation of Three Clones from Human Embryonic Stem Cell Lines by FACS Sorting and Their Characterization,Bernard E. Tuch,Stem Cells and Development,10.1089/scd.2005.15.61,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed a normal 46 XX karyotype.""}]","46,XX",10,GB,Karyotyping showed a normal 46 XX karyotype.,[],,,,,,[],"[{""ethics_number"": ""HREC 01270"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of New South Wales""}, {""ethics_number"": ""HREC 02247"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of New South Wales""}]",,HREC 01270 | HREC 02247,University of New South Wales | University of New South Wales,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""Trypsin digestion""}]",,Trypsin digestion,0.05,,,,False,,,,,,
H9 NGN2 B6 p12,38244534,H9 NGN2 B6 p12_m.json,38244534/H9 NGN2 B6 p12_m.json,"[{""cell_line_alt_name"": ""H9 NGN2 B6"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,H9 NGN2 B6,"[{""group"": ""University of Wollongong""}]",University of Wollongong,"[{""group"": ""Molecular Horizons, School of Medical, Indigenous and Health Sciences University of Wollongong"", ""first_name"": ""Mirella"", ""last_name"": ""Dottori"", ""name_initials"": ""None"", ""e_mail"": ""mirella.dottori@uow.edu.au"", ""phone_number"": ""None""}]",Dottori,"Molecular Horizons, School of Medical, Indigenous and Health Sciences University of Wollongong",mirella.dottori@uow.edu.au,,,Mirella,"[{""doi"": ""10.1016/j.scr.2024.103312"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of a gene-edited H9 embryonic stem cell line carrying a DOX-inducible NGN2 expression cassette in the CLYBL locus"", ""first_author"": ""Sara Miellet"", ""last_author"": ""Mirella Dottori"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Sara Miellet,Generation of a gene-edited H9 embryonic stem cell line carrying a DOX-inducible NGN2 expression cassette in the CLYBL locus,Mirella Dottori,Stem Cell Research,10.1016/j.scr.2024.103312,"[{""age"": ""46"", ""sex"": ""F"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,F,,46,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Lipid-mediated transfection of RNP"", ""description"": ""Dox-inducible NGN2 insertion with floxed Blasticidin resistance and nuclear mApple"", ""genotype"": ""None"", ""loci_name"": ""CLYBL""}]",,,,Dox-inducible NGN2 insertion with floxed Blasticidin resistance and nuclear mApple,Lipid-mediated transfection of RNP,CLYBL,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""6"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed typical pluripotent stem cell morphology.""}]","46,XX",6,GB,Karyotyping confirmed typical pluripotent stem cell morphology.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,,,[],"[{""ethics_number"": ""2020/451"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Wollongong Health and Medical Human Research Ethics Committee""}]",,2020/451,University of Wollongong Health and Medical Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""20%"", ""passage_method"": ""Trypsinization""}]",20%,Trypsinization,5%,,,,,,,,,,
H9 NGN2 B6 p10,38244534,H9 NGN2 B6 p10_m.json,38244534/H9 NGN2 B6 p10_m.json,"[{""cell_line_alt_name"": ""H9 NGN2 B6"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,H9 NGN2 B6,"[{""group"": ""University of Wollongong""}]",University of Wollongong,"[{""group"": ""Molecular Horizons, School of Medical, Indigenous and Health Sciences University of Wollongong"", ""first_name"": ""Mirella"", ""last_name"": ""Dottori"", ""name_initials"": ""None"", ""e_mail"": ""mirella.dottori@uow.edu.au"", ""phone_number"": ""None""}]",Dottori,"Molecular Horizons, School of Medical, Indigenous and Health Sciences University of Wollongong",mirella.dottori@uow.edu.au,,,Mirella,"[{""doi"": ""10.1016/j.scr.2024.103312"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of a gene-edited H9 embryonic stem cell line carrying a DOX-inducible NGN2 expression cassette in the CLYBL locus"", ""first_author"": ""Sara Miellet"", ""last_author"": ""Mirella Dottori"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Sara Miellet,Generation of a gene-edited H9 embryonic stem cell line carrying a DOX-inducible NGN2 expression cassette in the CLYBL locus,Mirella Dottori,Stem Cell Research,10.1016/j.scr.2024.103312,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""Homology directed repair (HDR)"", ""cytoband"": ""None"", ""delivery_method"": ""Lipid-mediated transfection of RNP"", ""description"": ""Insertion of a gene cassette in the CLYBL safe-harbor locus"", ""genotype"": ""None"", ""loci_name"": ""CLYBL""}]",,Homology directed repair (HDR),,Insertion of a gene cassette in the CLYBL safe-harbor locus,Lipid-mediated transfection of RNP,CLYBL,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""100% match with WA09/H9"", ""karyotype_method"": ""STR profiling"", ""summary"": ""Karyotyping confirmed the genetic identity of H9 NGN2 B6 p10.""}]",100% match with WA09/H9,10,STR profiling,Karyotyping confirmed the genetic identity of H9 NGN2 B6 p10.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,,,[],"[{""ethics_number"": ""Approval # 2020/451"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Wollongong Health and Medical Human Research Ethics Committee""}]",,Approval # 2020/451,University of Wollongong Health and Medical Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""20%"", ""passage_method"": ""EDTA treatment""}]",20%,EDTA treatment,5%,,,,,,,,,,
H9 NGN2 B6,38244534,H9 NGN2 B6_m.json,38244534/H9 NGN2 B6_m.json,"[{""cell_line_alt_name"": ""H9 NGN2 B6"", ""cell_type"": ""hESC"", ""frozen"": ""False""}]",hESC,False,H9 NGN2 B6,"[{""group"": ""University of Wollongong""}]",University of Wollongong,"[{""group"": ""Molecular Horizons, School of Medical, Indigenous and Health Sciences University of Wollongong"", ""first_name"": ""Mirella"", ""last_name"": ""Dottori"", ""name_initials"": ""None"", ""e_mail"": ""mirella.dottori@uow.edu.au"", ""phone_number"": ""None""}]",Dottori,"Molecular Horizons, School of Medical, Indigenous and Health Sciences University of Wollongong",mirella.dottori@uow.edu.au,,,Mirella,"[{""doi"": ""10.1016/j.scr.2024.103312"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of a gene-edited H9 embryonic stem cell line carrying a DOX-inducible NGN2 expression cassette in the CLYBL locus"", ""first_author"": ""Sara Miellet"", ""last_author"": ""Mirella Dottori"", ""year"": ""2024"", ""pmid"": ""None""}]",2024,,Sara Miellet,Generation of a gene-edited H9 embryonic stem cell line carrying a DOX-inducible NGN2 expression cassette in the CLYBL locus,Mirella Dottori,Stem Cell Research,10.1016/j.scr.2024.103312,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""Homology directed repair (HDR)"", ""cytoband"": ""None"", ""delivery_method"": ""Lipid-mediated transfection of RNP"", ""description"": ""Insertion of NGN2 into one allele of CLYBL tested by junction PCR"", ""genotype"": ""None"", ""loci_name"": ""CLYBL""}]",,Homology directed repair (HDR),,Insertion of NGN2 into one allele of CLYBL tested by junction PCR,Lipid-mediated transfection of RNP,CLYBL,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": 3, ""karyotype"": ""100% match with WA09/H9"", ""karyotype_method"": ""STR profiling"", ""summary"": ""Karyotyping was performed at passage 3.""}]",100% match with WA09/H9,3,STR profiling,Karyotyping was performed at passage 3.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,,,[],"[{""ethics_number"": ""Approval # 2020/451"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Wollongong Health and Medical Human Research Ethics Committee""}]",,Approval # 2020/451,University of Wollongong Health and Medical Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""20%"", ""passage_method"": ""None""}]",20%,,5%,,,,,,,,,,
oGL_38,32442534,oGL_38_m.json,32442534/oGL_38_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,,"[{""group"": ""Monash University""}]",Monash University,"[{""group"": ""Monash University"", ""first_name"": ""Jose"", ""last_name"": ""Polo"", ""name_initials"": ""M"", ""e_mail"": ""jose.polo@monash.edu"", ""phone_number"": ""None""}]",Polo,Monash University,jose.polo@monash.edu,,M,Jose,"[{""doi"": ""10.1016/j.stemcr.2020.04.007"", ""journal"": ""Stem Cell Reports"", ""title"": ""A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia co-culture"", ""first_author"": ""Alexandra Grubman"", ""last_author"": ""Jose M. Polo"", ""year"": ""2020"", ""pmid"": ""32562659""}]",2020,32562659,Alexandra Grubman,A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia co-culture,Jose M. Polo,Stem Cell Reports,10.1016/j.stemcr.2020.04.007,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,[],,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,[],[],,,,"[{""co2_concentration"": ""None"", ""o2_concentration"": ""None"", ""passage_method"": ""None""}]",,,,,,,,,,,,,
iMGL_abud+cholesterol,32442534,iMGL_abud+cholesterol_m.json,32442534/iMGL_abud+cholesterol_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""iMGL"", ""frozen"": ""True""}]",iMGL,True,,"[{""group"": ""Monash University""}]",Monash University,"[{""group"": ""Monash University"", ""first_name"": ""Jose"", ""last_name"": ""Polo"", ""name_initials"": ""M."", ""e_mail"": ""jose.polo@monash.edu"", ""phone_number"": ""None""}]",Polo,Monash University,jose.polo@monash.edu,,M.,Jose,"[{""doi"": ""10.1016/j.stemcr.2020.04.007"", ""journal"": ""Stem Cell Reports"", ""title"": ""A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture"", ""first_author"": ""Alexandra Grubman"", ""last_author"": ""Jose M. Polo"", ""year"": ""2020"", ""pmid"": ""32562818""}]",2020,32562818,Alexandra Grubman,A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture,Jose M. Polo,Stem Cell Reports,10.1016/j.stemcr.2020.04.007,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR/Cas9"", ""description"": ""Insertion of tdTomato and nanoluciferase gene into the genome."", ""genotype"": ""None"", ""loci_name"": ""CX3CR1""}]",,,,Insertion of tdTomato and nanoluciferase gene into the genome.,CRISPR/Cas9,CX3CR1,"[{""cell_type"": ""iMGL"", ""show_potency"": ""True"", ""marker_list"": ""P2RY12; TREML2; CD45; CD11B"", ""method_used"": ""FACS"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""12"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal karyotype.""}]","46,XX",12,GB,Karyotyping confirmed normal karyotype.,"[{""i_source_cell_type_term"": ""human embryonic stem cells"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""2017"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2017,,,,human embryonic stem cells,,"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,iMGL,FACS,P2RY12; TREML2; CD45; CD11B,True,in vitro directed differentiation,,,,,
iMGL_52,32442534,iMGL_52_m.json,32442534/iMGL_52_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,,"[{""group"": ""Monash University""}]",Monash University,"[{""group"": ""Monash University"", ""first_name"": ""Jose"", ""last_name"": ""Polo"", ""name_initials"": ""M"", ""e_mail"": ""jose.polo@monash.edu"", ""phone_number"": ""None""}]",Polo,Monash University,jose.polo@monash.edu,,M,Jose,"[{""doi"": ""10.1016/j.stemcr.2020.04.007"", ""journal"": ""Stem Cell Reports"", ""title"": ""A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture"", ""first_author"": ""Alexandra Grubman"", ""last_author"": ""Jose M. Polo"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Alexandra Grubman,A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture,Jose M. Polo,Stem Cell Reports,10.1016/j.stemcr.2020.04.007,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""None""}]",,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]",[],,,,"[{""co2_concentration"": ""None"", ""o2_concentration"": ""None"", ""passage_method"": ""None""}]",,,,,,,False,,,,,,
iMGL_abud+ReN,32442534,iMGL_abud+ReN_m.json,32442534/iMGL_abud+ReN_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,,"[{""group"": ""Monash University""}]",Monash University,"[{""group"": ""Monash University"", ""first_name"": ""Jose"", ""last_name"": ""Polo"", ""name_initials"": ""M."", ""e_mail"": ""jose.polo@monash.edu"", ""phone_number"": ""None""}]",Polo,Monash University,jose.polo@monash.edu,,M.,Jose,"[{""doi"": ""10.1016/j.stemcr.2020.04.007"", ""journal"": ""Stem Cell Reports"", ""title"": ""A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia co-culture"", ""first_author"": ""Alexandra Grubman"", ""last_author"": ""Jose M. Polo"", ""year"": ""2020"", ""pmid"": ""32563261""}]",2020,32563261,Alexandra Grubman,A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia co-culture,Jose M. Polo,Stem Cell Reports,10.1016/j.stemcr.2020.04.007,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR"", ""description"": ""Insertion of tdTomato and nanoluciferase gene into the genome."", ""genotype"": ""None"", ""loci_name"": ""CX3CR1""}]",,,,Insertion of tdTomato and nanoluciferase gene into the genome.,CRISPR,CX3CR1,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""RNA-seq"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""None""}]",,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]",[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,RNA-seq,,False,in vitro directed differentiation,,,,,
iMGL_muffat,32442534,iMGL_muffat_m.json,32442534/iMGL_muffat_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""iMGL"", ""frozen"": ""False""}]",iMGL,False,,"[{""group"": ""Monash University""}]",Monash University,"[{""group"": ""Monash University"", ""first_name"": ""Jose"", ""last_name"": ""Polo"", ""name_initials"": ""M."", ""e_mail"": ""jose.polo@monash.edu"", ""phone_number"": ""None""}]",Polo,Monash University,jose.polo@monash.edu,,M.,Jose,"[{""doi"": ""10.1016/j.stemcr.2020.04.007"", ""journal"": ""Stem Cell Reports"", ""title"": ""A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture"", ""first_author"": ""Alexandra Grubman"", ""last_author"": ""Jose M. Polo"", ""year"": ""2020"", ""pmid"": ""32562805""}]",2020,32562805,Alexandra Grubman,A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture,Jose M. Polo,Stem Cell Reports,10.1016/j.stemcr.2020.04.007,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR/Cas9"", ""description"": ""Insertion of tdTomato and nanoluciferase genes into the genome."", ""genotype"": ""None"", ""loci_name"": ""CX3CR1""}]",,,,Insertion of tdTomato and nanoluciferase genes into the genome.,CRISPR/Cas9,CX3CR1,"[{""cell_type"": ""iMGL"", ""show_potency"": ""True"", ""marker_list"": ""CX3CR1; CD11B; IBA1; TREML2"", ""method_used"": ""FACS"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""iMGLs were generated from H9 CX3CR1-tdTomato ESCs.""}]",,,,iMGLs were generated from H9 CX3CR1-tdTomato ESCs.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]","[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,iMGL,FACS,CX3CR1; CD11B; IBA1; TREML2,True,in vitro directed differentiation,,,,,
iMGL_douvaras,32442534,iMGL_douvaras_m.json,32442534/iMGL_douvaras_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""iMGL"", ""frozen"": ""False""}]",iMGL,False,,"[{""group"": ""Monash University""}]",Monash University,"[{""group"": ""Monash University"", ""first_name"": ""Jose"", ""last_name"": ""Polo"", ""name_initials"": ""M."", ""e_mail"": ""jose.polo@monash.edu"", ""phone_number"": ""None""}]",Polo,Monash University,jose.polo@monash.edu,,M.,Jose,"[{""doi"": ""10.1016/j.stemcr.2020.04.007"", ""journal"": ""Stem Cell Reports"", ""title"": ""A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture"", ""first_author"": ""Alexandra Grubman"", ""last_author"": ""Jose M. Polo"", ""year"": ""2020"", ""pmid"": ""32592651""}]",2020,32592651,Alexandra Grubman,A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture,Jose M. Polo,Stem Cell Reports,10.1016/j.stemcr.2020.04.007,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR"", ""description"": ""Insertion of tdTomato and nanoluciferase gene into the genome."", ""genotype"": ""None"", ""loci_name"": ""CX3CR1""}]",,,,Insertion of tdTomato and nanoluciferase gene into the genome.,CRISPR,CX3CR1,"[{""cell_type"": ""iMGL"", ""show_potency"": ""True"", ""marker_list"": ""CX3CR1; CD45; CD11b; TREML2"", ""method_used"": ""FACS"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""iMGLs derived from H9 CX3CR1-tdTomato ESCs.""}]",,,,iMGLs derived from H9 CX3CR1-tdTomato ESCs.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]","[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,iMGL,FACS,CX3CR1; CD45; CD11b; TREML2,True,in vitro directed differentiation,,,,,
oGL_52,32442534,oGL_52_m.json,32442534/oGL_52_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,,"[{""group"": ""Monash University""}]",Monash University,"[{""group"": ""Monash University"", ""first_name"": ""Alexandra"", ""last_name"": ""Grubman"", ""name_initials"": ""None"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Grubman,Monash University,,,,Alexandra,"[{""doi"": ""10.1016/j.stemcr.2020.04.007"", ""journal"": ""Stem Cell Reports"", ""title"": ""A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia co-culture"", ""first_author"": ""Alexandra Grubman"", ""last_author"": ""Jose M. Polo"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Alexandra Grubman,A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia co-culture,Jose M. Polo,Stem Cell Reports,10.1016/j.stemcr.2020.04.007,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""None""}]",,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]",[],,,,"[{""co2_concentration"": ""None"", ""o2_concentration"": ""None"", ""passage_method"": ""None""}]",,,,,,,False,,,,,,
iMGL_rat_neuron,32442534,iMGL_rat_neuron_m.json,32442534/iMGL_rat_neuron_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""iMGL"", ""frozen"": ""False""}]",iMGL,False,,"[{""group"": ""Monash University""}]",Monash University,"[{""group"": ""Monash University"", ""first_name"": ""Jose"", ""last_name"": ""Polo"", ""name_initials"": ""M."", ""e_mail"": ""jose.polo@monash.edu"", ""phone_number"": ""None""}]",Polo,Monash University,jose.polo@monash.edu,,M.,Jose,"[{""doi"": ""10.1016/j.stemcr.2020.04.007"", ""journal"": ""Stem Cell Reports"", ""title"": ""A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia co-culture"", ""first_author"": ""Alexandra Grubman"", ""last_author"": ""Jose M. Polo"", ""year"": ""2020"", ""pmid"": ""32562679""}]",2020,32562679,Alexandra Grubman,A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia co-culture,Jose M. Polo,Stem Cell Reports,10.1016/j.stemcr.2020.04.007,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR/Cas9"", ""description"": ""Insertion of tdTomato and nanoluciferase genes into the genome."", ""genotype"": ""None"", ""loci_name"": ""CX3CR1""}]",,,,Insertion of tdTomato and nanoluciferase genes into the genome.,CRISPR/Cas9,CX3CR1,"[{""cell_type"": ""iMGL"", ""show_potency"": ""True"", ""marker_list"": ""CX3CR1; CD11B; TREML2"", ""method_used"": ""FACS"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""12"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed the genomic integrity of the iMGL cell line.""}]","46,XX",12,GB,Karyotyping confirmed the genomic integrity of the iMGL cell line.,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]",[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Trypsinization""}]",21%,Trypsinization,5%,iMGL,FACS,CX3CR1; CD11B; TREML2,True,in vitro directed differentiation,,,,,
iMGL_abud,32442534,iMGL_abud_m.json,32442534/iMGL_abud_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,,"[{""group"": ""Monash University""}]",Monash University,"[{""group"": ""Monash University"", ""first_name"": ""Jose"", ""last_name"": ""Polo"", ""name_initials"": ""M."", ""e_mail"": ""jose.polo@monash.edu"", ""phone_number"": ""None""}]",Polo,Monash University,jose.polo@monash.edu,,M.,Jose,"[{""doi"": ""10.1016/j.stemcr.2020.04.007"", ""journal"": ""Stem Cell Reports"", ""title"": ""A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture"", ""first_author"": ""Alexandra Grubman"", ""last_author"": ""Jose M. Polo"", ""year"": ""2020"", ""pmid"": ""32562630""}]",2020,32562630,Alexandra Grubman,A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture,Jose M. Polo,Stem Cell Reports,10.1016/j.stemcr.2020.04.007,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR/Cas9"", ""description"": ""Insertion of tdTomato and nanoluciferase gene into the genome."", ""genotype"": ""None"", ""loci_name"": ""CX3CR1""}]",,,,Insertion of tdTomato and nanoluciferase gene into the genome.,CRISPR/Cas9,CX3CR1,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""None""}]",,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]",[],,,,"[{""co2_concentration"": ""None"", ""o2_concentration"": ""None"", ""passage_method"": ""None""}]",,,,,,,False,,,,,,
HP1003-A,35728439,HP1003-A_m.json,35728439/HP1003-A_m.json,"[{""cell_line_alt_name"": ""HP1003-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HP1003-A,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""None"", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,,Joshua,"[{""doi"": ""10.1016/j.scr.2022.102829"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p. Ala172Glu) variant in the ACTA1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Gianina Ravenscroft"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Joshua S. Clayton,Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p. Ala172Glu) variant in the ACTA1 gene,Gianina Ravenscroft,Stem Cell Research,10.1016/j.scr.2022.102829,"[{""age"": ""3"", ""sex"": ""M"", ""disease_name"": ""Nemaline myopathy"", ""disease_description"": ""Intermediate form of nemaline myopathy""}]",Intermediate form of nemaline myopathy,M,Nemaline myopathy,3,"[{""mutation_type"": ""Heterozygous"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""ACTA1 variant (c.515C > A)"", ""genotype"": ""None"", ""loci_name"": ""ACTA1""}]",,Heterozygous,,ACTA1 variant (c.515C > A),,ACTA1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Normal female karyotype""}]","46,XX",,GB,Normal female karyotype,"[{""i_source_cell_type_term"": ""EBV-immortalized lymphoblastoid cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2021"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0""}]",2021,CytoTune-iPS 2.0,SV,blood,EBV-immortalized lymphoblastoid cell,,"[{""ethics_number"": ""None"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Western Australia Ethics Committee""}]",21/07/10,,University of Western Australia Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
AIBNi013-A,34507143,AIBNi013-A_m.json,34507143/AIBNi013-A_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102527"", ""journal"": ""Stem Cell Research"", ""title"": ""Reprogramming of human olfactory neurosphere-derived cells from olfactory mucosal biopsies of a control cohort"", ""first_author"": ""Hannah C. Leeson"", ""last_author"": ""Ernst J. Wolvetang"", ""year"": ""2021"", ""pmid"": ""None""}]",2021,,Hannah C. Leeson,Reprogramming of human olfactory neurosphere-derived cells from olfactory mucosal biopsies of a control cohort,Ernst J. Wolvetang,Stem Cell Research,10.1016/j.scr.2021.102527,"[{""age"": ""None"", ""sex"": ""Unknown"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,Unknown,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,Non-integrative Sendai virus delivery,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 400 bphs.""}]","46,XX",,GB,Karyotyping occurred at a resolution of 400 bphs.,"[{""i_source_cell_type_term"": ""olfactory neurosphere-derived cells"", ""i_source_cell_origin_term"": ""olfactory mucosa"", ""derivation_year"": ""None"", ""non_int_vector"": ""Sendai virus"", ""non_int_vector_name"": ""None""}]",,,Sendai virus,olfactory mucosa,olfactory neurosphere-derived cells,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]","[{""ethics_number"": ""2019/900/159"", ""approval_date"": ""09/04/2019"", ""institutional_HREC"": ""UQ HREC""}]",09/04/2019,2019/900/159,UQ HREC,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,False,,,,,,
HPI002-A,34388489,HPI002-A_m.json,34388489/HPI002-A_m.json,"[{""cell_line_alt_name"": ""HPI002-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HPI002-A,"[{""group"": ""Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia""}]","Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia","[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""None"", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,,Joshua,"[{""doi"": ""10.1016/j.scr.2021.102482"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two isogenic induced pluripotent stem cell lines from a 10-year-old typical nemaline myopathy patient with a heterozygous dominant c.541G>A (p.Asp179Asn) pathogenic variant in the ACTA1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Rhonda L. Taylor"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Joshua S. Clayton,Generation of two isogenic induced pluripotent stem cell lines from a 10-year-old typical nemaline myopathy patient with a heterozygous dominant c.541G>A (p.Asp179Asn) pathogenic variant in the ACTA1 gene,Rhonda L. Taylor,Stem Cell Research,10.1016/j.scr.2021.102482,"[{""age"": ""10"", ""sex"": ""F"", ""disease_name"": ""Nemaline myopathy"", ""disease_description"": ""Congenital myopathy characterized by skeletal muscle weakness""}]",Congenital myopathy characterized by skeletal muscle weakness,F,Nemaline myopathy,10,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous ACTA1 mutation"", ""genotype"": ""c.541G>A (p.Asp179Asn)"", ""loci_name"": ""ACTA1""}]",,,c.541G>A (p.Asp179Asn),Heterozygous ACTA1 mutation,,ACTA1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""47,XX,+X"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping revealed additional X chromosome.""}]","47,XX,+X",10,GB,Karyotyping revealed additional X chromosome.,"[{""i_source_cell_type_term"": ""lymphoblastoid cell line"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune-iPS 2.0 Sendai Reprogramming Kit""}]",2020,CytoTune-iPS 2.0 Sendai Reprogramming Kit,SV,blood,lymphoblastoid cell line,[],"[{""ethics_number"": ""No. EC-2018-994"", ""approval_date"": ""21/07/20"", ""institutional_HREC"": ""University of Western Australia's Human Research Ethics Committee""}]",21/07/20,No. EC-2018-994,University of Western Australia's Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
HPI002-B,34388489,HPI002-B_m.json,34388489/HPI002-B_m.json,"[{""cell_line_alt_name"": ""HPI002-A; HPI002-B; IPS-789-C1; IPS-789-C2"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HPI002-A; HPI002-B; IPS-789-C1; IPS-789-C2,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""S."", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,S.,Joshua,"[{""doi"": ""10.1016/j.scr.2021.102482"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two isogenic induced pluripotent stem cell lines from a 10-year-old typical nemaline myopathy patient with a heterozygous dominant c.541G>A (p.Asp179Asn) pathogenic variant in the ACTA1 gene"", ""first_author"": ""Joshua S. Clayton"", ""last_author"": ""Rhonda L. Taylor"", ""year"": ""2021"", ""pmid"": ""34753601""}]",2021,34753601,Joshua S. Clayton,Generation of two isogenic induced pluripotent stem cell lines from a 10-year-old typical nemaline myopathy patient with a heterozygous dominant c.541G>A (p.Asp179Asn) pathogenic variant in the ACTA1 gene,Rhonda L. Taylor,Stem Cell Research,10.1016/j.scr.2021.102482,"[{""age"": ""10"", ""sex"": ""F"", ""disease_name"": ""Nemaline myopathy"", ""disease_description"": ""Congenital myopathy characterized by skeletal muscle weakness""}]",Congenital myopathy characterized by skeletal muscle weakness,F,Nemaline myopathy,10,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""c.541G>A (p.Asp179Asn)"", ""loci_name"": ""ACTA1""}]",,,c.541G>A (p.Asp179Asn),,,ACTA1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""10"", ""karyotype"": ""47,XX,+X"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping revealed an additional X chromosome.""}]","47,XX,+X",10,GB,Karyotyping revealed an additional X chromosome.,"[{""i_source_cell_type_term"": ""lymphoblastoid cell line"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,lymphoblastoid cell line,[],"[{""ethics_number"": ""No. EC-2018-994"", ""approval_date"": ""September 2020"", ""institutional_HREC"": ""University of Western Australia\u2019s Human Research Ethics Committee""}]",September 2020,No. EC-2018-994,University of Western Australia’s Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
Cat#A18945,32931148,Cat#A18945_m.json,32931148/Cat#A18945_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,,"[{""group"": ""Lions Eye Institute, Nedlands, WA, Australia""}]","Lions Eye Institute, Nedlands, WA, Australia","[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mcLenachan@lei.org.au"", ""phone_number"": ""None""}]",McLenachan,Lions Eye Institute,s.mcLenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1002/mgg3.1489"", ""journal"": ""Molecular Genetics & Genomic Medicine"", ""title"": ""Characterization of CRB1 splicing in retinal organoids derived from a patient with adult-onset rod-cone dystrophy caused by the c.1892A>G and c.2548G>A variants"", ""first_author"": ""Xiao Zhang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Xiao Zhang,Characterization of CRB1 splicing in retinal organoids derived from a patient with adult-onset rod-cone dystrophy caused by the c.1892A>G and c.2548G>A variants,Fred K. Chen,Molecular Genetics & Genomic Medicine,10.1002/mgg3.1489,"[{""age"": ""50"", ""sex"": ""F"", ""disease_name"": ""Rod-cone dystrophy"", ""disease_description"": ""Adult-onset rod-cone dystrophy caused by CRB1 mutations""}]",Adult-onset rod-cone dystrophy caused by CRB1 mutations,F,Rod-cone dystrophy,50,"[{""mutation_type"": ""missense"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""c.1892A>G and c.2548G>A variants in CRB1"", ""genotype"": ""c.1892A>G; c.2548G>A"", ""loci_name"": ""CRB1""}]",,missense,c.1892A>G; c.2548G>A,c.1892A>G and c.2548G>A variants in CRB1,,CRB1,"[{""cell_type"": ""PPC"", ""show_potency"": ""True"", ""marker_list"": ""PAX6; RCVRN; CRB1"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""N/A""}]",,,,N/A,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""GNT1188694"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia Ethics Committee""}]",,GNT1188694,University of Western Australia Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,PPC,qPCR,PAX6; RCVRN; CRB1,True,in vitro directed differentiation,,,,,
LEIi006-A,32931148,LEIi006-A_m.json,32931148/LEIi006-A_m.json,"[{""cell_line_alt_name"": ""LEIi006-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEIi006-A,"[{""group"": ""Lions Eye Institute, Nedlands, WA, Australia""}]","Lions Eye Institute, Nedlands, WA, Australia","[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mclenachan@lei.org.au"", ""phone_number"": ""None""}]",McLenachan,Lions Eye Institute,s.mclenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1002/mgg3.1489"", ""journal"": ""Molecular Genetics & Genomic Medicine"", ""title"": ""Characterization of CRB1 splicing in retinal organoids derived from a patient with adult-onset rod-cone dystrophy caused by the c.1892A>G and c.2548G>A variants"", ""first_author"": ""Xiao Zhang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Xiao Zhang,Characterization of CRB1 splicing in retinal organoids derived from a patient with adult-onset rod-cone dystrophy caused by the c.1892A>G and c.2548G>A variants,Fred K. Chen,Molecular Genetics & Genomic Medicine,10.1002/mgg3.1489,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""None"", ""show_potency"": ""False"", ""marker_list"": ""None"", ""method_used"": ""None"", ""differentiation_profile"": ""None""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""None""}]",,,,,"[{""i_source_cell_type_term"": ""None"", ""i_source_cell_origin_term"": ""None"", ""derivation_year"": ""None"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",,,,,,"[{""embryo_stage"": ""None"", ""zp_removal_technique"": ""None"", ""trophectoderm_morphology"": ""None"", ""icm_morphology"": ""None"", ""e_preimplant_genetic_diagnosis"": ""None""}]",[],,,,"[{""co2_concentration"": ""None"", ""o2_concentration"": ""None"", ""passage_method"": ""None""}]",,,,,,,False,,,,,,
NRO,32931148,NRO_m.json,32931148/NRO_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""NRO"", ""frozen"": ""False""}]",NRO,False,,"[{""group"": ""Lions Eye Institute, Nedlands, WA, Australia""}]","Lions Eye Institute, Nedlands, WA, Australia","[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mcLenachan@lei.org.au"", ""phone_number"": ""None""}]",McLenachan,Lions Eye Institute,s.mcLenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1002/mgg3.1489"", ""journal"": ""Molecular Genetics & Genomic Medicine"", ""title"": ""Characterization of CRB1 splicing in retinal organoids derived from a patient with adult-onset rod-cone dystrophy caused by the c.1892A>G and c.2548G>A variants"", ""first_author"": ""Xiao Zhang"", ""last_author"": ""Fred K. Chen"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Xiao Zhang,Characterization of CRB1 splicing in retinal organoids derived from a patient with adult-onset rod-cone dystrophy caused by the c.1892A>G and c.2548G>A variants,Fred K. Chen,Molecular Genetics & Genomic Medicine,10.1002/mgg3.1489,"[{""age"": ""50_54"", ""sex"": ""F"", ""disease_name"": ""Rod-cone dystrophy"", ""disease_description"": ""Adult-onset rod-cone dystrophy""}]",Adult-onset rod-cone dystrophy,F,Rod-cone dystrophy,50_54,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""c.1892A>G; c.2548G>A"", ""loci_name"": ""CRB1""}]",,,c.1892A>G; c.2548G>A,,,CRB1,"[{""cell_type"": ""PPC"", ""show_potency"": ""True"", ""marker_list"": ""PAX6; RCVRN; CRB1"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""35"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""NRO displayed typical optic cup morphology with retinal progenitor cells.""}]",,35,,NRO displayed typical optic cup morphology with retinal progenitor cells.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2019"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2019,,,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""RA/4/20/5717"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia Ethics Committee""}]",,RA/4/20/5717,University of Western Australia Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EDTA""}]",21%,EDTA,5%,PPC,qPCR,PAX6; RCVRN; CRB1,True,in vitro directed differentiation,,,,,
UOWi007-A,32006803,UOWi007-A_m.json,32006803/UOWi007-A_m.json,"[{""cell_line_alt_name"": ""UOWi007"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,UOWi007,"[{""group"": ""Illawarra Health and Medical Research Institute, University of Wollongong""}]","Illawarra Health and Medical Research Institute, University of Wollongong","[{""group"": ""Illawarra Health and Medical Research Institute"", ""first_name"": ""Lezanne"", ""last_name"": ""Ooi"", ""name_initials"": ""L."", ""e_mail"": ""lezanne@uow.edu.au"", ""phone_number"": ""None""}]",Ooi,Illawarra Health and Medical Research Institute,lezanne@uow.edu.au,,L.,Lezanne,"[{""doi"": ""10.1016/j.scr.2020.101701"", ""journal"": ""Stem Cell Research"", ""title"": ""The mRNA-based reprogramming of fibroblasts from a SOD1E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007"", ""first_author"": ""Rachelle Balez"", ""last_author"": ""Lezanne Ooi"", ""year"": ""2020"", ""pmid"": ""None""}]",2020,,Rachelle Balez,The mRNA-based reprogramming of fibroblasts from a SOD1E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007,Lezanne Ooi,Stem Cell Research,10.1016/j.scr.2020.101701,"[{""age"": ""43"", ""sex"": ""M"", ""disease_name"": ""Amyotrophic lateral sclerosis"", ""disease_description"": ""SOD1E101G mutation""}]",SOD1E101G mutation,M,Amyotrophic lateral sclerosis,43,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""mRNA transfections"", ""description"": ""SOD1E101G mutation"", ""genotype"": ""None"", ""loci_name"": ""SOD1""}]",,,,SOD1E101G mutation,mRNA transfections,SOD1,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""24"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 400 bphs. Fifteen metaphase spreads were analysed.""}]","46,XY",24,GB,Karyotyping occurred at a resolution of 400 bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""fibroblast"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2018"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2018,,,skin,fibroblast,,"[{""ethics_number"": ""HE13/272"", ""approval_date"": ""12.04.2018"", ""institutional_HREC"": ""University of Wollongong Human Research Ethics Committee""}]",12.04.2018,HE13/272,University of Wollongong Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,,,,,,,,,,
SIVF002,20198447,SIVF002_m.json,20198447/SIVF002_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,,"[{""group"": ""Sydney IVF Stem Cells""}]",Sydney IVF Stem Cells,"[{""group"": ""Australian Stem Cell Centre, University of Queensland"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""T"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,"Australian Stem Cell Centre, University of Queensland",,,T,Teija,"[{""doi"": ""10.1007/s16216-010-9298-y"", ""journal"": ""In Vitro Cell Dev Biol\u2014Animal"", ""title"": ""Derivation of three new human embryonic stem cell lines"", ""first_author"": ""Cara K. Bradley"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2010"", ""pmid"": ""None""}]",2010,,Cara K. Bradley,Derivation of three new human embryonic stem cell lines,Tomas Stojanov,In Vitro Cell Dev Biol—Animal,10.1007/s16216-010-9298-y,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""7"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""None"", ""summary"": ""Karyotyping confirmed normal chromosomal structure.""}]","46,XY",7,,Karyotyping confirmed normal chromosomal structure.,[],,,,,,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual passaging""}]",21%,Manual passaging,5%,,,,,,,,,,
SIVF014,20198447,SIVF014_m.json,20198447/SIVF014_m.json,"[{""cell_line_alt_name"": ""None"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,,"[{""group"": ""Sydney IVF Stem Cells""}]",Sydney IVF Stem Cells,"[{""group"": ""Australian Stem Cell Centre"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""T"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,Australian Stem Cell Centre,,,T,Teija,"[{""doi"": ""10.1007/s16216-010-9298-y"", ""journal"": ""In Vitro Cell Dev Biol - Animal"", ""title"": ""Derivation of three new human embryonic stem cell lines"", ""first_author"": ""Cara K. Bradley"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2010"", ""pmid"": ""None""}]",2010,,Cara K. Bradley,Derivation of three new human embryonic stem cell lines,Tomas Stojanov,In Vitro Cell Dev Biol - Animal,10.1007/s16216-010-9298-y,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""7"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping showed normal chromosomal structure.""}]","46,XX",7,GB,Karyotyping showed normal chromosomal structure.,[],,,,,,[],"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""None""}]",,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual passaging""}]",21%,Manual passaging,5%,,,,,,,,,,
SIVF001,20198447,SIVF001_m.json,20198447/SIVF001_m.json,"[{""cell_line_alt_name"": ""SIVF001"", ""cell_type"": ""ESC"", ""frozen"": ""True""}]",ESC,True,SIVF001,"[{""group"": ""Sydney IVF Stem Cells""}]",Sydney IVF Stem Cells,"[{""group"": ""Australian Stem Cell Centre, University of Queensland"", ""first_name"": ""Teija"", ""last_name"": ""Peura"", ""name_initials"": ""T"", ""e_mail"": ""None"", ""phone_number"": ""None""}]",Peura,"Australian Stem Cell Centre, University of Queensland",,,T,Teija,"[{""doi"": ""10.1007/s16216-010-9298-y"", ""journal"": ""In Vitro Cell Dev Biol - Animal"", ""title"": ""Derivation of three new human embryonic stem cell lines"", ""first_author"": ""Cara K. Bradley"", ""last_author"": ""Tomas Stojanov"", ""year"": ""2010"", ""pmid"": ""None""}]",2010,,Cara K. Bradley,Derivation of three new human embryonic stem cell lines,Tomas Stojanov,In Vitro Cell Dev Biol - Animal,10.1007/s16216-010-9298-y,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""None"", ""disease_description"": ""None""}]",,,,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""3"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping confirmed normal chromosomal structure.""}]","46,XX",3,GB,Karyotyping confirmed normal chromosomal structure.,[],,,,,,[],[],,,,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""Manual passaging""}]",21%,Manual passaging,5%,,,,,,,,,,
LEi1017-A,34198153,LEi1017-A_m.json,34198153/LEi1017-A_m.json,"[{""cell_line_alt_name"": ""LEi1017-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEi1017-B,"[{""group"": ""Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia""}]","Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia","[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mclenachan@lei.org.au"", ""phone_number"": ""None""}]",McLenachan,Lions Eye Institute,s.mclenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2021.102448"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a patient with Stargardt disease caused by compound heterozygous mutations in the ABCA4 gene"", ""first_author"": ""Di Huang"", ""last_author"": ""Samuel McLenachan"", ""year"": ""2021"", ""pmid"": ""None""}]",2021,,Di Huang,Generation of two induced pluripotent stem cell lines from a patient with Stargardt disease caused by compound heterozygous mutations in the ABCA4 gene,Samuel McLenachan,Stem Cell Research,10.1016/j.scr.2021.102448,"[{""age"": ""16"", ""sex"": ""F"", ""disease_name"": ""Stargardt disease"", ""disease_description"": ""Autosomal recessive Stargardt disease is the most common form of juvenile-onset macular degeneration.""}]",Autosomal recessive Stargardt disease is the most common form of juvenile-onset macular degeneration.,F,Stargardt disease,16,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""S"", ""summary"": ""Karyotyping demonstrated a normal karyotype.""}]","46,XX",,S,Karyotyping demonstrated a normal karyotype.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,skin,fibroblasts,[],"[{""ethics_number"": ""RA/41/7/916"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia Human Research Ethics Committee""}]",,RA/41/7/916,University of Western Australia Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
LEi1017-B,34198153,LEi1017-B_m.json,34198153/LEi1017-B_m.json,"[{""cell_line_alt_name"": ""LEi1017-A; LEi1017-B"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,LEi1017-A; LEi1017-B,"[{""group"": ""Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia""}]","Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia","[{""group"": ""Lions Eye Institute"", ""first_name"": ""Samuel"", ""last_name"": ""McLenachan"", ""name_initials"": ""None"", ""e_mail"": ""s.mcLenachan@lei.org.au"", ""phone_number"": ""None""}]",McLenachan,Lions Eye Institute,s.mcLenachan@lei.org.au,,,Samuel,"[{""doi"": ""10.1016/j.scr.2021.102448"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a patient with Stargardt disease caused by compound heterozygous mutations in the ABCA4 gene"", ""first_author"": ""Di Huang"", ""last_author"": ""Samuel McLenachan"", ""year"": ""2021"", ""pmid"": ""None""}]",2021,,Di Huang,Generation of two induced pluripotent stem cell lines from a patient with Stargardt disease caused by compound heterozygous mutations in the ABCA4 gene,Samuel McLenachan,Stem Cell Research,10.1016/j.scr.2021.102448,"[{""age"": ""16"", ""sex"": ""F"", ""disease_name"": ""Stargardt disease"", ""disease_description"": ""Juvenile-onset macular degeneration""}]",Juvenile-onset macular degeneration,F,Stargardt disease,16,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 500 kb.""}]","46,XX",,GB,Karyotyping occurred at a resolution of 500 kb.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2020"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2020,,,skin,fibroblasts,[],"[{""ethics_number"": ""RA/41/7/916"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia Human Research Ethics Committee""}]",,RA/41/7/916,University of Western Australia Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
GENIE 38,34649201,GENIE 38_m.json,34649201/GENIE 38_m.json,"[{""cell_line_alt_name"": ""GENIE 38"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,GENIE 38,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,35,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""54086"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,54086,University of Queensland Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""EF""}]",,EF,0.05,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
AIBNi001-A,34649201,AIBNi001-A_m.json,34649201/AIBNi001-A_m.json,"[{""cell_line_alt_name"": ""GENI 1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENI 1,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,35,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""2021/02273"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,2021/02273,University of Queensland Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
GENIE 74,34649201,GENIE 74_m.json,34649201/GENIE 74_m.json,"[{""cell_line_alt_name"": ""GENIE 74"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,GENIE 74,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""None"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX1; FOXA2; NANOG"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""None""}]",,,,,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,2019/QRBW/54086,University of Queensland Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""EF""}]",,EF,0.05,EN | ME,qPCR | qPCR,SOX1; FOXA2; NANOG | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
GENIE 70,34649201,GENIE 70_m.json,34649201/GENIE 70_m.json,"[{""cell_line_alt_name"": ""GENIE 70"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,GENIE 70,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""31"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,31,"[{""mutation_type"": ""Genetic Modification"", ""cytoband"": ""None"", ""delivery_method"": ""non-integrative Sendai virus"", ""description"": ""Transgenes: OCT4, SOX2, KLF4 and c-MYC"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,Genetic Modification,,"Transgenes: OCT4, SOX2, KLF4 and c-MYC",non-integrative Sendai virus,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX17; FOXA2"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,2019/QRBW/54086,University of Queensland Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,EN | ME,qPCR | qPCR,SOX17; FOXA2 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
GENIE 1,34649201,GENIE 1_m.json,34649201/GENIE 1_m.json,"[{""cell_line_alt_name"": ""GENIE 1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 1,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}, {""age"": ""48"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}, {""age"": ""19"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}, {""age"": ""31"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}, {""age"": ""24"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan | nan | nan | nan | nan,F | F | F | F | F,Epilepsy | Epilepsy | Epilepsy | Epilepsy | Epilepsy,35 | 48 | 19 | 31 | 24,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,2019/QRBW/54086,University of Queensland Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""EF""}]",,EF,0.05,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
AIBNi005-A,34649201,AIBNi005-A_m.json,34649201/AIBNi005-A_m.json,"[{""cell_line_alt_name"": ""GENIE 1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 1,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,35,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020-01-01"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020-01-01,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""1872361"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,1872361,University of Queensland Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""EF""}]",,EF,0.05,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
GENIE 68,34649201,GENIE 68_m.json,34649201/GENIE 68_m.json,"[{""cell_line_alt_name"": ""GENIE 68"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,GENIE 68,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""31"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,31,"[{""mutation_type"": ""Genetic Modification"", ""cytoband"": ""None"", ""delivery_method"": ""non-integrative Sendai virus"", ""description"": ""Transgenes: OCT4, SOX2, KLF4 and c-MYC"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,Genetic Modification,,"Transgenes: OCT4, SOX2, KLF4 and c-MYC",non-integrative Sendai virus,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""SOX17; FOXA2"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""RUNX1; HAND1"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2021/02273"", ""approval_date"": ""None"", ""institutional_HREC"": ""The University of Queensland Human Ethics Research Office""}]",,2021/02273,The University of Queensland Human Ethics Research Office,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME,qPCR | qPCR,SOX17; FOXA2 | RUNX1; HAND1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
AIBNi004-A,34649201,AIBNi004-A_m.json,34649201/AIBNi004-A_m.json,"[{""cell_line_alt_name"": ""GENIE 1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 1,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,35,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",,2019/QRBW/54086,University of Queensland Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,0.05,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
AIBNi003-A,34649201,AIBNi003-A_m.json,34649201/AIBNi003-A_m.json,"[{""cell_line_alt_name"": ""GENIE 1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 1,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""19"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,19,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""non-integrative Sendai virus"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,non-integrative Sendai virus,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""2019/QRBW/54086"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,2019/QRBW/54086,University of Queensland Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""EF""}]",,EF,0.05,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
AIBNi002-A,34649201,AIBNi002-A_m.json,34649201/AIBNi002-A_m.json,"[{""cell_line_alt_name"": ""GENIE 1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 1,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,35,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020-01-01"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020-01-01,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""1872361"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,1872361,University of Queensland Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""EF""}]",,EF,0.05,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
AIBNi006-A,34649201,AIBNi006-A_m.json,34649201/AIBNi006-A_m.json,"[{""cell_line_alt_name"": ""GENIE 1"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,GENIE 1,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""35"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,35,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.""}]","46,XX",9,GB,Karyotyping occurred at a resolution of 300bphs. Fifteen metaphase spreads were analysed.,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""1872361"", ""approval_date"": ""21/07/10"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",21/07/10,1872361,University of Queensland Ethics Committee,"[{""co2_concentration"": ""0.05"", ""o2_concentration"": ""None"", ""passage_method"": ""EF""}]",,EF,0.05,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
GENIE 69,34649201,GENIE 69_m.json,34649201/GENIE 69_m.json,"[{""cell_line_alt_name"": ""GENIE 69"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,GENIE 69,"[{""group"": ""Australian Institute for Bioengineering and Nanotechnology""}]",Australian Institute for Bioengineering and Nanotechnology,"[{""group"": ""Wolvetang-AIBN"", ""first_name"": ""Ernst"", ""last_name"": ""Wolvetang"", ""name_initials"": ""J"", ""e_mail"": ""e.wolvetang@uq.edu.au"", ""phone_number"": ""None""}]",Wolvetang,Wolvetang-AIBN,e.wolvetang@uq.edu.au,,J,Ernst,"[{""doi"": ""10.1016/j.scr.2021.102564"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients"", ""first_author"": ""Zoe L. Hunter"", ""last_author"": ""Lata Vadlamudi"", ""year"": ""2021"", ""pmid"": ""34649201""}]",2021,34649201,Zoe L. Hunter,Generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells of three drug resistant and three drug responsive epilepsy patients,Lata Vadlamudi,Stem Cell Research,10.1016/j.scr.2021.102564,"[{""age"": ""None"", ""sex"": ""F"", ""disease_name"": ""Epilepsy"", ""disease_description"": ""nan""}]",nan,F,Epilepsy,,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""None"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,,,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""OCT4; SOX2"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""RUNX1; HAND1"", ""method_used"": ""qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""None"", ""karyotype_method"": ""None"", ""summary"": ""None""}]",,,,,"[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""[kit] CytoTune-iPS 2.0 Sendai reprogramming kit""}]",2020,[kit] CytoTune-iPS 2.0 Sendai reprogramming kit,SV,blood,peripheral blood mononuclear cell,[],"[{""ethics_number"": ""2021/QRBW/54086"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Queensland Ethics Committee""}]",,2021/QRBW/54086,University of Queensland Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,EN | ME,qPCR | qPCR,OCT4; SOX2 | RUNX1; HAND1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
UOMELBi002-A,34088002,UOMELBi002-A_m.json,34088002/UOMELBi002-A_m.json,"[{""cell_line_alt_name"": ""F16574c3_A1_G8"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,F16574c3_A1_G8,"[{""group"": ""The University of Melbourne""}]",The University of Melbourne,"[{""group"": ""The University of Melbourne"", ""first_name"": ""Damian"", ""last_name"": ""Hern\u00e1ndez"", ""name_initials"": ""None"", ""e_mail"": ""damian.hernandez@unimelb.edu.au"", ""phone_number"": ""None""}]",Hernández,The University of Melbourne,damian.hernandez@unimelb.edu.au,,,Damian,"[{""doi"": ""10.1016/j.scr.2021.102373"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of a gene-corrected human isogenic iPSC line from an Alzheimer's disease iPSC line carrying the London mutation in APP (V717I)"", ""first_author"": ""Dami\u00e1n Hern\u00e1ndez"", ""last_author"": ""Alison M. Goate"", ""year"": ""2021"", ""pmid"": ""None""}]",2021,,Damián Hernández,Generation of a gene-corrected human isogenic iPSC line from an Alzheimer's disease iPSC line carrying the London mutation in APP (V717I),Alison M. Goate,Stem Cell Research,10.1016/j.scr.2021.102373,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""Alzheimer's disease"", ""disease_description"": ""APP London mutation (V717I)""}]",APP London mutation (V717I),,Alzheimer's disease,,"[{""mutation_type"": ""Gene Correction"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR Cas9"", ""description"": ""Gene correction and silent mutation in one single allele (Heterozygous mutation)."", ""genotype"": ""None"", ""loci_name"": ""APP""}]",,Gene Correction,,Gene correction and silent mutation in one single allele (Heterozygous mutation).,CRISPR Cas9,APP,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""None"", ""summary"": ""Karyotyping occurred at a resolution of 450-500. Sex chromosomes were confirmed.""}]","46,XX",,,Karyotyping occurred at a resolution of 450-500. Sex chromosomes were confirmed.,"[{""i_source_cell_type_term"": ""fibroblasts"", ""i_source_cell_origin_term"": ""skin"", ""derivation_year"": ""2018"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2018,,,skin,fibroblasts,[],"[{""ethics_number"": ""1545394"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Melbourne""}]",,1545394,University of Melbourne,"[{""co2_concentration"": ""None"", ""o2_concentration"": ""None"", ""passage_method"": ""None""}]",,,,,,,,,,,,,
F16574C3_A_1_G8,34088002,F16574C3_A_1_G8_m.json,34088002/F16574C3_A_1_G8_m.json,"[{""cell_line_alt_name"": ""F16574C3_A_1_G8"", ""cell_type"": ""iPSC"", ""frozen"": ""False""}]",iPSC,False,F16574C3_A_1_G8,"[{""group"": ""The University of Melbourne""}]",The University of Melbourne,"[{""group"": ""The University of Melbourne"", ""first_name"": ""Damian"", ""last_name"": ""Hern\u00e1ndez"", ""name_initials"": ""None"", ""e_mail"": ""damian.hernandez@unimelb.edu.au"", ""phone_number"": ""None""}]",Hernández,The University of Melbourne,damian.hernandez@unimelb.edu.au,,,Damian,"[{""doi"": ""10.1016/j.scr.2021.102373"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of a gene-corrected human isogenic iPSC line from an Alzheimer\u2019s disease iPSC line carrying the London mutation in APP (V717I)"", ""first_author"": ""Dami\u00e1n Hern\u00e1ndez"", ""last_author"": ""Alison M. Goate"", ""year"": ""2021"", ""pmid"": ""None""}]",2021,,Damián Hernández,Generation of a gene-corrected human isogenic iPSC line from an Alzheimer’s disease iPSC line carrying the London mutation in APP (V717I),Alison M. Goate,Stem Cell Research,10.1016/j.scr.2021.102373,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""Alzheimer's disease"", ""disease_description"": ""APP London mutation (V717I)""}]",APP London mutation (V717I),,Alzheimer's disease,,"[{""mutation_type"": ""Gene Correction"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR Cas9"", ""description"": ""Gene correction and silent mutation in one single allele (Heterozygous mutation)"", ""genotype"": ""None"", ""loci_name"": ""APP""}]",,Gene Correction,,Gene correction and silent mutation in one single allele (Heterozygous mutation),CRISPR Cas9,APP,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,[],,,,,[],,,,,,[],"[{""ethics_number"": ""1545394"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Melbourne Ethics Committee""}]",,1545394,University of Melbourne Ethics Committee,"[{""co2_concentration"": ""None"", ""o2_concentration"": ""None"", ""passage_method"": ""None""}]",,,,,,,,,,,,,
F16574,34088002,F16574_m.json,34088002/F16574_m.json,"[{""cell_line_alt_name"": ""F16574; UOMELBi002-A"", ""cell_type"": ""iPSC"", ""frozen"": ""False""}]",iPSC,False,F16574; UOMELBi002-A,"[{""group"": ""The University of Melbourne""}]",The University of Melbourne,"[{""group"": ""The University of Melbourne"", ""first_name"": ""Damian"", ""last_name"": ""Hern\u00e1ndez"", ""name_initials"": ""None"", ""e_mail"": ""damian.hernandez@unimelb.edu.au"", ""phone_number"": ""None""}]",Hernández,The University of Melbourne,damian.hernandez@unimelb.edu.au,,,Damian,"[{""doi"": ""10.1016/j.scr.2021.102373"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of a gene-corrected human isogenic iPSC line from an Alzheimer\u2019s disease iPSC line carrying the London mutation in APP (V717I)"", ""first_author"": ""Dami\u00e1n Hern\u00e1ndez"", ""last_author"": ""Alison M. Goate"", ""year"": ""2021"", ""pmid"": ""None""}]",2021,,Damián Hernández,Generation of a gene-corrected human isogenic iPSC line from an Alzheimer’s disease iPSC line carrying the London mutation in APP (V717I),Alison M. Goate,Stem Cell Research,10.1016/j.scr.2021.102373,"[{""age"": ""None"", ""sex"": ""None"", ""disease_name"": ""Alzheimer's disease"", ""disease_description"": ""APP London mutation (V717I)""}]",APP London mutation (V717I),,Alzheimer's disease,,"[{""mutation_type"": ""Gene Correction"", ""cytoband"": ""None"", ""delivery_method"": ""CRISPR Cas9"", ""description"": ""Gene correction and silent mutation in one single allele (Heterozygous mutation)"", ""genotype"": ""None"", ""loci_name"": ""APP""}]",,Gene Correction,,Gene correction and silent mutation in one single allele (Heterozygous mutation),CRISPR Cas9,APP,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Karyotyping occurred at a resolution of 450-500. Six chromosomes were confirmed.""}]","46,XX",,GB,Karyotyping occurred at a resolution of 450-500. Six chromosomes were confirmed.,[],,,,,,[],"[{""ethics_number"": ""1545394"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Melbourne Ethics Committee""}]",,1545394,University of Melbourne Ethics Committee,"[{""co2_concentration"": ""None"", ""o2_concentration"": ""None"", ""passage_method"": ""None""}]",,,,,,,,,,,,,
HPI005-B,38029555,HPI005-B_m.json,38029555/HPI005-B_m.json,"[{""cell_line_alt_name"": ""HPI005-A; HPI005-B; HPI005-5; HPI005-8"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HPI005-A; HPI005-B; HPI005-5; HPI005-8,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""None"", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,,Joshua,"[{""doi"": ""10.1016/j.scr.2023.103258"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a 33-year-old central core disease patient with a heterozygous dominant c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) deletion in the RYR1 gene"", ""first_author"": ""Karrison Driver"", ""last_author"": ""Joshua S. Clayton"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Karrison Driver,Generation of two induced pluripotent stem cell lines from a 33-year-old central core disease patient with a heterozygous dominant c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) deletion in the RYR1 gene,Joshua S. Clayton,Stem Cell Research,10.1016/j.scr.2023.103258,"[{""age"": ""33"", ""sex"": ""None"", ""disease_name"": ""Central core disease"", ""disease_description"": ""A genetic disorder that results in hypotonia, delayed motor development, and areas of reduced oxidative activity in the muscle fibers.""}]","A genetic disorder that results in hypotonia, delayed motor development, and areas of reduced oxidative activity in the muscle fibers.",,Central core disease,33,"[{""mutation_type"": ""Deletion"", ""cytoband"": ""None"", ""delivery_method"": ""Sendai virus"", ""description"": ""Heterozygous deletion c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) in the RYR1 gene."", ""genotype"": ""None"", ""loci_name"": ""RYR1""}]",,Deletion,,Heterozygous deletion c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) in the RYR1 gene.,Sendai virus,RYR1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""TBXT; BMP4"", ""method_used"": ""STEMdiff\u2122 trilineage differentiation"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""OTX2; SOX17"", ""method_used"": ""STEMdiff\u2122 trilineage differentiation"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Both clones demonstrated normal karyotype.""}]","46,XX",,GB,Both clones demonstrated normal karyotype.,"[{""i_source_cell_type_term"": ""lymphoblastoid cells"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune\u2122 2.0""}]",2020,CytoTune™ 2.0,SV,blood,lymphoblastoid cells,,"[{""ethics_number"": ""None"", ""approval_date"": ""None"", ""institutional_HREC"": ""University of Western Australia Ethics Committee""}]",,,University of Western Australia Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,EN | ME,STEMdiff™ trilineage differentiation | STEMdiff™ trilineage differentiation,TBXT; BMP4 | OTX2; SOX17,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
HPI005-A,38029555,HPI005-A_m.json,38029555/HPI005-A_m.json,"[{""cell_line_alt_name"": ""HPI005-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,HPI005-A,"[{""group"": ""Harry Perkins Institute of Medical Research""}]",Harry Perkins Institute of Medical Research,"[{""group"": ""Harry Perkins Institute of Medical Research"", ""first_name"": ""Joshua"", ""last_name"": ""Clayton"", ""name_initials"": ""None"", ""e_mail"": ""joshua.clayton@perkins.org.au"", ""phone_number"": ""None""}]",Clayton,Harry Perkins Institute of Medical Research,joshua.clayton@perkins.org.au,,,Joshua,"[{""doi"": ""10.1016/j.scr.2023.103258"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two induced pluripotent stem cell lines from a 33-year-old central core disease patient with a heterozygous dominant c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) deletion in the RYR1 gene"", ""first_author"": ""Karrison Driver"", ""last_author"": ""Joshua S. Clayton"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Karrison Driver,Generation of two induced pluripotent stem cell lines from a 33-year-old central core disease patient with a heterozygous dominant c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) deletion in the RYR1 gene,Joshua S. Clayton,Stem Cell Research,10.1016/j.scr.2023.103258,"[{""age"": ""33"", ""sex"": ""None"", ""disease_name"": ""Central core disease"", ""disease_description"": ""A genetic disorder that results in hypotonia, delayed motor development, and areas of reduced oxidative activity in the muscle fibers.""}]","A genetic disorder that results in hypotonia, delayed motor development, and areas of reduced oxidative activity in the muscle fibers.",,Central core disease,33,"[{""mutation_type"": ""deletion"", ""cytoband"": ""None"", ""delivery_method"": ""Sendai virus"", ""description"": ""Heterozygous deletion c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) in the RYR1 gene."", ""genotype"": ""None"", ""loci_name"": ""RYR1""}]",,deletion,,Heterozygous deletion c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) in the RYR1 gene.,Sendai virus,RYR1,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""FOXA2; SOX17"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}, {""cell_type"": ""ME"", ""show_potency"": ""True"", ""marker_list"": ""HAND1; RUNX1"", ""method_used"": ""RT-qPCR"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""None"", ""karyotype"": ""46,XY"", ""karyotype_method"": ""GB"", ""summary"": ""Both lines demonstrated normal karyotype.""}]","46,XY",,GB,Both lines demonstrated normal karyotype.,"[{""i_source_cell_type_term"": ""lymphoblastoid cells"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2020"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""CytoTune\u2122 2.0""}]",2020,CytoTune™ 2.0,SV,blood,lymphoblastoid cells,,"[{""ethics_number"": ""AC-2018-3156"", ""approval_date"": ""27/07/2020"", ""institutional_HREC"": ""University of Western Australia's Human Research Ethics Committee""}]",27/07/2020,AC-2018-3156,University of Western Australia's Human Research Ethics Committee,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""EF""}]",21%,EF,5%,EN | ME,RT-qPCR | RT-qPCR,FOXA2; SOX17 | HAND1; RUNX1,True | True,in vitro directed differentiation | in vitro directed differentiation,,,,,
CLAU1002-C,37385135,CLAU1002-C_m.json,37385135/CLAU1002-C_m.json,"[{""cell_line_alt_name"": ""UBC3 M1"", ""cell_type"": ""hiPSC"", ""frozen"": ""False""}]",hiPSC,False,UBC3 M1,"[{""group"": ""Centenary Institute of Cancer Medicine and Cell Biology""}]",Centenary Institute of Cancer Medicine and Cell Biology,"[{""group"": ""Centenary Institute of Cancer Medicine and Cell Biology"", ""first_name"": ""Christopher"", ""last_name"": ""Semsarian"", ""name_initials"": ""C"", ""e_mail"": ""c.semsarian@centenary.org.au"", ""phone_number"": ""None""}]",Semsarian,Centenary Institute of Cancer Medicine and Cell Biology,c.semsarian@centenary.org.au,,C,Christopher,"[{""doi"": ""10.1016/j.scr.2023.103153"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of an induced pluripotent stem cell line from a patient with conduction disease and recurrent ventricular fibrillation with a sodium voltage-gated channel alpha subunit 5 (SCN5A) gene c.392 + 3A > G splice-site variant"", ""first_author"": ""Serena Li"", ""last_author"": ""Semsarian"", ""year"": ""2023"", ""pmid"": ""None""}]",2023,,Serena Li,Generation of an induced pluripotent stem cell line from a patient with conduction disease and recurrent ventricular fibrillation with a sodium voltage-gated channel alpha subunit 5 (SCN5A) gene c.392 + 3A > G splice-site variant,Semsarian,Stem Cell Research,10.1016/j.scr.2023.103153,"[{""age"": ""30"", ""sex"": ""F"", ""disease_name"": ""Recurrent ventricular fibrillation"", ""disease_description"": ""Conduction disease, non-ischemic cardiomyopathy""}]","Conduction disease, non-ischemic cardiomyopathy",F,Recurrent ventricular fibrillation,30,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""None"", ""description"": ""Heterozygous SCN5A c.392 + 3A > G variant"", ""genotype"": ""None"", ""loci_name"": ""SCN5A""}]",,,,Heterozygous SCN5A c.392 + 3A > G variant,,SCN5A,[],"[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""18"", ""karyotype"": ""Normal"", ""karyotype_method"": ""PCR"", ""summary"": ""Karyotyping performed with no abnormalities detected.""}]",Normal,18,PCR,Karyotyping performed with no abnormalities detected.,"[{""i_source_cell_type_term"": ""Peripheral blood mononuclear cells"", ""i_source_cell_origin_term"": ""Blood"", ""derivation_year"": ""2021"", ""non_int_vector"": ""None"", ""non_int_vector_name"": ""None""}]",2021,,,Blood,Peripheral blood mononuclear cells,[],"[{""ethics_number"": ""X19-10108"", ""approval_date"": ""2021"", ""institutional_HREC"": ""Sydney Local Health District""}, {""ethics_number"": ""2019/ETH00461"", ""approval_date"": ""2019"", ""institutional_HREC"": ""Sydney Local Health District""}]",2021 | 2019,X19-10108 | 2019/ETH00461,Sydney Local Health District | Sydney Local Health District,"[{""co2_concentration"": ""5%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,5%,,,,,,,,,,
UOCI002-A,35917601,UOCI002-A_m.json,35917601/UOCI002-A_m.json,"[{""cell_line_alt_name"": ""UOCI002-A"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,UOCI002-A,"[{""group"": ""University of Calgary""}]",University of Calgary,"[{""group"": ""Chad A. Bousman"", ""first_name"": ""Chad"", ""last_name"": ""Bousman"", ""name_initials"": ""A."", ""e_mail"": ""chad.bousman@ucalgary.ca"", ""phone_number"": ""None""}]",Bousman,Chad A. Bousman,chad.bousman@ucalgary.ca,,A.,Chad,"[{""doi"": ""10.1016/j.scr.2022.102877"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two human induced pluripotent stem cell lines from peripheral blood mononuclear cells of clozapine-tolerant and clozapine-induced myocarditis patients with treatment-resistant schizophrenia"", ""first_author"": ""Nazanin Vaziri"", ""last_author"": ""Chad A. Bousman"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Nazanin Vaziri,Generation of two human induced pluripotent stem cell lines from peripheral blood mononuclear cells of clozapine-tolerant and clozapine-induced myocarditis patients with treatment-resistant schizophrenia,Chad A. Bousman,Stem Cell Research,10.1016/j.scr.2022.102877,"[{""age"": ""36"", ""sex"": ""M"", ""disease_name"": ""Schizophrenia"", ""disease_description"": ""Clozapine-induced myocarditis""}, {""age"": ""34"", ""sex"": ""M"", ""disease_name"": ""Schizophrenia"", ""disease_description"": ""Clozapine-induced myocarditis""}]",Clozapine-induced myocarditis | Clozapine-induced myocarditis,M | M,Schizophrenia | Schizophrenia,36 | 34,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""Delivery of OCT4, SOX2, KLF4 and c-MYC transgenes"", ""genotype"": ""None"", ""loci_name"": ""None""}]",,,,"Delivery of OCT4, SOX2, KLF4 and c-MYC transgenes",Non-integrative Sendai virus delivery,,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""\u03b1-Fetoprotein; \u03b2-Tubulin; Smooth muscle actin"", ""method_used"": ""Embryoid body formation; Immunofluorescence"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""0"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Normal karyotype 46, XX""}]","46,XX",0,GB,"Normal karyotype 46, XX","[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2017"", ""non_int_vector"": ""SV"", ""non_int_vector_name"": ""None""}]",2017,,SV,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""RB1817994"", ""approval_date"": ""01/01/2017"", ""institutional_HREC"": ""Conjoint Health Research Ethics Board at the University of Calgary""}]",01/01/2017,RB1817994,Conjoint Health Research Ethics Board at the University of Calgary,"[{""co2_concentration"": ""10%"", ""o2_concentration"": ""21%"", ""passage_method"": ""None""}]",21%,,10%,EN,Embryoid body formation; Immunofluorescence,α-Fetoprotein; β-Tubulin; Smooth muscle actin,True,in vitro directed differentiation,,,,,
UOCI001-A,35917601,UOCI001-A_m.json,35917601/UOCI001-A_m.json,"[{""cell_line_alt_name"": ""UOCI001-A; UOCI002-A; CIMO01-A (UOCI001-AJ); CIMO02-A (UOCI002-A)"", ""cell_type"": ""hiPSC"", ""frozen"": ""True""}]",hiPSC,True,UOCI001-A; UOCI002-A; CIMO01-A (UOCI001-AJ); CIMO02-A (UOCI002-A),"[{""group"": ""University of Calgary""}]",University of Calgary,"[{""group"": ""Dr. Chad Bousman"", ""first_name"": ""Chad"", ""last_name"": ""Bousman"", ""name_initials"": ""A."", ""e_mail"": ""chad.bousman@ucalgary.ca"", ""phone_number"": ""None""}]",Bousman,Dr. Chad Bousman,chad.bousman@ucalgary.ca,,A.,Chad,"[{""doi"": ""10.1016/j.scr.2022.102877"", ""journal"": ""Stem Cell Research"", ""title"": ""Generation of two human induced pluripotent stem cell lines from peripheral blood mononuclear cells of clozapine-tolerant and clozapine-induced myocarditis patients with treatment-resistant schizophrenia"", ""first_author"": ""Nazanin Vaziri"", ""last_author"": ""Chad A. Bousman"", ""year"": ""2022"", ""pmid"": ""None""}]",2022,,Nazanin Vaziri,Generation of two human induced pluripotent stem cell lines from peripheral blood mononuclear cells of clozapine-tolerant and clozapine-induced myocarditis patients with treatment-resistant schizophrenia,Chad A. Bousman,Stem Cell Research,10.1016/j.scr.2022.102877,"[{""age"": ""36; 34"", ""sex"": ""M; M"", ""disease_name"": ""Schizophrenia; Clozapine-induced myocarditis"", ""disease_description"": ""nan""}]",nan,M; M,Schizophrenia; Clozapine-induced myocarditis,36; 34,"[{""mutation_type"": ""None"", ""cytoband"": ""None"", ""delivery_method"": ""Non-integrative Sendai virus delivery"", ""description"": ""N/A"", ""genotype"": ""N/A"", ""loci_name"": ""N/A""}]",,,N/A,N/A,Non-integrative Sendai virus delivery,N/A,"[{""cell_type"": ""EN"", ""show_potency"": ""True"", ""marker_list"": ""\u03b1-Fetoprotein; \u03b2-Tubulin; Smooth muscle actin"", ""method_used"": ""Embryoid body formation; Immunofluorescence"", ""differentiation_profile"": ""in vitro directed differentiation""}]","[{""epi_pluri_score"": ""None"", ""pluri_test_score"": ""None"", ""pluri_novelty_score"": ""None""}]",,,,"[{""passage_number"": ""9"", ""karyotype"": ""46,XX"", ""karyotype_method"": ""GB"", ""summary"": ""Normal karyotype 46, XX.""}]","46,XX",9,GB,"Normal karyotype 46, XX.","[{""i_source_cell_type_term"": ""peripheral blood mononuclear cell"", ""i_source_cell_origin_term"": ""blood"", ""derivation_year"": ""2017"", ""non_int_vector"": ""N/A"", ""non_int_vector_name"": ""N/A""}]",2017,N/A,N/A,blood,peripheral blood mononuclear cell,,"[{""ethics_number"": ""RBI17-1994"", ""approval_date"": ""01 Jun 2017"", ""institutional_HREC"": ""Conjoint Health Research Ethics Board at the University of Calgary""}]",01 Jun 2017,RBI17-1994,Conjoint Health Research Ethics Board at the University of Calgary,"[{""co2_concentration"": ""10%"", ""o2_concentration"": ""21%"", ""passage_method"": ""N/A""}]",21%,N/A,10%,EN,Embryoid body formation; Immunofluorescence,α-Fetoprotein; β-Tubulin; Smooth muscle actin,True,in vitro directed differentiation,,,,,
